BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews PW, Beighton G, Bello PA, Benvenisty N, Berry LS, Bevan S, Blum B, Brooking J, Chen KG, Choo AB, Churchill GA, Corbel M, Damjanov I, Draper JS, Dvorak P, Emanuelsson K, Fleck RA, Ford A, Gertow K, Gertsenstein M, Gokhale PJ, Hamilton RS, Hampl A, Healy LE, Hovatta O, Hyllner J, Imreh MP, Itskovitz-Eldor J, Jackson J, Johnson JL, Jones M, Kee K, King BL, Knowles BB, Lako M, Lebrin F, Mallon BS, Manning D, Mayshar Y, McKay RD, Michalska AE, Mikkola M, Mileikovsky M, Minger SL, Moore HD, Mummery CL, Nagy A, Nakatsuji N, O'Brien CM, Oh SK, Olsson C, Otonkoski T, Park KY, Passier R, Patel H, Patel M, Pedersen R, Pera MF, Piekarczyk MS, Pera RA, Reubinoff BE, Robins AJ, Rossant J, Rugg-Gunn P, Schulz TC, Semb H, Sherrer ES, Siemen H, Stacey GN, Stojkovic M, Suemori H, Szatkiewicz J, Turetsky T, Tuuri T, van den Brink S, Vintersten K, Vuoristo S, Ward D, Weaver TA, Young LA, Zhang W; International Stem Cell Initiative. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol 2007;25:803-16. [PMID: 17572666 DOI: 10.1038/nbt1318] [Cited by in Crossref: 776] [Cited by in F6Publishing: 645] [Article Influence: 55.4] [Reference Citation Analysis]
Number Citing Articles
1 P. De Miguel M, Fuentes-julián S, Alcaina Y. Pluripotent Stem Cells: Origin, Maintenance and Induction. Stem Cell Rev and Rep 2010;6:633-49. [DOI: 10.1007/s12015-010-9170-1] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
2 da Cruz L, Fynes K, Georgiadis O, Kerby J, Luo YH, Ahmado A, Vernon A, Daniels JT, Nommiste B, Hasan SM, Gooljar SB, Carr AF, Vugler A, Ramsden CM, Bictash M, Fenster M, Steer J, Harbinson T, Wilbrey A, Tufail A, Feng G, Whitlock M, Robson AG, Holder GE, Sagoo MS, Loudon PT, Whiting P, Coffey PJ. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. Nat Biotechnol 2018;36:328-37. [PMID: 29553577 DOI: 10.1038/nbt.4114] [Cited by in Crossref: 240] [Cited by in F6Publishing: 165] [Article Influence: 80.0] [Reference Citation Analysis]
3 Duggal G, Heindryckx B, Warrier S, O'Leary T, Van der Jeught M, Lierman S, Vossaert L, Deroo T, Deforce D, Chuva de Sousa Lopes SM, De Sutter P. Influence of activin A supplementation during human embryonic stem cell derivation on germ cell differentiation potential. Stem Cells Dev 2013;22:3141-55. [PMID: 23829223 DOI: 10.1089/scd.2013.0024] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
4 Shekari F, Han CL, Lee J, Mirzaei M, Gupta V, Haynes PA, Lee B, Baharvand H, Chen YJ, Hosseini Salekdeh G. Surface markers of human embryonic stem cells: a meta analysis of membrane proteomics reports. Expert Rev Proteomics 2018;15:911-22. [PMID: 30358457 DOI: 10.1080/14789450.2018.1539669] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
5 Wolfrum K, Wang Y, Prigione A, Sperling K, Lehrach H, Adjaye J. The LARGE principle of cellular reprogramming: lost, acquired and retained gene expression in foreskin and amniotic fluid-derived human iPS cells. PLoS One 2010;5:e13703. [PMID: 21060825 DOI: 10.1371/journal.pone.0013703] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 4.3] [Reference Citation Analysis]
6 Pistollato F, Bremer-Hoffmann S, Healy L, Young L, Stacey G. Standardization of pluripotent stem cell cultures for toxicity testing. Expert Opin Drug Metab Toxicol 2012;8:239-57. [PMID: 22248265 DOI: 10.1517/17425255.2012.639763] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
7 Asprer JS, Lakshmipathy U. Current methods and challenges in the comprehensive characterization of human pluripotent stem cells. Stem Cell Rev Rep 2015;11:357-72. [PMID: 25504379 DOI: 10.1007/s12015-014-9580-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
8 Van Hoof D, Muñoz J, Braam SR, Pinkse MW, Linding R, Heck AJ, Mummery CL, Krijgsveld J. Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell 2009;5:214-26. [PMID: 19664995 DOI: 10.1016/j.stem.2009.05.021] [Cited by in Crossref: 257] [Cited by in F6Publishing: 237] [Article Influence: 21.4] [Reference Citation Analysis]
9 Stroud H, Feng S, Morey Kinney S, Pradhan S, Jacobsen SE. 5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol 2011;12:R54. [PMID: 21689397 DOI: 10.1186/gb-2011-12-6-r54] [Cited by in Crossref: 328] [Cited by in F6Publishing: 280] [Article Influence: 32.8] [Reference Citation Analysis]
10 Dirks RAM, van Mierlo G, Kerstens HHD, Bernardo AS, Kobolák J, Bock I, Maruotti J, Pedersen RA, Dinnyés A, Huynen MA, Jouneau A, Marks H. Allele-specific RNA-seq expression profiling of imprinted genes in mouse isogenic pluripotent states. Epigenetics Chromatin 2019;12:14. [PMID: 30767785 DOI: 10.1186/s13072-019-0259-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
11 Fenno LE, Ptaszek LM, Cowan CA. Human embryonic stem cells: emerging technologies and practical applications. Current Opinion in Genetics & Development 2008;18:324-9. [DOI: 10.1016/j.gde.2008.06.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
12 Lensch MW, Schlaeger TM, Zon LI, Daley GQ. Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera. Cell Stem Cell 2007;1:253-8. [PMID: 18371359 DOI: 10.1016/j.stem.2007.07.019] [Cited by in Crossref: 102] [Cited by in F6Publishing: 82] [Article Influence: 7.3] [Reference Citation Analysis]
13 Liang Q, Monetti C, Shutova MV, Neely EJ, Hacibekiroglu S, Yang H, Kim C, Zhang P, Li C, Nagy K, Mileikovsky M, Gyongy I, Sung HK, Nagy A. Linking a cell-division gene and a suicide gene to define and improve cell therapy safety. Nature 2018;563:701-4. [PMID: 30429614 DOI: 10.1038/s41586-018-0733-7] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 17.3] [Reference Citation Analysis]
14 Holm F, Nikdin H, Kjartansdóttir KR, Gaudenzi G, Fried K, Aspenström P, Hermanson O, Bergström-tengzelius R. Passaging Techniques and ROCK Inhibitor Exert Reversible Effects on Morphology and Pluripotency Marker Gene Expression of Human Embryonic Stem Cell Lines. Stem Cells and Development 2013;22:1883-92. [DOI: 10.1089/scd.2012.0412] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
15 Tsugata T, Nikoh N, Kin T, Saitoh I, Noguchi Y, Ueki H, Watanabe M, James Shapiro AM, Noguchi H. Potential Factors for the Differentiation of ESCs/iPSCs Into Insulin-Producing Cells. Cell Med. 2014;7:83-93. [PMID: 26858897 DOI: 10.3727/215517914x685178] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
16 Flöttmann M, Scharp T, Klipp E. A stochastic model of epigenetic dynamics in somatic cell reprogramming. Front Physiol 2012;3:216. [PMID: 22754535 DOI: 10.3389/fphys.2012.00216] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
17 Lu J, Kong X, Luo C, Li KK. Application of epigenome-modifying small molecules in induced pluripotent stem cells. Med Res Rev 2013;33:790-822. [PMID: 22581616 DOI: 10.1002/med.21265] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
18 Beltrami AP, Cesselli D, Beltrami CA. Pluripotency rush! Molecular cues for pluripotency, genetic reprogramming of adult stem cells, and widely multipotent adult cells. Pharmacol Ther 2009;124:23-30. [PMID: 19545589 DOI: 10.1016/j.pharmthera.2009.06.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
19 Killian JK, Dorssers LC, Trabert B, Gillis AJ, Cook MB, Wang Y, Waterfall JJ, Stevenson H, Smith WI Jr, Noyes N, Retnakumar P, Stoop JH, Oosterhuis JW, Meltzer PS, McGlynn KA, Looijenga LH. Imprints and DPPA3 are bypassed during pluripotency- and differentiation-coupled methylation reprogramming in testicular germ cell tumors. Genome Res 2016;26:1490-504. [PMID: 27803193 DOI: 10.1101/gr.201293.115] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 6.4] [Reference Citation Analysis]
20 Papamichos SI, Kotoula V, Tarlatzis BC, Agorastos T, Papazisis K, Lambropoulos AF. OCT4B1 isoform: the novel OCT4 alternative spliced variant as a putative marker of stemness. Molecular Human Reproduction 2009;15:269-70. [DOI: 10.1093/molehr/gap018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
21 Kolle G, Ho M, Zhou Q, Chy HS, Krishnan K, Cloonan N, Bertoncello I, Laslett AL, Grimmond SM. Identification of human embryonic stem cell surface markers by combined membrane-polysome translation state array analysis and immunotranscriptional profiling. Stem Cells. 2009;27:2446-2456. [PMID: 19650036 DOI: 10.1002/stem.182] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 5.1] [Reference Citation Analysis]
22 Stacey GN. Cell culture contamination. Methods Mol Biol 2011;731:79-91. [PMID: 21516399 DOI: 10.1007/978-1-61779-080-5_7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
23 Bjørlykke Y, Søviknes AM, Hoareau L, Vethe H, Mathisen AF, Chera S, Vaudel M, Ghila LM, Ræder H. Reprogrammed Cells Display Distinct Proteomic Signatures Associated with Colony Morphology Variability. Stem Cells Int 2019;2019:8036035. [PMID: 31827534 DOI: 10.1155/2019/8036035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Scott CT, Reijo Pera RA. The road to pluripotence: the research response to the embryonic stem cell debate. Hum Mol Genet 2008;17:R3-9. [PMID: 18632694 DOI: 10.1093/hmg/ddn074] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
25 Ng AHM, Khoshakhlagh P, Rojo Arias JE, Pasquini G, Wang K, Swiersy A, Shipman SL, Appleton E, Kiaee K, Kohman RE, Vernet A, Dysart M, Leeper K, Saylor W, Huang JY, Graveline A, Taipale J, Hill DE, Vidal M, Melero-Martin JM, Busskamp V, Church GM. A comprehensive library of human transcription factors for cell fate engineering. Nat Biotechnol 2021;39:510-9. [PMID: 33257861 DOI: 10.1038/s41587-020-0742-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 17.0] [Reference Citation Analysis]
26 Chung IH, Yamaza T, Zhao H, Choung PH, Shi S, Chai Y. Stem cell property of postmigratory cranial neural crest cells and their utility in alveolar bone regeneration and tooth development. Stem Cells 2009;27:866-77. [PMID: 19350689 DOI: 10.1002/stem.2] [Cited by in Crossref: 76] [Cited by in F6Publishing: 62] [Article Influence: 6.3] [Reference Citation Analysis]
27 Schuster J, Halvardson J, Pilar Lorenzo L, Ameur A, Sobol M, Raykova D, Annerén G, Feuk L, Dahl N. Transcriptome Profiling Reveals Degree of Variability in Induced Pluripotent Stem Cell Lines: Impact for Human Disease Modeling. Cell Reprogram 2015;17:327-37. [PMID: 26348590 DOI: 10.1089/cell.2015.0009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
28 Liu W, Sun X. Skewed X chromosome inactivation in diploid and triploid female human embryonic stem cells. Human Reproduction 2009;24:1834-43. [DOI: 10.1093/humrep/dep126] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
29 Inamdar MS, Venu P, Srinivas M, Rao K, Vijayraghavan K. Derivation and Characterization of Two Sibling Human Embryonic Stem Cell Lines From Discarded Grade III Embryos. Stem Cells and Development 2009;18:423-34. [DOI: 10.1089/scd.2008.0131] [Cited by in Crossref: 35] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
30 Healy LE, Ludwig TE, Choo A. International banking: checks, deposits, and withdrawals. Cell Stem Cell 2008;2:305-6. [PMID: 18397749 DOI: 10.1016/j.stem.2008.03.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
31 Barbaric I, Jones M, Buchner K, Baker D, Andrews PW, Moore HD. Pinacidil enhances survival of cryopreserved human embryonic stem cells. Cryobiology 2011;63:298-305. [PMID: 22027383 DOI: 10.1016/j.cryobiol.2011.10.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
32 Chen KG, Mallon BS, Hamilton RS, Kozhich OA, Park K, Hoeppner DJ, Robey PG, McKay RD. Non-colony type monolayer culture of human embryonic stem cells. Stem Cell Res 2012;9:237-48. [PMID: 22910561 DOI: 10.1016/j.scr.2012.06.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
33 Miyoshi N, Ishii H, Sekimoto M, Haraguchi N, Doki Y, Mori M. Properties and identification of cancer stem cells: A changing insight into intractable cancer. Surg Today 2010;40:608-13. [DOI: 10.1007/s00595-009-4106-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
34 Fong C, Gauthaman K, Bongso A. Teratomas from pluripotent stem cells: A clinical hurdle. J Cell Biochem 2010;111:769-81. [DOI: 10.1002/jcb.22775] [Cited by in Crossref: 144] [Cited by in F6Publishing: 120] [Article Influence: 13.1] [Reference Citation Analysis]
35 Borstlap J, Stacey G, Kurtz A, Elstner A, Damaschun A, Arán B, Veiga A. First evaluation of the European hESCreg. Nat Biotechnol 2008;26:859-60. [DOI: 10.1038/nbt0808-859] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
36 Gray PC, Vale W. Cripto/GRP78 modulation of the TGF-β pathway in development and oncogenesis. FEBS Lett 2012;586:1836-45. [PMID: 22306319 DOI: 10.1016/j.febslet.2012.01.051] [Cited by in Crossref: 66] [Cited by in F6Publishing: 53] [Article Influence: 7.3] [Reference Citation Analysis]
37 Pennington BO, Clegg DO, Melkoumian ZK, Hikita ST. Defined culture of human embryonic stem cells and xeno-free derivation of retinal pigmented epithelial cells on a novel, synthetic substrate. Stem Cells Transl Med 2015;4:165-77. [PMID: 25593208 DOI: 10.5966/sctm.2014-0179] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
38 Földes G, Harding SE, Ali NN. Cardiomyocytes from embryonic stem cells: towards human therapy. Expert Opinion on Biological Therapy 2008;8:1473-83. [DOI: 10.1517/14712598.8.10.1473] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
39 Hovatta O, Rodin S, Antonsson L, Tryggvason K. Concise review: animal substance-free human embryonic stem cells aiming at clinical applications. Stem Cells Transl Med 2014;3:1269-74. [PMID: 25298372 DOI: 10.5966/sctm.2014-0129] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
40 Marolt D, Knezevic M, Novakovic GV. Bone tissue engineering with human stem cells. Stem Cell Res Ther. 2010;1:10. [PMID: 20637059 DOI: 10.1186/scrt10] [Cited by in Crossref: 121] [Cited by in F6Publishing: 98] [Article Influence: 11.0] [Reference Citation Analysis]
41 Kawabe K, Tateyama D, Toyoda H, Kawasaki N, Hashii N, Nakao H, Matsumoto S, Nonaka M, Matsumura H, Hirose Y, Morita A, Katayama M, Sakuma M, Kawasaki N, Furue MK, Kawasaki T. A novel antibody for human induced pluripotent stem cells and embryonic stem cells recognizes a type of keratan sulfate lacking oversulfated structures. Glycobiology 2013;23:322-36. [PMID: 23154990 DOI: 10.1093/glycob/cws159] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
42 Gundry RL, Boheler KR, Van Eyk JE, Wollscheid B. A novel role for proteomics in the discovery of cell-surface markers on stem cells: Scratching the surface. Proteomics Clin Appl 2008;2:892-903. [PMID: 19526049 DOI: 10.1002/prca.200780122] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
43 Hug K. Banks, repositories and registries of stem cell lines in Europe: regulatory and ethical aspects. Stem Cell Rev Rep 2009;5:18-35. [PMID: 19205929 DOI: 10.1007/s12015-009-9053-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
44 Yu RK, Itokazu Y. Glycolipid and Glycoprotein Expression During Neural Development. In: Yu RK, Schengrund C, editors. Glycobiology of the Nervous System. New York: Springer; 2014. pp. 185-222. [DOI: 10.1007/978-1-4939-1154-7_9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
45 Conway AE, Lindgren A, Galic Z, Pyle AD, Wu H, Zack JA, Pelligrini M, Teitell MA, Clark AT. A self-renewal program controls the expansion of genetically unstable cancer stem cells in pluripotent stem cell-derived tumors. Stem Cells 2009;27:18-28. [PMID: 19224508 DOI: 10.1634/stemcells.2008-0529] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
46 Kaufman DS. Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. Blood. 2009;114:3513-3523. [PMID: 19652198 DOI: 10.1182/blood-2009-03-191304] [Cited by in Crossref: 114] [Cited by in F6Publishing: 96] [Article Influence: 9.5] [Reference Citation Analysis]
47 Brafman DA, Shah KD, Fellner T, Chien S, Willert K. Defining long-term maintenance conditions of human embryonic stem cells with arrayed cellular microenvironment technology. Stem Cells Dev. 2009;18:1141-1154. [PMID: 19327010 DOI: 10.1089/scd.2008.0410] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
48 Yilmaz A, Benvenisty N. Defining Human Pluripotency. Cell Stem Cell 2019;25:9-22. [PMID: 31271751 DOI: 10.1016/j.stem.2019.06.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 24.0] [Reference Citation Analysis]
49 Ben-David U, Kopper O, Benvenisty N. Expanding the boundaries of embryonic stem cells. Cell Stem Cell. 2012;10:666-677. [PMID: 22704506 DOI: 10.1016/j.stem.2012.05.003] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
50 Santos J, Pereira CF, Di-Gregorio A, Spruce T, Alder O, Rodriguez T, Azuara V, Merkenschlager M, Fisher AG. Differences in the epigenetic and reprogramming properties of pluripotent and extra-embryonic stem cells implicate chromatin remodelling as an important early event in the developing mouse embryo. Epigenetics Chromatin 2010;3:1. [PMID: 20157423 DOI: 10.1186/1756-8935-3-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
51 Isasi R. Stem Cell Research and Banking: Towards Policy on Disclosing Research Results and Incidental Findings. In: Ilic D, editor. Stem Cell Banking. New York: Springer; 2014. pp. 29-40. [DOI: 10.1007/978-1-4939-0585-0_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
52 Ye L, Zhang S, Greder L, Dutton J, Keirstead SA, Lepley M, Zhang L, Kaufman D, Zhang J. Effective cardiac myocyte differentiation of human induced pluripotent stem cells requires VEGF. PLoS One 2013;8:e53764. [PMID: 23326500 DOI: 10.1371/journal.pone.0053764] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 5.5] [Reference Citation Analysis]
53 Ringe J, Leinhase I, Stich S, Loch A, Neumann K, Haisch A, Häupl T, Manz R, Kaps C, Sittinger M. Human mastoid periosteum-derived stem cells: promising candidates for skeletal tissue engineering. J Tissue Eng Regen Med 2008;2:136-46. [PMID: 18383554 DOI: 10.1002/term.75] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
54 Yang CH, Wang HL, Lin YS, Kumar KP, Lin HC, Chang CJ, Lu CC, Huang TT, Martel J, Ojcius DM. Identification of CD24 as a cancer stem cell marker in human nasopharyngeal carcinoma. PLoS One. 2014;9:e99412. [PMID: 24955581 DOI: 10.1371/journal.pone.0099412] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
55 Choi M, Park HH, Choi D, Han U, Park TH, Lee H, Park J, Hong J. Multilayer Nanofilms via Inkjet Printing for Stabilizing Growth Factor and Designing Desired Cell Developments. Adv Healthc Mater 2017;6. [PMID: 28436215 DOI: 10.1002/adhm.201700216] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
56 Fernandes AM, Meletti T, Guimarães R, Stelling MP, Marinho PAN, Valladão AS, Rehen SK. Worldwide Survey of Published Procedures to Culture Human Embryonic Stem Cells. Cell Transplant 2010;19:509-23. [DOI: 10.3727/096368909x485067] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
57 Andrews PW. Toward safer regenerative medicine. Nat Biotechnol 2011;29:803-5. [PMID: 21904323 DOI: 10.1038/nbt.1974] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
58 Ron-Bigger S, Bar-Nur O, Isaac S, Bocker M, Lyko F, Eden A. Aberrant epigenetic silencing of tumor suppressor genes is reversed by direct reprogramming. Stem Cells 2010;28:1349-54. [PMID: 20572015 DOI: 10.1002/stem.468] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
59 Gavrilov S, Marolt D, Douglas NC, Prosser RW, Khalid I, Sauer MV, Landry DW, Vunjak-Novakovic G, Papaioannou VE. Derivation of two new human embryonic stem cell lines from nonviable human embryos. Stem Cells Int 2011;2011:765378. [PMID: 21716665 DOI: 10.4061/2011/765378] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
60 Ausubel LJ, Lopez PM, Couture LA. GMP scale-up and banking of pluripotent stem cells for cellular therapy applications. Methods Mol Biol. 2011;767:147-159. [PMID: 21822873 DOI: 10.1007/978-1-61779-201-4_11] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
61 Assou S, Cerecedo D, Tondeur S, Pantesco V, Hovatta O, Klein B, Hamamah S, De Vos J. A gene expression signature shared by human mature oocytes and embryonic stem cells. BMC Genomics 2009;10:10. [PMID: 19128516 DOI: 10.1186/1471-2164-10-10] [Cited by in Crossref: 87] [Cited by in F6Publishing: 82] [Article Influence: 7.3] [Reference Citation Analysis]
62 Gossett DR, Tse HT, Lee SA, Ying Y, Lindgren AG, Yang OO, Rao J, Clark AT, Di Carlo D. Hydrodynamic stretching of single cells for large population mechanical phenotyping. Proc Natl Acad Sci U S A 2012;109:7630-5. [PMID: 22547795 DOI: 10.1073/pnas.1200107109] [Cited by in Crossref: 491] [Cited by in F6Publishing: 335] [Article Influence: 54.6] [Reference Citation Analysis]
63 Stacey GN, Coecke S, Price A, Healy L, Jennings P, Wilmes A, Pinset C, Ingelman-sundberg M, Louisse J, Haupt S, Kidd D, Robitski A, Jahnke H, Lemaitre G, Myatt G. Ensuring the Quality of Stem Cell-Derived In Vitro Models for Toxicity Testing. In: Eskes C, Whelan M, editors. Validation of Alternative Methods for Toxicity Testing. Cham: Springer International Publishing; 2016. pp. 259-97. [DOI: 10.1007/978-3-319-33826-2_11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
64 Kučírek M, Bagherpoor AJ, Jaroš J, Hampl A, Štros M. HMGB2 is a negative regulator of telomerase activity in human embryonic stem and progenitor cells. FASEB J 2019;33:14307-24. [PMID: 31661640 DOI: 10.1096/fj.201901465RRR] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
65 Stachelscheid H, Wulf-Goldenberg A, Eckert K, Jensen J, Edsbagge J, Björquist P, Rivero M, Strehl R, Jozefczuk J, Prigione A, Adjaye J, Urbaniak T, Bussmann P, Zeilinger K, Gerlach JC. Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors. J Tissue Eng Regen Med 2013;7:729-41. [PMID: 22438087 DOI: 10.1002/term.1467] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
66 Lambshead JW, Meagher L, O’Brien C, Laslett AL. Defining synthetic surfaces for human pluripotent stem cell culture. Cell Regen (Lond). 2013;2:7. [PMID: 25408879 DOI: 10.1186/2045-9769-2-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
67 Kim JH, Alderton A, Crook JM, Benvenisty N, Brandsten C, Firpo M, Harrison PW, Kawamata S, Kawase E, Kurtz A, Loring JF, Ludwig T, Man J, Mountford JC, Turner ML, Oh S, da Veiga Pereira L, Pranke P, Sheldon M, Steeg R, Sullivan S, Yaffe M, Zhou Q, Stacey GN. A Report from a Workshop of the International Stem Cell Banking Initiative, Held in Collaboration of Global Alliance for iPSC Therapies and the Harvard Stem Cell Institute, Boston, 2017. Stem Cells 2019;37:1130-5. [PMID: 31021472 DOI: 10.1002/stem.3003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
68 Lund RJ, Närvä E, Lahesmaa R. Genetic and epigenetic stability of human pluripotent stem cells. Nat Rev Genet 2012;13:732-44. [PMID: 22965355 DOI: 10.1038/nrg3271] [Cited by in Crossref: 160] [Cited by in F6Publishing: 131] [Article Influence: 17.8] [Reference Citation Analysis]
69 Dziedzicka D, Tewary M, Keller A, Tilleman L, Prochazka L, Östblom J, Couvreu De Deckersberg E, Markouli C, Franck S, Van Nieuwerburgh F, Spits C, Zandstra PW, Sermon K, Geens M. Endogenous suppression of WNT signalling in human embryonic stem cells leads to low differentiation propensity towards definitive endoderm. Sci Rep 2021;11:6137. [PMID: 33731744 DOI: 10.1038/s41598-021-85447-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
70 Virant-Klun I, Stimpfel M, Cvjeticanin B, Vrtacnik-Bokal E, Skutella T. Small SSEA-4-positive cells from human ovarian cell cultures: related to embryonic stem cells and germinal lineage? J Ovarian Res. 2013;6:24. [PMID: 23570331 DOI: 10.1186/1757-2215-6-24] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
71 Kakarala M, Wicha MS. Cancer stem cells: implications for cancer treatment and prevention. Cancer J. 2007;13:271-275. [PMID: 17921723 DOI: 10.1097/PPO.0b013e318156da4e] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
72 Zhang X, Yalcin S, Lee DF, Yeh TY, Lee SM, Su J, Mungamuri SK, Rimmelé P, Kennedy M, Sellers R, Landthaler M, Tuschl T, Chi NW, Lemischka I, Keller G, Ghaffari S. FOXO1 is an essential regulator of pluripotency in human embryonic stem cells. Nat Cell Biol 2011;13:1092-9. [PMID: 21804543 DOI: 10.1038/ncb2293] [Cited by in Crossref: 166] [Cited by in F6Publishing: 143] [Article Influence: 16.6] [Reference Citation Analysis]
73 Oh S, Choo A. Stem Cells. Comprehensive Biotechnology. Elsevier; 2011. pp. 341-65. [DOI: 10.1016/b978-0-08-088504-9.00038-6] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
74 Wagner W, Ho AD. Mesenchymal stem cell preparations--comparing apples and oranges. Stem Cell Rev. 2007;3:239-248. [PMID: 18074246 DOI: 10.1007/s12015-007-9001-1] [Cited by in Crossref: 191] [Cited by in F6Publishing: 182] [Article Influence: 14.7] [Reference Citation Analysis]
75 Jelinkova S, Fojtik P, Kohutova A, Vilotic A, Marková L, Pesl M, Jurakova T, Kruta M, Vrbsky J, Gaillyova R, Valášková I, Frák I, Lacampagne A, Forte G, Dvorak P, Meli AC, Rotrekl V. Dystrophin Deficiency Leads to Genomic Instability in Human Pluripotent Stem Cells via NO Synthase-Induced Oxidative Stress. Cells 2019;8:E53. [PMID: 30650618 DOI: 10.3390/cells8010053] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
76 French A, Bravery C, Smith J, Chandra A, Archibald P, Gold JD, Artzi N, Kim HW, Barker RW, Meissner A, Wu JC, Knowles JC, Williams D, García-Cardeña G, Sipp D, Oh S, Loring JF, Rao MS, Reeve B, Wall I, Carr AJ, Bure K, Stacey G, Karp JM, Snyder EY, Brindley DA. Enabling consistency in pluripotent stem cell-derived products for research and development and clinical applications through material standards. Stem Cells Transl Med 2015;4:217-23. [PMID: 25650438 DOI: 10.5966/sctm.2014-0233] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
77 Fukusumi H, Shofuda T, Bamba Y, Yamamoto A, Kanematsu D, Handa Y, Okita K, Nakamura M, Yamanaka S, Okano H, Kanemura Y. Establishment of Human Neural Progenitor Cells from Human Induced Pluripotent Stem Cells with Diverse Tissue Origins. Stem Cells Int 2016;2016:7235757. [PMID: 27212953 DOI: 10.1155/2016/7235757] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
78 Ghodsizadeh A, Taei A, Totonchi M, Seifinejad A, Gourabi H, Pournasr B, Aghdami N, Malekzadeh R, Almadani N, Salekdeh GH. Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells. Stem Cell Rev. 2010;6:622-632. [PMID: 20821352 DOI: 10.1007/s12015-010-9189-3.] [Reference Citation Analysis]
79 Burns AJ, Goldstein AM, Newgreen DF, Stamp L, Schäfer KH, Metzger M, Hotta R, Young HM, Andrews PW, Thapar N, Belkind-Gerson J, Bondurand N, Bornstein JC, Chan WY, Cheah K, Gershon MD, Heuckeroth RO, Hofstra RM, Just L, Kapur RP, King SK, McCann CJ, Nagy N, Ngan E, Obermayr F, Pachnis V, Pasricha PJ, Sham MH, Tam P, Vanden Berghe P. White paper on guidelines concerning enteric nervous system stem cell therapy for enteric neuropathies. Dev Biol 2016;417:229-51. [PMID: 27059883 DOI: 10.1016/j.ydbio.2016.04.001] [Cited by in Crossref: 70] [Cited by in F6Publishing: 47] [Article Influence: 14.0] [Reference Citation Analysis]
80 Awan A, Oliveri RS, Jensen PL, Christensen ST, Andersen CY. Immunoflourescence and mRNA analysis of human embryonic stem cells (hESCs) grown under feeder-free conditions. Methods Mol Biol 2010;584:195-210. [PMID: 19907979 DOI: 10.1007/978-1-60761-369-5_11] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
81 Hawkins PG, Morris KV. Transcriptional regulation of Oct4 by a long non-coding RNA antisense to Oct4-pseudogene 5. Transcription 2010;1:165-75. [PMID: 21151833 DOI: 10.4161/trns.1.3.13332] [Cited by in Crossref: 148] [Cited by in F6Publishing: 127] [Article Influence: 13.5] [Reference Citation Analysis]
82 Harkness L, Chen X, Gillard M, Gray PP, Davies AM. Media composition modulates human embryonic stem cell morphology and may influence preferential lineage differentiation potential. PLoS One 2019;14:e0213678. [PMID: 30889226 DOI: 10.1371/journal.pone.0213678] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
83 Van Hoof D, Heck AJ, Krijgsveld J, Mummery CL. Proteomics and human embryonic stem cells. Stem Cell Res 2008;1:169-82. [PMID: 19383398 DOI: 10.1016/j.scr.2008.05.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
84 Liu LP, Zheng YW. Predicting differentiation potential of human pluripotent stem cells: Possibilities and challenges. World J Stem Cells. 2019;11:375-382. [PMID: 31396366 DOI: 10.4252/wjsc.v11.i7.375] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
85 Ghodsizadeh A, Taei A, Totonchi M, Seifinejad A, Gourabi H, Pournasr B, Aghdami N, Malekzadeh R, Almadani N, Salekdeh GH. Generation of liver disease-specific induced pluripotent stem cells along with efficient differentiation to functional hepatocyte-like cells. Stem Cell Rev. 2010;6:622-632. [PMID: 20821352 DOI: 10.1007/s12015-010-9189-3] [Cited by in Crossref: 118] [Cited by in F6Publishing: 89] [Article Influence: 11.8] [Reference Citation Analysis]
86 International Stem Cell Banking Initiative. Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev Rep 2009;5:301-14. [PMID: 20016957 DOI: 10.1007/s12015-009-9085-x] [Cited by in Crossref: 106] [Cited by in F6Publishing: 78] [Article Influence: 9.6] [Reference Citation Analysis]
87 Miranda-Sayago JM, Fernandez-Arcas N, Reyes-Engel A, Benito C, Narbona I, Alonso A. Changes in CDKN2D , TP53, and miR125a expression: potential role in the evaluation of human amniotic fluid-derived mesenchymal stromal cell fitness. Genes Cells 2012;17:673-87. [PMID: 22747700 DOI: 10.1111/j.1365-2443.2012.01623.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
88 Jelinkova S, Vilotic A, Pribyl J, Aimond F, Salykin A, Acimovic I, Pesl M, Caluori G, Klimovic S, Urban T, Dobrovolna H, Soska V, Skladal P, Lacampagne A, Dvorak P, Meli AC, Rotrekl V. DMD Pluripotent Stem Cell Derived Cardiac Cells Recapitulate in vitro Human Cardiac Pathophysiology. Front Bioeng Biotechnol 2020;8:535. [PMID: 32656189 DOI: 10.3389/fbioe.2020.00535] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
89 Yoo DH, Im YS, Jo EH, Kim BY, Jo HY, Park MH, Koo SK, Kim YO. Simple differentiation method using FBS identifies DUSP6 as a marker for fine-tuning of FGF-ERK signaling activity in human pluripotent stem cells. Biochem Biophys Res Commun 2020;521:375-82. [PMID: 31668921 DOI: 10.1016/j.bbrc.2019.10.081] [Reference Citation Analysis]
90 Guo J, Wu B, Li S, Bao S, Zhao L, Hu S, Sun W, Su J, Dai Y, Li X. Contribution of Mouse Embryonic Stem Cells and Induced Pluripotent Stem Cells to Chimeras through Injection and Coculture of Embryos. Stem Cells Int. 2014;2014:409021. [PMID: 25610470 DOI: 10.1155/2014/409021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
91 Ben-Yehudah A, Easley CA 4th, Hermann BP, Castro C, Simerly C, Orwig KE, Mitalipov S, Schatten G. Systems biology discoveries using non-human primate pluripotent stem and germ cells: novel gene and genomic imprinting interactions as well as unique expression patterns. Stem Cell Res Ther 2010;1:24. [PMID: 20699013 DOI: 10.1186/scrt24] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
92 Pekkanen-Mattila M, Pelto-Huikko M, Kujala V, Suuronen R, Skottman H, Aalto-Setälä K, Kerkelä E. Spatial and temporal expression pattern of germ layer markers during human embryonic stem cell differentiation in embryoid bodies. Histochem Cell Biol 2010;133:595-606. [PMID: 20369364 DOI: 10.1007/s00418-010-0689-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
93 Valletta E, Kučera L, Prokeš L, Amato F, Pivetta T, Hampl A, Havel J, Vaňhara P. Multivariate Calibration Approach for Quantitative Determination of Cell-Line Cross Contamination by Intact Cell Mass Spectrometry and Artificial Neural Networks. PLoS One 2016;11:e0147414. [PMID: 26821236 DOI: 10.1371/journal.pone.0147414] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
94 Brill LM, Xiong W, Lee KB, Ficarro SB, Crain A, Xu Y, Terskikh A, Snyder EY, Ding S. Phosphoproteomic analysis of human embryonic stem cells. Cell Stem Cell 2009;5:204-13. [PMID: 19664994 DOI: 10.1016/j.stem.2009.06.002] [Cited by in Crossref: 150] [Cited by in F6Publishing: 142] [Article Influence: 12.5] [Reference Citation Analysis]
95 Oskarsson T, Acharyya S, Zhang XH, Vanharanta S, Tavazoie SF, Morris PG, Downey RJ, Manova-Todorova K, Brogi E, Massagué J. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med. 2011;17:867-874. [PMID: 21706029 DOI: 10.1038/nm.2379] [Cited by in Crossref: 562] [Cited by in F6Publishing: 494] [Article Influence: 56.2] [Reference Citation Analysis]
96 Lin SA, Kolle G, Grimmond SM, Zhou Q, Doust E, Little MH, Aronow B, Ricardo SD, Pera MF, Bertram JF, Laslett AL. Subfractionation of differentiating human embryonic stem cell populations allows the isolation of a mesodermal population enriched for intermediate mesoderm and putative renal progenitors. Stem Cells Dev 2010;19:1637-48. [PMID: 20143954 DOI: 10.1089/scd.2010.0017] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 4.2] [Reference Citation Analysis]
97 Holubcová Z, Matula P, Sedláčková M, Vinarský V, Doležalová D, Bárta T, Dvořák P, Hampl A. Human embryonic stem cells suffer from centrosomal amplification. Stem Cells 2011;29:46-56. [PMID: 20960514 DOI: 10.1002/stem.549] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
98 Ahn S, Goode RJA, Simpson RJ. Stem cell markers: Insights from membrane proteomics? Proteomics 2008;8:4946-57. [DOI: 10.1002/pmic.200800312] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
99 Nakano-Okuno M, Borah BR, Nakano I. Ethics of iPSC-based clinical research for age-related macular degeneration: patient-centered risk-benefit analysis. Stem Cell Rev Rep 2014;10:743-52. [PMID: 24974102 DOI: 10.1007/s12015-014-9536-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
100 Lifantseva N, Koltsova A, Krylova T, Yakovleva T, Poljanskaya G, Gordeeva O. Expression patterns of cancer-testis antigens in human embryonic stem cells and their cell derivatives indicate lineage tracks. Stem Cells Int 2011;2011:795239. [PMID: 21785609 DOI: 10.4061/2011/795239] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.0] [Reference Citation Analysis]
101 Boroviak T, Loos R, Lombard P, Okahara J, Behr R, Sasaki E, Nichols J, Smith A, Bertone P. Lineage-Specific Profiling Delineates the Emergence and Progression of Naive Pluripotency in Mammalian Embryogenesis. Dev Cell 2015;35:366-82. [PMID: 26555056 DOI: 10.1016/j.devcel.2015.10.011] [Cited by in Crossref: 252] [Cited by in F6Publishing: 177] [Article Influence: 50.4] [Reference Citation Analysis]
102 Kollár P, Bárta T, Závalová V, Smejkal K, Hampl A. Geranylated flavanone tomentodiplacone B inhibits proliferation of human monocytic leukaemia (THP-1) cells. Br J Pharmacol 2011;162:1534-41. [PMID: 21175584 DOI: 10.1111/j.1476-5381.2010.01171.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
103 Martí M, Mulero L, Pardo C, Morera C, Carrió M, Laricchia-Robbio L, Esteban CR, Izpisua Belmonte JC. Characterization of pluripotent stem cells. Nat Protoc. 2013;8:223-253. [PMID: 23306458 DOI: 10.1038/nprot.2012.154] [Cited by in Crossref: 102] [Cited by in F6Publishing: 70] [Article Influence: 12.8] [Reference Citation Analysis]
104 Galán A, Montaner D, Póo ME, Valbuena D, Ruiz V, Aguilar C, Dopazo J, Simón C. Functional genomics of 5- to 8-cell stage human embryos by blastomere single-cell cDNA analysis. PLoS One 2010;5:e13615. [PMID: 21049019 DOI: 10.1371/journal.pone.0013615] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
105 Cedervall J, Gertow K, Damjanov I, Ährlund-richter L. Characterization of Human Pluripotent Stem Cell-Derived Teratomas. Human Stem Cell Manual. Elsevier; 2012. pp. 345-59. [DOI: 10.1016/b978-0-12-385473-5.00022-9] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
106 Lim J, Kim J, Kang J, Jo D. Partial somatic to stem cell transformations induced by cell-permeable reprogramming factors. Sci Rep 2014;4:4361. [PMID: 24618595 DOI: 10.1038/srep04361] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
107 Barbaric I, Jones M, Harley DJ, Gokhale PJ, Andrews PW. High-Content Screening for Chemical Modulators of Embryonal Carcinoma Cell Differentiation and Survival. J Biomol Screen 2011;16:603-17. [DOI: 10.1177/1087057111406547] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
108 Busletta C, Novo E, Parola M. Human-induced pluripotent stem cells as a source of hepatocyte-like cells: new kids on the block. Hepatol Int 2013;7:299-305. [DOI: 10.1007/s12072-011-9300-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
109 Xie P, Ouyang Q, Leng L, Hu L, Cheng D, Tan Y, Lu G, Lin G. The dynamic changes of X chromosome inactivation during early culture of human embryonic stem cells. Stem Cell Research 2016;17:84-92. [DOI: 10.1016/j.scr.2016.05.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
110 Hughes CS, Nuhn AA, Postovit LM, Lajoie GA. Proteomics of human embryonic stem cells. Proteomics 2011;11:675-90. [DOI: 10.1002/pmic.201000407] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
111 Kjartansdóttir KR, Reda A, Panula S, Day K, Hultenby K, Söder O, Hovatta O, Stukenborg JB. A Combination of Culture Conditions and Gene Expression Analysis Can Be Used to Investigate and Predict hES Cell Differentiation Potential towards Male Gonadal Cells. PLoS One 2015;10:e0144029. [PMID: 26630562 DOI: 10.1371/journal.pone.0144029] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
112 Wang H, Zhang K, Liu Y, Fu Y, Gao S, Gong P, Wang H, Zhou Z, Zeng M, Wu Z, Sun Y, Chen T, Li S, Liu L. Telomere heterogeneity linked to metabolism and pluripotency state revealed by simultaneous analysis of telomere length and RNA-seq in the same human embryonic stem cell. BMC Biol 2017;15:114. [PMID: 29216888 DOI: 10.1186/s12915-017-0453-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
113 Alaminos M, Pérez-Köhler B, Garzón I, García-Honduvilla N, Romero B, Campos A, Buján J. Transdifferentiation potentiality of human Wharton's jelly stem cells towards vascular endothelial cells. J Cell Physiol 2010;223:640-7. [PMID: 20143331 DOI: 10.1002/jcp.22062] [Cited by in Crossref: 3] [Cited by in F6Publishing: 17] [Article Influence: 0.3] [Reference Citation Analysis]
114 Kojima J, Fukuda A, Taira H, Kawasaki T, Ito H, Kuji N, Isaka K, Umezawa A, Akutsu H. Efficient production of trophoblast lineage cells from human induced pluripotent stem cells. Lab Invest 2017;97:1188-200. [PMID: 28287635 DOI: 10.1038/labinvest.2016.159] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
115 Bohaciakova D, Renzova T, Fedorova V, Barak M, Kunova Bosakova M, Hampl A, Cajanek L. An Efficient Method for Generation of Knockout Human Embryonic Stem Cells Using CRISPR/Cas9 System. Stem Cells Dev 2017;26:1521-7. [PMID: 28835165 DOI: 10.1089/scd.2017.0058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
116 Esch MB, Smith AS, Prot JM, Oleaga C, Hickman JJ, Shuler ML. How multi-organ microdevices can help foster drug development. Adv Drug Deliv Rev 2014;69-70:158-69. [PMID: 24412641 DOI: 10.1016/j.addr.2013.12.003] [Cited by in Crossref: 114] [Cited by in F6Publishing: 94] [Article Influence: 16.3] [Reference Citation Analysis]
117 Yu L, Li J, Hong J, Takashima Y, Fujimoto N, Nakajima M, Yamamoto A, Dong X, Dang Y, Hou Y, Yang W, Minami I, Okita K, Tanaka M, Luo C, Tang F, Chen Y, Tang C, Kotera H, Liu L. Low Cell-Matrix Adhesion Reveals Two Subtypes of Human Pluripotent Stem Cells. Stem Cell Reports 2018;11:142-56. [PMID: 30008324 DOI: 10.1016/j.stemcr.2018.06.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
118 Jukes J, Both S, Post J, Blitterswijk CV, Karperien M, Boer JD. Stem cells. Tissue Engineering. Elsevier; 2008. pp. 1-26. [DOI: 10.1016/b978-0-12-370869-4.00001-x] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
119 Pera MF, Tam PP. Extrinsic regulation of pluripotent stem cells. Nature 2010;465:713-20. [PMID: 20535200 DOI: 10.1038/nature09228] [Cited by in Crossref: 210] [Cited by in F6Publishing: 184] [Article Influence: 19.1] [Reference Citation Analysis]
120 Kathawala MH, Xiong S, Richards M, Ng KW, George S, Loo SCJ. Emerging In Vitro Models for Safety Screening of High-Volume Production Nanomaterials under Environmentally Relevant Exposure Conditions. Small 2013;9:1504-20. [DOI: 10.1002/smll.201201452] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
121 Pekkanen-Mattila M, Kerkelä E, Tanskanen JM, Pietilä M, Pelto-Huikko M, Hyttinen J, Skottman H, Suuronen R, Aalto-Setälä K. Substantial variation in the cardiac differentiation of human embryonic stem cell lines derived and propagated under the same conditions--a comparison of multiple cell lines. Ann Med. 2009;41:360-370. [PMID: 19165643 DOI: 10.1080/07853890802609542] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 3.6] [Reference Citation Analysis]
122 Balachandar V, Dhivya V, Gomathi M, Mohanadevi S, Venkatesh B, Geetha B. A review of Rett syndrome (RTT) with induced pluripotent stem cells. Stem Cell Investig 2016;3:52. [PMID: 27777941 DOI: 10.21037/sci.2016.09.05] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
123 Bifari F, Decimo I, Chiamulera C, Bersan E, Malpeli G, Johansson J, Lisi V, Bonetti B, Fumagalli G, Pizzolo G, Krampera M. Novel stem/progenitor cells with neuronal differentiation potential reside in the leptomeningeal niche. J Cell Mol Med 2009;13:3195-208. [PMID: 19228261 DOI: 10.1111/j.1582-4934.2009.00706.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
124 Catalina P, Bueno C, Montes R, Nieto A, Ligero G, Sanchez L, Jara M, Rasillo A, Orfao A, Cigudosa J, Hovatta O, Greaves M, Menendez P. Genetic stability of human embryonic stem cells: A first-step toward the development of potential hESC-based systems for modeling childhood leukemia. Leuk Res 2009;33:980-90. [PMID: 18930318 DOI: 10.1016/j.leukres.2008.08.028] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
125 Zeira E, Abramovitch R, Meir K, Even Ram S, Gil Y, Bulvik B, Bromberg Z, Levkovitch O, Nahmansson N, Adar R, Reubinoff B, Galun E, Gropp M. The knockdown of H19lncRNA reveals its regulatory role in pluripotency and tumorigenesis of human embryonic carcinoma cells. Oncotarget 2015;6:34691-703. [PMID: 26415227 DOI: 10.18632/oncotarget.5787] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
126 Miyoshi N, Ishii H, Nagano H, Haraguchi N, Dewi DL, Kano Y, Nishikawa S, Tanemura M, Mimori K, Tanaka F, Saito T, Nishimura J, Takemasa I, Mizushima T, Ikeda M, Yamamoto H, Sekimoto M, Doki Y, Mori M. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell. 2011;8:633-638. [PMID: 21620789 DOI: 10.1016/j.stem.2011.05.001] [Cited by in Crossref: 535] [Cited by in F6Publishing: 457] [Article Influence: 59.4] [Reference Citation Analysis]
127 Damoiseaux R, Sherman SP, Alva JA, Peterson C, Pyle AD. Integrated chemical genomics reveals modifiers of survival in human embryonic stem cells. Stem Cells 2009;27:533-42. [PMID: 19074420 DOI: 10.1634/stemcells.2008-0596] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
128 Hayashi Y, Ohnuma K, Furue MK. Pluripotent Stem Cell Heterogeneity. In: Birbrair A, editor. Stem Cells Heterogeneity - Novel Concepts. Cham: Springer International Publishing; 2019. pp. 71-94. [DOI: 10.1007/978-3-030-11096-3_6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
129 Kohutova A, Raška J, Kruta M, Seneklova M, Barta T, Fojtik P, Jurakova T, Walter CA, Hampl A, Dvorak P, Rotrekl V. Ligase 3–mediated end‐joining maintains genome stability of human embryonic stem cells. FASEB j 2019;33:6778-88. [DOI: 10.1096/fj.201801877rr] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
130 Kato R, Matsumoto M, Sasaki H, Joto R, Okada M, Ikeda Y, Kanie K, Suga M, Kinehara M, Yanagihara K, Liu Y, Uchio-Yamada K, Fukuda T, Kii H, Uozumi T, Honda H, Kiyota Y, Furue MK. Parametric analysis of colony morphology of non-labelled live human pluripotent stem cells for cell quality control. Sci Rep 2016;6:34009. [PMID: 27667091 DOI: 10.1038/srep34009] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 8.2] [Reference Citation Analysis]
131 Titmarsh DM, Ovchinnikov DA, Wolvetang EJ, Cooper-White JJ. Full factorial screening of human embryonic stem cell maintenance with multiplexed microbioreactor arrays. Biotechnol J 2013;8:822-34. [PMID: 23813764 DOI: 10.1002/biot.201200375] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
132 Moon SH, Kim SW, Kim JS, Park SJ, Do JT, Lee DR, Chung HM. Gene expression profiles in CHA3 and CHA4 human embryonic stem cells and embryoid bodies. Mol Cells 2011;31:315-26. [PMID: 21359678 DOI: 10.1007/s10059-011-0039-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
133 Pešková L, Vinarský V, Bárta T, Hampl A. Human Embryonic Stem Cells Acquire Responsiveness to TRAIL upon Exposure to Cisplatin. Stem Cells Int 2019;2019:4279481. [PMID: 30805008 DOI: 10.1155/2019/4279481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
134 Kossack N, Meneses J, Shefi S, Nguyen HN, Chavez S, Nicholas C, Gromoll J, Turek PJ, Reijo-Pera RA. Isolation and characterization of pluripotent human spermatogonial stem cell-derived cells. Stem Cells 2009;27:138-49. [PMID: 18927477 DOI: 10.1634/stemcells.2008-0439] [Cited by in Crossref: 199] [Cited by in F6Publishing: 166] [Article Influence: 16.6] [Reference Citation Analysis]
135 Polanco JC, Ho MS, Wang B, Zhou Q, Wolvetang E, Mason E, Wells CA, Kolle G, Grimmond SM, Bertoncello I, O'brien C, Laslett AL. Identification of Unsafe Human Induced Pluripotent Stem Cell Lines Using a Robust Surrogate Assay for Pluripotency: Identification of Unsafe Human iPS Cell Lines. STEM CELLS 2013;31:1498-510. [DOI: 10.1002/stem.1425] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
136 Nettersheim D, Jostes S, Sharma R, Schneider S, Hofmann A, Ferreira HJ, Hoffmann P, Kristiansen G, Esteller MB, Schorle H. BMP Inhibition in Seminomas Initiates Acquisition of Pluripotency via NODAL Signaling Resulting in Reprogramming to an Embryonal Carcinoma. PLoS Genet 2015;11:e1005415. [PMID: 26226633 DOI: 10.1371/journal.pgen.1005415] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
137 Panek M, Antunović M, Pribolšan L, Ivković A, Gotić M, Vukasović A, Caput Mihalić K, Pušić M, Jurkin T, Marijanović I. Bone Tissue Engineering in a Perfusion Bioreactor Using Dexamethasone-Loaded Peptide Hydrogel. Materials (Basel) 2019;12:E919. [PMID: 30893951 DOI: 10.3390/ma12060919] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
138 Stacey G. Current developments in cell culture technology. Adv Exp Med Biol 2012;745:1-13. [PMID: 22437809 DOI: 10.1007/978-1-4614-3055-1_1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
139 Alejandra MR, Juan AB, Ana SR. Cell therapy for liver diseases: current medicine and future promises. Expert Rev Gastroenterol Hepatol 2015;9:837-50. [PMID: 25747732 DOI: 10.1586/17474124.2015.1016913] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
140 Virant-Klun I, Zech N, Rozman P, Vogler A, Cvjeticanin B, Klemenc P, Malicev E, Meden-Vrtovec H. Putative stem cells with an embryonic character isolated from the ovarian surface epithelium of women with no naturally present follicles and oocytes. Differentiation. 2008;76:843-856. [PMID: 18452550 DOI: 10.1111/j.1432-0436.2008.00268.x] [Cited by in Crossref: 166] [Cited by in F6Publishing: 142] [Article Influence: 12.8] [Reference Citation Analysis]
141 Baker AEG, Cui H, Ballios BG, Ing S, Yan P, Wolfer J, Wright T, Dang M, Gan NY, Cooke MJ, Ortín-Martínez A, Wallace VA, van der Kooy D, Devenyi R, Shoichet MS. Stable oxime-crosslinked hyaluronan-based hydrogel as a biomimetic vitreous substitute. Biomaterials 2021;271:120750. [PMID: 33725584 DOI: 10.1016/j.biomaterials.2021.120750] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
142 Garitaonandia I, Amir H, Boscolo FS, Wambua GK, Schultheisz HL, Sabatini K, Morey R, Waltz S, Wang YC, Tran H, Leonardo TR, Nazor K, Slavin I, Lynch C, Li Y, Coleman R, Gallego Romero I, Altun G, Reynolds D, Dalton S, Parast M, Loring JF, Laurent LC. Increased risk of genetic and epigenetic instability in human embryonic stem cells associated with specific culture conditions. PLoS One. 2015;10:e0118307. [PMID: 25714340 DOI: 10.1371/journal.pone.0118307] [Cited by in Crossref: 85] [Cited by in F6Publishing: 66] [Article Influence: 14.2] [Reference Citation Analysis]
143 Forsyth NR, Kay A, Hampson K, Downing A, Talbot R, McWhir J. Transcriptome alterations due to physiological normoxic (2% O2) culture of human embryonic stem cells. Regen Med. 2008;3:817-833. [PMID: 18947306 DOI: 10.2217/17460751.3.6.817] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
144 Tao Y, Yen MR, Chitiashvili T, Nakano H, Kim R, Hosohama L, Tan YC, Nakano A, Chen PY, Clark AT. TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency. Stem Cell Reports 2018;10:243-56. [PMID: 29290627 DOI: 10.1016/j.stemcr.2017.11.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
145 Gao X, Nowak-Imialek M, Chen X, Chen D, Herrmann D, Ruan D, Chen ACH, Eckersley-Maslin MA, Ahmad S, Lee YL, Kobayashi T, Ryan D, Zhong J, Zhu J, Wu J, Lan G, Petkov S, Yang J, Antunes L, Campos LS, Fu B, Wang S, Yong Y, Wang X, Xue SG, Ge L, Liu Z, Huang Y, Nie T, Li P, Wu D, Pei D, Zhang Y, Lu L, Yang F, Kimber SJ, Reik W, Zou X, Shang Z, Lai L, Surani A, Tam PPL, Ahmed A, Yeung WSB, Teichmann SA, Niemann H, Liu P. Establishment of porcine and human expanded potential stem cells. Nat Cell Biol. 2019;21:687-699. [PMID: 31160711 DOI: 10.1038/s41556-019-0333-2] [Cited by in Crossref: 110] [Cited by in F6Publishing: 88] [Article Influence: 55.0] [Reference Citation Analysis]
146 Park JH, Hong J. Continuous release of bFGF from multilayer nanofilm to maintain undifferentiated human iPS cell cultures. Integr Biol 2014;6:1196-200. [DOI: 10.1039/c4ib00210e] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
147 Gokhale PJ, Andrews PW. The development of pluripotent stem cells. Current Opinion in Genetics & Development 2012;22:403-8. [DOI: 10.1016/j.gde.2012.07.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
148 Calvanese V, Fraga MF. Epigenetics of embryonic stem cells. Adv Exp Med Biol 2012;741:231-53. [PMID: 22457114 DOI: 10.1007/978-1-4614-2098-9_16] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
149 Liu CC, Ma DL, Yan TD, Fan X, Poon Z, Poon LF, Goh SA, Rozen SG, Hwang WY, Tergaonkar V, Tan P, Ghosh S, Virshup DM, Goh EL, Li S. Distinct Responses of Stem Cells to Telomere Uncapping-A Potential Strategy to Improve the Safety of Cell Therapy. Stem Cells 2016;34:2471-84. [PMID: 27299710 DOI: 10.1002/stem.2431] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
150 Vossaert L, O'Leary T, Van Neste C, Heindryckx B, Vandesompele J, De Sutter P, Deforce D. Reference loci for RT-qPCR analysis of differentiating human embryonic stem cells. BMC Mol Biol 2013;14:21. [PMID: 24028740 DOI: 10.1186/1471-2199-14-21] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
151 Gamie Z, Tran GT, Vyzas G, Korres N, Heliotis M, Mantalaris A, Tsiridis E. Stem cells combined with bone graft substitutes in skeletal tissue engineering. Expert Opinion on Biological Therapy 2012;12:713-29. [DOI: 10.1517/14712598.2012.679652] [Cited by in Crossref: 63] [Cited by in F6Publishing: 42] [Article Influence: 7.0] [Reference Citation Analysis]
152 Borstlap J, Kurtz A, Stacey G, Elstner A, Damaschun A, Arán B, Gerlach JC, Izpisúa JC, Veiga A. Development of a European human embryonic stem cell registry. Regen Med 2008;3:945-51. [PMID: 18947315 DOI: 10.2217/17460751.3.6.945] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
153 Singh VK, Kalsan M, Kumar N, Saini A, Chandra R. Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery. Front Cell Dev Biol. 2015;3:2. [PMID: 25699255 DOI: 10.3389/fcell.2015.00002] [Cited by in Crossref: 198] [Cited by in F6Publishing: 144] [Article Influence: 33.0] [Reference Citation Analysis]
154 Gokhale PJ, Au-Young JK, Dadi S, Keys DN, Harrison NJ, Jones M, Soneji S, Enver T, Sherlock JK, Andrews PW. Culture adaptation alters transcriptional hierarchies among single human embryonic stem cells reflecting altered patterns of differentiation. PLoS One 2015;10:e0123467. [PMID: 25875838 DOI: 10.1371/journal.pone.0123467] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
155 Schuldt BM, Guhr A, Lenz M, Kobold S, MacArthur BD, Schuppert A, Löser P, Müller FJ. Power-laws and the use of pluripotent stem cell lines. PLoS One 2013;8:e52068. [PMID: 23300961 DOI: 10.1371/journal.pone.0052068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
156 King FW, Ritner C, Liszewski W, Kwan HC, Pedersen A, Leavitt AD, Bernstein HS. Subpopulations of human embryonic stem cells with distinct tissue-specific fates can be selected from pluripotent cultures. Stem Cells Dev 2009;18:1441-50. [PMID: 19254177 DOI: 10.1089/scd.2009.0012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.0] [Reference Citation Analysis]
157 Luong MX, Smith KP, Crook JM, Stacey G. Biobanks for Pluripotent Stem Cells. Human Stem Cell Manual. Elsevier; 2012. pp. 105-25. [DOI: 10.1016/b978-0-12-385473-5.00008-4] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
158 Arabadjiev B, Petkova R, Chakarov S, Momchilova A, Pankov R. Do We Need More Human Embryonic Stem Cell Lines? Biotechnology & Biotechnological Equipment 2014;24:1921-7. [DOI: 10.2478/v10133-010-0071-x] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
159 Guillevic O, Ferratge S, Pascaud J, Driancourt C, Boyer-Di-Ponio J, Uzan G. A Novel Molecular and Functional Stemness Signature Assessing Human Cord Blood-Derived Endothelial Progenitor Cell Immaturity. PLoS One 2016;11:e0152993. [PMID: 27043207 DOI: 10.1371/journal.pone.0152993] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
160 Vestergaard ML, Awan A, Warzecha CB, Christensen ST, Andersen CY. Immunofluorescence Microscopy and mRNA Analysis of Human Embryonic Stem Cells (hESCs) Including Primary Cilia Associated Signaling Pathways.Methods Mol Biol. 2016;1307:123-140. [PMID: 25304206 DOI: 10.1007/7651_2014_127] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
161 Prasad SM, Czepiel M, Cetinkaya C, Smigielska K, Weli SC, Lysdahl H, Gabrielsen A, Petersen K, Ehlers N, Fink T, Minger SL, Zachar V. Continuous hypoxic culturing maintains activation of Notch and allows long-term propagation of human embryonic stem cells without spontaneous differentiation. Cell Prolif 2009;42:63-74. [PMID: 19143764 DOI: 10.1111/j.1365-2184.2008.00571.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 68] [Article Influence: 5.9] [Reference Citation Analysis]
162 Hansen A, Mjoseng HK, Zhang R, Kalloudis M, Koutsos V, de Sousa PA, Bradley M. High-density polymer microarrays: identifying synthetic polymers that control human embryonic stem cell growth. Adv Healthc Mater. 2014;3:848-853. [PMID: 24353271 DOI: 10.1002/adhm.201300489] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
163 Simara P, Tesarova L, Rehakova D, Matula P, Stejskal S, Hampl A, Koutna I. DNA double-strand breaks in human induced pluripotent stem cell reprogramming and long-term in vitro culturing. Stem Cell Res Ther. 2017;8:73. [PMID: 28327192 DOI: 10.1186/s13287-017-0522-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
164 Chen SM, Lee MS, Chang CY, Lin SZ, Cheng EH, Liu YH, Pan HC, Lee HC, Su HL. Prerequisite OCT4 Maintenance Potentiates the Neural Induction of Differentiating Human Embryonic Stem Cells and Induced Pluripotent Stem Cells. Cell Transplant. 2015;24:829-844. [PMID: 24256943 DOI: 10.3727/096368913x675179] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
165 Arora N, Daley GQ. Pluripotent stem cells in research and treatment of hemoglobinopathies. Cold Spring Harb Perspect Med 2012;2:a011841. [PMID: 22474618 DOI: 10.1101/cshperspect.a011841] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
166 Ordonez MP, Roberts EA, Kidwell CU, Yuan SH, Plaisted WC, Goldstein LS. Disruption and therapeutic rescue of autophagy in a human neuronal model of Niemann Pick type C1. Hum Mol Genet 2012;21:2651-62. [PMID: 22437840 DOI: 10.1093/hmg/dds090] [Cited by in Crossref: 84] [Cited by in F6Publishing: 72] [Article Influence: 9.3] [Reference Citation Analysis]
167 Ooi J, Liu P. Pluripotency and its layers of complexity. Cell Regen 2012;1:7. [PMID: 25408870 DOI: 10.1186/2045-9769-1-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
168 Anguera MC, Sadreyev R, Zhang Z, Szanto A, Payer B, Sheridan SD, Kwok S, Haggarty SJ, Sur M, Alvarez J, Gimelbrant A, Mitalipova M, Kirby JE, Lee JT. Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes. Cell Stem Cell 2012;11:75-90. [PMID: 22770242 DOI: 10.1016/j.stem.2012.03.008] [Cited by in Crossref: 98] [Cited by in F6Publishing: 79] [Article Influence: 10.9] [Reference Citation Analysis]
169 Caterson B, Melrose J. Keratan sulfate, a complex glycosaminoglycan with unique functional capability. Glycobiology 2018;28:182-206. [PMID: 29340594 DOI: 10.1093/glycob/cwy003] [Cited by in Crossref: 81] [Cited by in F6Publishing: 52] [Article Influence: 27.0] [Reference Citation Analysis]
170 Makhlouf M, Rougeulle C. Linking X chromosome inactivation to pluripotency: Necessity or fate? Trends Mol Med 2011;17:329-36. [PMID: 21411371 DOI: 10.1016/j.molmed.2011.02.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
171 Lagarkova MA, Eremeev AV, Svetlakov AV, Rubtsov NB, Kiselev SL. Human embryonic stem cell lines isolation, cultivation, and characterization. In Vitro Cell Dev Biol Anim. 2010;46:284-293. [PMID: 20178000 DOI: 10.1007/s11626-010-9282-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
172 Pannetier M, Feil R. Epigenetic stability of embryonic stem cells and developmental potential. Trends Biotechnol 2007;25:556-62. [PMID: 17983676 DOI: 10.1016/j.tibtech.2007.09.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
173 Kidder BL, Palmer S, Knott JG. SWI/SNF-Brg1 regulates self-renewal and occupies core pluripotency-related genes in embryonic stem cells. Stem Cells 2009;27:317-28. [PMID: 19056910 DOI: 10.1634/stemcells.2008-0710] [Cited by in Crossref: 172] [Cited by in F6Publishing: 157] [Article Influence: 14.3] [Reference Citation Analysis]
174 Ishikawa T, Hagiwara K, Ochiya T. Generation and hepatic differentiation of human iPS cells. Methods Mol Biol 2012;826:103-14. [PMID: 22167643 DOI: 10.1007/978-1-61779-468-1_9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
175 Fojtík P, Beckerová D, Holomková K, Šenfluk M, Rotrekl V. Both Hypoxia-Inducible Factor 1 and MAPK Signaling Pathway Attenuate PI3K/AKT via Suppression of Reactive Oxygen Species in Human Pluripotent Stem Cells. Front Cell Dev Biol 2020;8:607444. [PMID: 33553145 DOI: 10.3389/fcell.2020.607444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Zweigerdt R. Large scale production of stem cells and their derivatives. Adv Biochem Eng Biotechnol 2009;114:201-35. [PMID: 19513633 DOI: 10.1007/10_2008_27] [Cited by in Crossref: 12] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
177 Azzi S, Rossignol S, Steunou V, Sas T, Thibaud N, Danton F, Le Jule M, Heinrichs C, Cabrol S, Gicquel C, Le Bouc Y, Netchine I. Multilocus methylation analysis in a large cohort of 11p15-related foetal growth disorders (Russell Silver and Beckwith Wiedemann syndromes) reveals simultaneous loss of methylation at paternal and maternal imprinted loci. Human Molecular Genetics 2009;18:4724-33. [DOI: 10.1093/hmg/ddp435] [Cited by in Crossref: 165] [Cited by in F6Publishing: 132] [Article Influence: 13.8] [Reference Citation Analysis]
178 Lees JG, Gardner DK, Harvey AJ. Pluripotent Stem Cell Metabolism and Mitochondria: Beyond ATP.Stem Cells Int. 2017;2017:2874283. [PMID: 28804500 DOI: 10.1155/2017/2874283] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
179 Anderson AJ, Haus DL, Hooshmand MJ, Perez H, Sontag CJ, Cummings BJ. Achieving stable human stem cell engraftment and survival in the CNS: is the future of regenerative medicine immunodeficient? Regen Med 2011;6:367-406. [PMID: 21548741 DOI: 10.2217/rme.11.22] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 6.2] [Reference Citation Analysis]
180 Looijenga LH, Gillis AJ, Stoop H, Biermann K, Oosterhuis JW. Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance. Int J Androl 2011;34:e234-51. [PMID: 21564133 DOI: 10.1111/j.1365-2605.2011.01157.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
181 Lefort N, Perrier AL, Laâbi Y, Varela C, Peschanski M. Human embryonic stem cells and genomic instability. Regen Med 2009;4:899-909. [PMID: 19903007 DOI: 10.2217/rme.09.63] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
182 Luong MX, Smith KP, Stein GS. Human embryonic stem cell registries: value, challenges and opportunities. J Cell Biochem 2008;105:625-32. [PMID: 18773439 DOI: 10.1002/jcb.21872] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
183 Gibson JD, Jakuba CM, Boucher N, Holbrook KA, Carter MG, Nelson CE. Single-cell transcript analysis of human embryonic stem cells. Integr Biol (Camb) 2009;1:540-51. [PMID: 20023769 DOI: 10.1039/b908276j] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
184 Zhao W, Jin L, Yuan H, Tan Z, Zhou C, Li LS, Ma L. Targeting human embryonic stem cells with quantum dot-conjugated phages. Sci Rep 2013;3:3134. [PMID: 24190250 DOI: 10.1038/srep03134] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
185 Pera RA. Status of human germ cell differentiation from pluripotent stem cells. Reprod Fertil Dev 2013;25:396-404. [PMID: 23445816 DOI: 10.1071/RD12047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
186 Horák D, Matulka K, Hlídková H, Lapčíková M, Beneš MJ, Jaroš J, Hampl A, Dvořák P. Pentapeptide-modified poly(N,N-diethylacrylamide) hydrogel scaffolds for tissue engineering. J Biomed Mater Res B Appl Biomater. 2011;98:54-67. [PMID: 21563303 DOI: 10.1002/jbm.b.31832] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
187 Dottori M, Tay C, Hughes SM. Neural development in human embryonic stem cells-applications of lentiviral vectors. J Cell Biochem 2011;112:1955-62. [DOI: 10.1002/jcb.23116] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
188 Dąbrowska AM, Skopiński P. Stem cells in regenerative medicine - from laboratory to clinical application - the eye. Cent Eur J Immunol 2017;42:173-80. [PMID: 28860936 DOI: 10.5114/ceji.2017.69360] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
189 Jones GN, Moschidou D, Abdulrazzak H, Kalirai BS, Vanleene M, Osatis S, Shefelbine SJ, Horwood NJ, Marenzana M, De Coppi P. Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta. Stem Cells Dev. 2014;23:262-276. [PMID: 24028330 DOI: 10.1089/scd.2013.0132] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
190 Ogura C, Hirano K, Mizumoto S, Yamada S, Nishihara S. Dermatan sulphate promotes neuronal differentiation in mouse and human stem cells. J Biochem 2021;169:55-64. [PMID: 32730567 DOI: 10.1093/jb/mvaa087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
191 Kalista T, Freeman HA, Behr B, Pera RR, Scott CT. Donation of embryos for human development and stem cell research. Cell Stem Cell 2011;8:360-2. [PMID: 21474099 DOI: 10.1016/j.stem.2011.02.018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
192 Kusuda Furue M, Tateyama D, Kinehara M, Na J, Okamoto T, Sato JD. Advantages and difficulties in culturing human pluripotent stem cells in growth factor-defined serum-free medium. In Vitro Cell Dev Biol Anim 2010;46:573-6. [PMID: 20428962 DOI: 10.1007/s11626-010-9317-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
193 Stephenson E, Ogilvie CM, Patel H, Cornwell G, Jacquet L, Kadeva N, Braude P, Ilic D. Safety paradigm: genetic evaluation of therapeutic grade human embryonic stem cells. J R Soc Interface 2010;7 Suppl 6:S677-88. [PMID: 20826474 DOI: 10.1098/rsif.2010.0343.focus] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
194 Kubikova I, Konecna H, Sedo O, Zdrahal Z, Rehulka P, Hribkova H, Rehulkova H, Hampl A, Chmelik J, Dvorak P. Proteomic profiling of human embryonic stem cell-derived microvesicles reveals a risk of transfer of proteins of bovine and mouse origin. Cytotherapy 2009;11:330-40, 1 p following 340. [PMID: 19401887 DOI: 10.1080/14653240802595531] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
195 Dvorak P, Bednar D, Vanacek P, Balek L, Eiselleova L, Stepankova V, Sebestova E, Kunova Bosakova M, Konecna Z, Mazurenko S, Kunka A, Vanova T, Zoufalova K, Chaloupkova R, Brezovsky J, Krejci P, Prokop Z, Dvorak P, Damborsky J. Computer-assisted engineering of hyperstable fibroblast growth factor 2. Biotechnol Bioeng 2018;115:850-62. [PMID: 29278409 DOI: 10.1002/bit.26531] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
196 Braam SR, Passier R, Mummery CL. Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery. Trends Pharmacol Sci 2009;30:536-45. [PMID: 19762090 DOI: 10.1016/j.tips.2009.07.001] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
197 Huang Z, Yang J, Luo G, Gan C, Cheng W, Yuan S, Peng X, Tan J, Wang X, Hu J, Yang S, Reisner Y, Ge L, Wei H, Cheng P, Wu J. Embryonic porcine skin precursors can successfully develop into integrated skin without teratoma formation posttransplantation in nude mouse model. PLoS One 2010;5:e8717. [PMID: 20090918 DOI: 10.1371/journal.pone.0008717] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
198 Hayes AJ, Melrose J. Keratan Sulphate in the Tumour Environment. Adv Exp Med Biol 2020;1245:39-66. [PMID: 32266652 DOI: 10.1007/978-3-030-40146-7_2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
199 Baker M. Scientific definition by political request. Nat Rep Stem Cells. [DOI: 10.1038/stemcells.2007.102] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
200 Brøchner CB, Johansen JS, Larsen LA, Bak M, Mikkelsen HB, Byskov AG, Andersen CY, Møllgård K. YKL-40 is differentially expressed in human embryonic stem cells and in cell progeny of the three germ layers. J Histochem Cytochem 2012;60:188-204. [PMID: 22140133 DOI: 10.1369/0022155411433331] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
201 Bongso A, Fong CY, Gauthaman K. Taking stem cells to the clinic: Major challenges. J Cell Biochem 2008;105:1352-60. [PMID: 18980213 DOI: 10.1002/jcb.21957] [Cited by in Crossref: 123] [Cited by in F6Publishing: 107] [Article Influence: 10.3] [Reference Citation Analysis]
202 Rai N, Singh AK, Singh SK, Gaurishankar B, Kamble SC, Mishra P, Kotiya D, Barik S, Atri N, Gautam V. Recent technological advancements in stem cell research for targeted therapeutics. Drug Deliv and Transl Res 2020;10:1147-69. [DOI: 10.1007/s13346-020-00766-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
203 Murdoch A, Braude P, Courtney A, Brison D, Hunt C, Lawford-davies J, Moore H, Stacey G, Sethe S; for the Procurement Working Group of the National Clinical hESC Forum. The Procurement of Cells for the Derivation of Human Embryonic Stem Cell Lines for Therapeutic Use: Recommendations for Good Practice. Stem Cell Rev and Rep 2012;8:91-9. [DOI: 10.1007/s12015-011-9288-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
204 Pamies D, Reig JA, Vilanova E, Sogorb MA. Expression of Neuropathy Target Esterase in mouse embryonic stem cells during differentiation. Arch Toxicol 2010;84:481-91. [DOI: 10.1007/s00204-010-0518-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
205 Gordeeva OF, Lifantseva NV, Khaidukov SV. Expression patterns of germ line specific genes in mouse and human pluripotent stem cells are associated with regulation of ground and primed state of pluripotency. Russ J Dev Biol 2011;42:355-75. [DOI: 10.1134/s1062360411060038] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
206 Fukusumi H, Shofuda T, Kanematsu D, Yamamoto A, Suemizu H, Nakamura M, Yamasaki M, Ohgushi M, Sasai Y, Kanemura Y. Feeder-free generation and long-term culture of human induced pluripotent stem cells using pericellular matrix of decidua derived mesenchymal cells. PLoS One 2013;8:e55226. [PMID: 23383118 DOI: 10.1371/journal.pone.0055226] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
207 Dick E, Rajamohan D, Ronksley J, Denning C. Evaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening. Biochem Soc Trans 2010;38:1037-45. [PMID: 20659000 DOI: 10.1042/BST0381037] [Cited by in Crossref: 87] [Cited by in F6Publishing: 37] [Article Influence: 7.9] [Reference Citation Analysis]
208 Zeng H, Park JW, Guo M, Lin G, Crandall L, Compton T, Wang X, Li XJ, Chen FP, Xu RH. Lack of ABCG2 expression and side population properties in human pluripotent stem cells. Stem Cells 2009;27:2435-45. [PMID: 19670287 DOI: 10.1002/stem.192] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.5] [Reference Citation Analysis]
209 Hall LL, Byron M, Butler J, Becker KA, Nelson A, Amit M, Itskovitz-Eldor J, Stein J, Stein G, Ware C, Lawrence JB. X-inactivation reveals epigenetic anomalies in most hESC but identifies sublines that initiate as expected. J Cell Physiol 2008;216:445-52. [PMID: 18340642 DOI: 10.1002/jcp.21411] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 6.0] [Reference Citation Analysis]
210 Tavakoli T, Xu X, Derby E, Serebryakova Y, Reid Y, Rao MS, Mattson MP, Ma W. Self-renewal and differentiation capabilities are variable between human embryonic stem cell lines I3, I6 and BG01V. BMC Cell Biol 2009;10:44. [PMID: 19500347 DOI: 10.1186/1471-2121-10-44] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
211 Sutiwisesak R, Kitiyanant N, Kotchabhakdi N, Felsenfeld G, Andrews PW, Wongtrakoongate P. Induced pluripotency enables differentiation of human nullipotent embryonal carcinoma cells N2102Ep. Biochim Biophys Acta. 2014;1843:2611-2619. [PMID: 25086345 DOI: 10.1016/j.bbamcr.2014.07.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
212 Bermejo-Alvarez P, Ramos-Ibeas P, Gutierrez-Adan A. Solving the "X" in embryos and stem cells. Stem Cells Dev 2012;21:1215-24. [PMID: 22309156 DOI: 10.1089/scd.2011.0685] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
213 Choi KH, Lee DK, Kim SW, Woo SH, Kim DY, Lee CK. Chemically Defined Media Can Maintain Pig Pluripotency Network In Vitro. Stem Cell Reports 2019;13:221-34. [PMID: 31257130 DOI: 10.1016/j.stemcr.2019.05.028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
214 Zoldan J, Karagiannis ED, Lee CY, Anderson DG, Langer R, Levenberg S. The influence of scaffold elasticity on germ layer specification of human embryonic stem cells. Biomaterials. 2011;32:9612-9621. [PMID: 21963156 DOI: 10.1016/j.biomaterials.2011.09.012] [Cited by in Crossref: 113] [Cited by in F6Publishing: 95] [Article Influence: 11.3] [Reference Citation Analysis]
215 Zachar V, Prasad SM, Weli SC, Gabrielsen A, Petersen K, Petersen MB, Fink T. The effect of human embryonic stem cells (hESCs) long-term normoxic and hypoxic cultures on the maintenance of pluripotency. In Vitro Cell Dev Biol Anim 2010;46:276-83. [PMID: 20177991 DOI: 10.1007/s11626-010-9305-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
216 Ferro F, Spelat R, Beltrami AP, Cesselli D, Curcio F. Isolation and characterization of human dental pulp derived stem cells by using media containing low human serum percentage as clinical grade substitutes for bovine serum. PLoS One 2012;7:e48945. [PMID: 23155430 DOI: 10.1371/journal.pone.0048945] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
217 Lipchina I, Elkabetz Y, Hafner M, Sheridan R, Mihailovic A, Tuschl T, Sander C, Studer L, Betel D. Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response. Genes Dev 2011;25:2173-86. [PMID: 22012620 DOI: 10.1101/gad.17221311] [Cited by in Crossref: 132] [Cited by in F6Publishing: 122] [Article Influence: 13.2] [Reference Citation Analysis]
218 Eiselleova L, Matulka K, Kriz V, Kunova M, Schmidtova Z, Neradil J, Tichy B, Dvorakova D, Pospisilova S, Hampl A, Dvorak P. A complex role for FGF-2 in self-renewal, survival, and adhesion of human embryonic stem cells. Stem Cells 2009;27:1847-57. [PMID: 19544431 DOI: 10.1002/stem.128] [Cited by in Crossref: 149] [Cited by in F6Publishing: 126] [Article Influence: 13.5] [Reference Citation Analysis]
219 Spike BT, Kelber JA, Booker E, Kalathur M, Rodewald R, Lipianskaya J, La J, He M, Wright T, Klemke R, Wahl GM, Gray PC. CRIPTO/GRP78 signaling maintains fetal and adult mammary stem cells ex vivo. Stem Cell Reports 2014;2:427-39. [PMID: 24749068 DOI: 10.1016/j.stemcr.2014.02.010] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 6.9] [Reference Citation Analysis]
220 Amini AR, Laurencin CT, Nukavarapu SP. Bone tissue engineering: recent advances and challenges. Crit Rev Biomed Eng. 2012;40:363-408. [PMID: 23339648 DOI: 10.1615/critrevbiomedeng.v40.i5.10] [Cited by in Crossref: 1133] [Cited by in F6Publishing: 353] [Article Influence: 141.6] [Reference Citation Analysis]
221 Nakao S, Tsukamoto T, Ueyama T, Kawamura T. STAT3 for Cardiac Regenerative Medicine: Involvement in Stem Cell Biology, Pathophysiology, and Bioengineering. Int J Mol Sci 2020;21:E1937. [PMID: 32178385 DOI: 10.3390/ijms21061937] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
222 Govaert E, Van Steendam K, Willems S, Vossaert L, Dhaenens M, Deforce D. Comparison of fractionation proteomics for local SWATH library building. Proteomics 2017;17. [PMID: 28664598 DOI: 10.1002/pmic.201700052] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
223 Van Hoof D, Dormeyer W, Braam SR, Passier R, Monshouwer-Kloots J, Ward-van Oostwaard D, Heck AJ, Krijgsveld J, Mummery CL. Identification of cell surface proteins for antibody-based selection of human embryonic stem cell-derived cardiomyocytes. J Proteome Res. 2010;9:1610-1618. [PMID: 20088484 DOI: 10.1021/pr901138a] [Cited by in Crossref: 77] [Cited by in F6Publishing: 63] [Article Influence: 7.0] [Reference Citation Analysis]
224 Keller A, Dziedzicka D, Zambelli F, Markouli C, Sermon K, Spits C, Geens M. Genetic and epigenetic factors which modulate differentiation propensity in human pluripotent stem cells. Hum Reprod Update 2018;24:162-75. [PMID: 29377992 DOI: 10.1093/humupd/dmx042] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
225 Campbell JM, Mitchell M, Nottle MB, Lane M. Development of a Mouse Model for Studying the Effect of Embryo Culture on Embryonic Stem Cell Derivation. Stem Cells and Development 2011;20:1577-86. [DOI: 10.1089/scd.2010.0357] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
226 White AK, VanInsberghe M, Petriv OI, Hamidi M, Sikorski D, Marra MA, Piret J, Aparicio S, Hansen CL. High-throughput microfluidic single-cell RT-qPCR. Proc Natl Acad Sci U S A 2011;108:13999-4004. [PMID: 21808033 DOI: 10.1073/pnas.1019446108] [Cited by in Crossref: 334] [Cited by in F6Publishing: 243] [Article Influence: 33.4] [Reference Citation Analysis]
227 Merkle FT, Ghosh S, Kamitaki N, Mitchell J, Avior Y, Mello C, Kashin S, Mekhoubad S, Ilic D, Charlton M, Saphier G, Handsaker RE, Genovese G, Bar S, Benvenisty N, McCarroll SA, Eggan K. Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations. Nature. 2017;545:229-233. [PMID: 28445466 DOI: 10.1038/nature22312] [Cited by in Crossref: 256] [Cited by in F6Publishing: 188] [Article Influence: 64.0] [Reference Citation Analysis]
228 Waldby C, Carroll K. Egg donation for stem cell research: ideas of surplus and deficit in Australian IVF patients' and reproductive donors' accounts. Sociol Health Illn 2012;34:513-28. [PMID: 21951180 DOI: 10.1111/j.1467-9566.2011.01399.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 6] [Article Influence: 3.6] [Reference Citation Analysis]
229 Sundberg M, Andersson PH, Åkesson E, Odeberg J, Holmberg L, Inzunza J, Falci S, Öhman J, Suuronen R, Skottman H, Lehtimäki K, Hovatta O, Narkilahti S, Sundström E. Markers of pluripotency and differentiation in human neural precursor cells derived from embryonic stem cells and CNS tissue. Cell Transplant 2011;20:177-91. [PMID: 20875224 DOI: 10.3727/096368910X527266] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
230 Harvey AJ, Rathjen J, Gardner DK. Metaboloepigenetic Regulation of Pluripotent Stem Cells. Stem Cells Int 2016;2016:1816525. [PMID: 26839556 DOI: 10.1155/2016/1816525] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
231 Hughes C, Radan L, Chang WY, Stanford WL, Betts DH, Postovit LM, Lajoie GA. Mass spectrometry-based proteomic analysis of the matrix microenvironment in pluripotent stem cell culture. Mol Cell Proteomics. 2012;11:1924-1936. [PMID: 23023296 DOI: 10.1074/mcp.m112.020057] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
232 Bradley CK, Chami O, Peura TT, Bosman A, Dumevska B, Schmidt U, Stojanov T. Derivation of three new human embryonic stem cell lines. In Vitro Cell Dev Biol Anim 2010;46:294-9. [PMID: 20198447 DOI: 10.1007/s11626-010-9298-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
233 Chen E, Tang MK, Yao Y, Yau WW, Lo LM, Yang X, Chui YL, Chan J, Lee KK. Silencing BRE expression in human umbilical cord perivascular (HUCPV) progenitor cells accelerates osteogenic and chondrogenic differentiation. PLoS One 2013;8:e67896. [PMID: 23935848 DOI: 10.1371/journal.pone.0067896] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
234 Andrews PW, Baker D, Benvinisty N, Miranda B, Bruce K, Brüstle O, Choi M, Choi YM, Crook JM, de Sousa PA, Dvorak P, Freund C, Firpo M, Furue MK, Gokhale P, Ha HY, Han E, Haupt S, Healy L, Hei DJ, Hovatta O, Hunt C, Hwang SM, Inamdar MS, Isasi RM, Jaconi M, Jekerle V, Kamthorn P, Kibbey MC, Knezevic I, Knowles BB, Koo SK, Laabi Y, Leopoldo L, Liu P, Lomax GP, Loring JF, Ludwig TE, Montgomery K, Mummery C, Nagy A, Nakamura Y, Nakatsuji N, Oh S, Oh SK, Otonkoski T, Pera M, Peschanski M, Pranke P, Rajala KM, Rao M, Ruttachuk R, Reubinoff B, Ricco L, Rooke H, Sipp D, Stacey GN, Suemori H, Takahashi TA, Takada K, Talib S, Tannenbaum S, Yuan BZ, Zeng F, Zhou Q. Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI). Regen Med 2015;10:1-44. [PMID: 25675265 DOI: 10.2217/rme.14.93] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 10.5] [Reference Citation Analysis]
235 Mayshar Y, Yanuka O, Benvenisty N. Teratogen screening using transcriptome profiling of differentiating human embryonic stem cells. J Cell Mol Med 2011;15:1393-401. [PMID: 20561110 DOI: 10.1111/j.1582-4934.2010.01105.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
236 Urbanska M, Winzi M, Neumann K, Abuhattum S, Rosendahl P, Müller P, Taubenberger A, Anastassiadis K, Guck J. Single-cell mechanical phenotype is an intrinsic marker of reprogramming and differentiation along the mouse neural lineage. Development 2017;144:4313-21. [DOI: 10.1242/dev.155218] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
237 Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861-872. [PMID: 18035408 DOI: 10.1016/j.cell.2007.11.019] [Cited by in Crossref: 13095] [Cited by in F6Publishing: 10303] [Article Influence: 1007.3] [Reference Citation Analysis]
238 Kim WT, Ryu CJ. Cancer stem cell surface markers on normal stem cells. BMB Rep. 2017;50:285-298. [PMID: 28270302 DOI: 10.5483/bmbrep.2017.50.6.039] [Cited by in Crossref: 102] [Cited by in F6Publishing: 63] [Article Influence: 34.0] [Reference Citation Analysis]
239 Pick M, Stelzer Y, Bar-Nur O, Mayshar Y, Eden A, Benvenisty N. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells 2009;27:2686-90. [PMID: 19711451 DOI: 10.1002/stem.205] [Cited by in Crossref: 138] [Cited by in F6Publishing: 123] [Article Influence: 12.5] [Reference Citation Analysis]
240 Prokhorova TA, Rigbolt KT, Johansen PT, Henningsen J, Kratchmarova I, Kassem M, Blagoev B. Stable isotope labeling by amino acids in cell culture (SILAC) and quantitative comparison of the membrane proteomes of self-renewing and differentiating human embryonic stem cells. Mol Cell Proteomics 2009;8:959-70. [PMID: 19151416 DOI: 10.1074/mcp.M800287-MCP200] [Cited by in Crossref: 95] [Cited by in F6Publishing: 32] [Article Influence: 7.9] [Reference Citation Analysis]
241 Mateizel I, Spits C, Verloes A, Mertzanidou A, Liebaers I, Sermon K. Characterization of CD30 expression in human embryonic stem cell lines cultured in serum-free media and passaged mechanically. Hum Reprod 2009;24:2477-89. [PMID: 19584135 DOI: 10.1093/humrep/dep234] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
242 Menon V, Thomas R, Elgueta C, Horl M, Osborn T, Hallett PJ, Bartos M, Isacson O, Pruszak J. Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells. Stem Cells 2019;37:1293-306. [PMID: 31381839 DOI: 10.1002/stem.3057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
243 Hasegawa K, Pomeroy JE, Pera MF. Current technology for the derivation of pluripotent stem cell lines from human embryos. Cell Stem Cell 2010;6:521-31. [PMID: 20569689 DOI: 10.1016/j.stem.2010.05.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
244 Prajumwongs P, Weeranantanapan O, Jaroonwitchawan T, Noisa P. Human Embryonic Stem Cells: A Model for the Study of Neural Development and Neurological Diseases. Stem Cells Int 2016;2016:2958210. [PMID: 27239201 DOI: 10.1155/2016/2958210] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 4.4] [Reference Citation Analysis]
245 Sato Y, Yamada T, Hiroyama T, Sudo K, Hasegawa N, Hyodo I, Nakamura Y. A robust culture method for maintaining tumorigenic cancer stem cells in the hepatocellular carcinoma cell line Li-7. Cancer Sci 2019;110:1644-52. [PMID: 30784169 DOI: 10.1111/cas.13978] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
246 Goff LA, Davila J, Swerdel MR, Moore JC, Cohen RI, Wu H, Sun YE, Hart RP. Ago2 immunoprecipitation identifies predicted microRNAs in human embryonic stem cells and neural precursors. PLoS One 2009;4:e7192. [PMID: 19784364 DOI: 10.1371/journal.pone.0007192] [Cited by in Crossref: 86] [Cited by in F6Publishing: 79] [Article Influence: 7.2] [Reference Citation Analysis]
247 Wada N, Wang B, Lin NH, Laslett AL, Gronthos S, Bartold PM. Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts. J Periodontal Res. 2011;46:438-447. [PMID: 21443752 DOI: 10.1111/j.1600-0765.2011.01358.x] [Cited by in Crossref: 87] [Cited by in F6Publishing: 71] [Article Influence: 8.7] [Reference Citation Analysis]
248 De Sousa PA, Gardner J, Sneddon S, Pells S, Tye BJ, Dand P, Collins DM, Stewart K, Shaw L, Przyborski S, Cooke M, McLaughlin KJ, Kimber SJ, Lieberman BA, Wilmut I, Brison DR. Clinically failed eggs as a source of normal human embryo stem cells. Stem Cell Res 2009;2:188-97. [PMID: 19393594 DOI: 10.1016/j.scr.2009.01.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
249 Deshpande R, Sharma S, Verfaillie CM, Hu WS, Myers CL. A scalable approach for discovering conserved active subnetworks across species. PLoS Comput Biol 2010;6:e1001028. [PMID: 21170309 DOI: 10.1371/journal.pcbi.1001028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
250 Sun Y, Li W, Lu Z, Chen R, Ling J, Ran Q, Jilka RL, Chen XD. Rescuing replication and osteogenesis of aged mesenchymal stem cells by exposure to a young extracellular matrix. FASEB J. 2011;25:1474-1485. [PMID: 21248241 DOI: 10.1096/fj.10-161497] [Cited by in Crossref: 128] [Cited by in F6Publishing: 107] [Article Influence: 12.8] [Reference Citation Analysis]
251 Chen HF, Kuo HC, Lin SP, Chien CL, Chiang MS, Ho HN. Hypoxic culture maintains self-renewal and enhances embryoid body formation of human embryonic stem cells. Tissue Eng Part A 2010;16:2901-13. [PMID: 20533883 DOI: 10.1089/ten.tea.2009.0722] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
252 Geens M, Seriola A, Barbé L, Santalo J, Veiga A, Dée K, Van Haute L, Sermon K, Spits C. Female human pluripotent stem cells rapidly lose X chromosome inactivation marks and progress to a skewed methylation pattern during culture. Mol Hum Reprod 2016;22:285-98. [DOI: 10.1093/molehr/gaw004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
253 Bártová E, Galiová G, Krejcí J, Harnicarová A, Strasák L, Kozubek S. Epigenome and chromatin structure in human embryonic stem cells undergoing differentiation. Dev Dyn. 2008;237:3690-3702. [PMID: 18985715 DOI: 10.1002/dvdy.21773] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 3.7] [Reference Citation Analysis]
254 Wongtrakoongate P, Jones M, Gokhale PJ, Andrews PW. STELLA facilitates differentiation of germ cell and endodermal lineages of human embryonic stem cells. PLoS One. 2013;8:e56893. [PMID: 23457636 DOI: 10.1371/journal.pone.0056893] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
255 Rezai Rad M, Liu D, He H, Brooks H, Xiao M, Wise GE, Yao S. The role of dentin matrix protein 1 (DMP1) in regulation of osteogenic differentiation of rat dental follicle stem cells (DFSCs). Arch Oral Biol 2015;60:546-56. [PMID: 25596638 DOI: 10.1016/j.archoralbio.2014.12.013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
256 Andrews PD. Discovering small molecules to control stem cell fate. Future Med Chem 2011;3:1539-49. [PMID: 21882946 DOI: 10.4155/fmc.11.98] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
257 Heiskanen A, Hirvonen T, Salo H, Impola U, Olonen A, Laitinen A, Tiitinen S, Natunen S, Aitio O, Miller-Podraza H, Wuhrer M, Deelder AM, Natunen J, Laine J, Lehenkari P, Saarinen J, Satomaa T, Valmu L. Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage. Glycoconj J 2009;26:367-84. [PMID: 19037724 DOI: 10.1007/s10719-008-9217-6] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
258 Masaki H, Ishikawa T, Takahashi S, Okumura M, Sakai N, Haga M, Kominami K, Migita H, McDonald F, Shimada F. Heterogeneity of pluripotent marker gene expression in colonies generated in human iPS cell induction culture. Stem Cell Res. 2007;1:105-115. [PMID: 19383391 DOI: 10.1016/j.scr.2008.01.001] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
259 Fang YL, Chen XG, W T G. Gene delivery in tissue engineering and regenerative medicine. J Biomed Mater Res B Appl Biomater 2015;103:1679-99. [PMID: 25557560 DOI: 10.1002/jbm.b.33354] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 2.1] [Reference Citation Analysis]
260 Ben-david U, Nudel N, Benvenisty N. Immunologic and chemical targeting of the tight-junction protein Claudin-6 eliminates tumorigenic human pluripotent stem cells. Nat Commun 2013;4. [DOI: 10.1038/ncomms2992] [Cited by in Crossref: 82] [Cited by in F6Publishing: 75] [Article Influence: 10.3] [Reference Citation Analysis]
261 Maruotti J, Dai XP, Brochard V, Jouneau L, Liu J, Bonnet-garnier A, Jammes H, Vallier L, Brons IGM, Pedersen R, Renard J, Zhou Q, Jouneau A. Nuclear Transfer-Derived Epiblast Stem Cells Are Transcriptionally and Epigenetically Distinguishable from Their Fertilized-Derived Counterparts. STEM CELLS 2010;28:743-52. [DOI: 10.1002/stem.400] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
262 Zhang J, Wilson GF, Soerens AG, Koonce CH, Yu J, Palecek SP, Thomson JA, Kamp TJ. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res. 2009;104:e30-e41. [PMID: 19213953 DOI: 10.1161/circresaha.108.192237] [Cited by in Crossref: 882] [Cited by in F6Publishing: 503] [Article Influence: 73.5] [Reference Citation Analysis]
263 Doğan A. Embryonic Stem Cells in Development and Regenerative Medicine. Adv Exp Med Biol 2018;1079:1-15. [PMID: 29464659 DOI: 10.1007/5584_2018_175] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
264 Sundberg M, Jansson L, Ketolainen J, Pihlajamäki H, Suuronen R, Skottman H, Inzunza J, Hovatta O, Narkilahti S. CD marker expression profiles of human embryonic stem cells and their neural derivatives, determined using flow-cytometric analysis, reveal a novel CD marker for exclusion of pluripotent stem cells. Stem Cell Res. 2009;2:113-124. [PMID: 19383417 DOI: 10.1016/j.scr.2008.08.001] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 5.5] [Reference Citation Analysis]
265 Moon SH, Ju J, Park SJ, Bae D, Chung HM, Lee SH. Optimizing human embryonic stem cells differentiation efficiency by screening size-tunable homogenous embryoid bodies. Biomaterials. 2014;35:5987-5997. [PMID: 24780170 DOI: 10.1016/j.biomaterials.2014.04.001] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
266 Stadler B, Ivanovska I, Mehta K, Song S, Nelson A, Tan Y, Mathieu J, Darby C, Blau CA, Ware C, Peters G, Miller DG, Shen L, Cleary MA, Ruohola-Baker H. Characterization of microRNAs involved in embryonic stem cell states. Stem Cells Dev 2010;19:935-50. [PMID: 20128659 DOI: 10.1089/scd.2009.0426] [Cited by in Crossref: 118] [Cited by in F6Publishing: 106] [Article Influence: 10.7] [Reference Citation Analysis]
267 Sobol M, Raykova D, Cavelier L, Khalfallah A, Schuster J, Dahl N. Methods of Reprogramming to Induced Pluripotent Stem Cell Associated with Chromosomal Integrity and Delineation of a Chromosome 5q Candidate Region for Growth Advantage. Stem Cells Dev. 2015;24:2032-2040. [PMID: 25867454 DOI: 10.1089/scd.2015.0061] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
268 Cheung AY, Horvath LM, Carrel L, Ellis J. X-chromosome inactivation in rett syndrome human induced pluripotent stem cells. Front Psychiatry 2012;3:24. [PMID: 22470355 DOI: 10.3389/fpsyt.2012.00024] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
269 Han W, Zhao Y, Fu X. Induced Pluripotent Stem Cells: The Dragon Awakens. BioScience 2010;60:278-85. [DOI: 10.1525/bio.2010.60.4.6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
270 Francipane MG, Bulanin D, Lagasse E. Establishment and Characterization of 5-Fluorouracil-Resistant Human Colorectal Cancer Stem-Like Cells: Tumor Dynamics under Selection Pressure. Int J Mol Sci 2019;20:E1817. [PMID: 31013771 DOI: 10.3390/ijms20081817] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
271 Sakurada K, Mcdonald F, Shimada F. Regenerative Medizin und stammzellbasierte Wirkstoffentwicklung. Angew Chem 2008;120:5802-23. [DOI: 10.1002/ange.200700724] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
272 Kelber JA, Shani G, Booker EC, Vale WW, Gray PC. Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal. J Biol Chem 2008;283:4490-500. [PMID: 18089557 DOI: 10.1074/jbc.M704960200] [Cited by in Crossref: 47] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
273 Brøchner CB, Holst CB, Møllgård K. Outer brain barriers in rat and human development. Front Neurosci 2015;9:75. [PMID: 25852456 DOI: 10.3389/fnins.2015.00075] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
274 Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW, Daley GQ. Reprogramming of human somatic cells to pluripotency with defined factors. Nature. 2008;451:141-146. [PMID: 18157115 DOI: 10.1038/nature06534] [Cited by in Crossref: 2081] [Cited by in F6Publishing: 1806] [Article Influence: 148.6] [Reference Citation Analysis]
275 Liao CH, Wang YH, Chang WW, Yang BC, Wu TJ, Liu WL, Yu AL, Yu J. Leucine-Rich Repeat Neuronal Protein 1 Regulates Differentiation of Embryonic Stem Cells by Post-Translational Modifications of Pluripotency Factors. Stem Cells 2018;36:1514-24. [PMID: 29893054 DOI: 10.1002/stem.2862] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
276 Bissels U, Eckardt D, Bosio A. Characterization and Classification of Stem Cells. In: Steinhoff G, editor. Regenerative Medicine. Dordrecht: Springer Netherlands; 2013. pp. 155-76. [DOI: 10.1007/978-94-007-5690-8_6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
277 Wakao S, Kitada M, Kuroda Y, Ogura F, Murakami T, Niwa A, Dezawa M. Morphologic and gene expression criteria for identifying human induced pluripotent stem cells. PLoS One 2012;7:e48677. [PMID: 23272044 DOI: 10.1371/journal.pone.0048677] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
278 Tang C, Drukker M. Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations. Semin Immunopathol 2011;33:563-72. [PMID: 21479877 DOI: 10.1007/s00281-011-0269-5] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
279 Darr H, Benvenisty N. Genetic analysis of the role of the reprogramming gene LIN-28 in human embryonic stem cells. Stem Cells 2009;27:352-62. [PMID: 19038789 DOI: 10.1634/stemcells.2008-0720] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 5.3] [Reference Citation Analysis]
280 Harvey AJ, Rathjen J, Yu LJ, Gardner DK. Oxygen modulates human embryonic stem cell metabolism in the absence of changes in self-renewal. Reprod Fertil Dev 2016;28:446. [DOI: 10.1071/rd14013] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
281 Diaferia GR, Cardano M, Cattaneo M, Spinelli CC, Dessì SS, Deblasio P, Biunno I. The science of stem cell biobanking: Investing in the future. J Cell Physiol 2012;227:14-9. [DOI: 10.1002/jcp.22732] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
282 Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J, Nery JR, Lee L, Ye Z, Ngo QM. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009;462:315-322. [PMID: 19829295 DOI: 10.1038/nature08514] [Cited by in Crossref: 3021] [Cited by in F6Publishing: 2508] [Article Influence: 251.8] [Reference Citation Analysis]
283 Müller FJ, Laurent LC, Kostka D, Ulitsky I, Williams R, Lu C, Park IH, Rao MS, Shamir R, Schwartz PH, Schmidt NO, Loring JF. Regulatory networks define phenotypic classes of human stem cell lines. Nature 2008;455:401-5. [PMID: 18724358 DOI: 10.1038/nature07213] [Cited by in Crossref: 253] [Cited by in F6Publishing: 215] [Article Influence: 19.5] [Reference Citation Analysis]
284 Akkouh IA, Hribkova H, Grabiec M, Budinska E, Szabo A, Kasparek T, Andreassen OA, Sun YM, Djurovic S. Derivation and Molecular Characterization of a Morphological Subpopulation of Human iPSC Astrocytes Reveal a Potential Role in Schizophrenia and Clozapine Response. Schizophr Bull 2021:sbab092. [PMID: 34357384 DOI: 10.1093/schbul/sbab092] [Reference Citation Analysis]
285 Gaspard N, Vanderhaeghen P. From stem cells to neural networks: recent advances and perspectives for neurodevelopmental disorders. Dev Med Child Neurol 2011;53:13-7. [PMID: 21087236 DOI: 10.1111/j.1469-8749.2010.03827.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 3.5] [Reference Citation Analysis]
286 Pesl M, Pribyl J, Acimovic I, Vilotic A, Jelinkova S, Salykin A, Lacampagne A, Dvorak P, Meli AC, Skladal P, Rotrekl V. Atomic force microscopy combined with human pluripotent stem cell derived cardiomyocytes for biomechanical sensing. Biosensors and Bioelectronics 2016;85:751-7. [DOI: 10.1016/j.bios.2016.05.073] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 7.2] [Reference Citation Analysis]
287 Hunt CJ. Cryopreservation of Human Stem Cells for Clinical Application: A Review. Transfus Med Hemother. 2011;38:107-123. [PMID: 21566712 DOI: 10.1159/000326623] [Cited by in Crossref: 197] [Cited by in F6Publishing: 145] [Article Influence: 19.7] [Reference Citation Analysis]
288 Narwani K, Biancotti JC, Golan-Lev T, Buehler N, Hill D, Shifman S, Benvenisty N, Lavon N. Human embryonic stem cells from aneuploid blastocysts identified by pre-implantation genetic screening. In Vitro Cell Dev Biol Anim 2010;46:309-16. [PMID: 20224970 DOI: 10.1007/s11626-010-9303-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
289 Chang KH, Nelson AM, Fields PA, Hesson JL, Ulyanova T, Cao H, Nakamoto B, Ware CB, Papayannopoulou T. Diverse hematopoietic potentials of five human embryonic stem cell lines. Exp Cell Res. 2008;314:2930-2940. [PMID: 18692044 DOI: 10.1016/j.yexcr.2008.07.019] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
290 Gu B, Zhang J, Wang W, Mo L, Zhou Y, Chen L, Liu Y, Zhang M. Global expression of cell surface proteins in embryonic stem cells. PLoS One 2010;5:e15795. [PMID: 21209962 DOI: 10.1371/journal.pone.0015795] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
291 Ribeiro AO, Schoof CR, Izzotti A, Pereira LV, Vasques LR. MicroRNAs: modulators of cell identity, and their applications in tissue engineering. Microrna 2014;3:45-53. [PMID: 25069512 DOI: 10.2174/2211536603666140522003539] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
292 Sundberg M, Isacson O. Advances in stem-cell–generated transplantation therapy for Parkinson's disease. Expert Opinion on Biological Therapy 2014;14:437-53. [DOI: 10.1517/14712598.2014.876986] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
293 Chen YS, Pelekanos RA, Ellis RL, Horne R, Wolvetang EJ, Fisk NM. Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells. Stem Cells Transl Med. 2012;1:83-95. [PMID: 23197756 DOI: 10.5966/sctm.2011-0022] [Cited by in Crossref: 124] [Cited by in F6Publishing: 104] [Article Influence: 13.8] [Reference Citation Analysis]
294 Brøchner CB, Møllgård K. SSEA-4 and YKL-40 positive progenitor subtypes in the subventricular zone of developing human neocortex. Glia 2016;64:90-104. [PMID: 26295543 DOI: 10.1002/glia.22905] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
295 Schindler M, Siriwardena D, Kohler TN, Ellermann AL, Slatery E, Munger C, Hollfelder F, Boroviak TE. Agarose microgel culture delineates lumenogenesis in naive and primed human pluripotent stem cells. Stem Cell Reports 2021;16:1347-62. [PMID: 33979603 DOI: 10.1016/j.stemcr.2021.04.009] [Reference Citation Analysis]
296 O’connor MD, Wederell E, Robertson G, Delaney A, Morozova O, Poon SS, Yap D, Fee J, Zhao Y, Mcdonald H, Zeng T, Hirst M, Marra MA, Aparicio SA, Eaves CJ. Retinoblastoma-binding proteins 4 and 9 are important for human pluripotent stem cell maintenance. Experimental Hematology 2011;39:866-879.e1. [DOI: 10.1016/j.exphem.2011.05.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
297 Cohen MA, Itsykson P, Reubinoff BE. The role of FGF-signaling in early neural specification of human embryonic stem cells. Dev Biol 2010;340:450-8. [PMID: 20149789 DOI: 10.1016/j.ydbio.2010.01.030] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
298 Cheong H, Lee H, Park B, Kim H, Jang M, Han Y, Kim S, Kim Y, Shin H. Epigenetic modification of retinoic acid-treated human embryonic stem cells. BMB Reports 2010;43:830-5. [DOI: 10.5483/bmbrep.2010.43.12.830] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
299 Blow N. Stem cells: in search of common ground. Nature 2008;451:855-8. [PMID: 18273022 DOI: 10.1038/451855a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
300 Wright A, Andrews N, Bardsley K, Nielsen JE, Avery K, Pewsey E, Jones M, Harley D, Nielsen AR, Moore H. Mapping the stem cell state: eight novel human embryonic stem and embryonal carcinoma cell antibodies. Int J Androl. 2011;34:e175-e187; discussion e175-e187. [PMID: 21651578 DOI: 10.1111/j.1365-2605.2011.01185.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
301 Keil M, Siegert A, Eckert K, Gerlach J, Haider W, Fichtner I. Transcriptional expression profile of cultured human embryonic stem cells in vitro and in vivo. In Vitro Cell Dev Biol Anim 2012;48:165-74. [PMID: 22311374 DOI: 10.1007/s11626-012-9487-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
302 Dewi CU, Mason M, Cohen-Hyams T, Killingsworth MC, Harman DG, Gnanasambandapillai V, Liyanage L, O'Connor MD. A simplified method for producing human lens epithelial cells and light-focusing micro-lenses from pluripotent stem cells. Exp Eye Res 2021;202:108317. [PMID: 33130031 DOI: 10.1016/j.exer.2020.108317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
303 Jones GN, Moschidou D, Puga-Iglesias TI, Kuleszewicz K, Vanleene M, Shefelbine SJ, Bou-Gharios G, Fisk NM, David AL, De Coppi P. Ontological differences in first compared to third trimester human fetal placental chorionic stem cells. PLoS One. 2012;7:e43395. [PMID: 22962584 DOI: 10.1371/journal.pone.0043395] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 5.3] [Reference Citation Analysis]
304 Kanherkar RR, Bhatia-Dey N, Makarev E, Csoka AB. Cellular reprogramming for understanding and treating human disease. Front Cell Dev Biol 2014;2:67. [PMID: 25429365 DOI: 10.3389/fcell.2014.00067] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
305 Fusaki N, Ban H, Nishiyama A, Saeki K, Hasegawa M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc Jpn Acad Ser B Phys Biol Sci. 2009;85:348-362. [PMID: 19838014 DOI: 10.2183/pjab.85.348] [Cited by in Crossref: 899] [Cited by in F6Publishing: 706] [Article Influence: 81.7] [Reference Citation Analysis]
306 Song Q, Yuan S, An Q, Chen Y, Mao FF, Liu Y, Liu Q, Fan G. Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis. Experimental Eye Research 2016;151:107-14. [DOI: 10.1016/j.exer.2016.08.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
307 de Vries WN, Evsikov AV, Brogan LJ, Anderson CP, Graber JH, Knowles BB, Solter D. Reprogramming and differentiation in mammals: motifs and mechanisms. Cold Spring Harb Symp Quant Biol 2008;73:33-8. [PMID: 19022741 DOI: 10.1101/sqb.2008.73.016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
308 Vaňhara P, Kučera L, Prokeš L, Jurečková L, Peña-Méndez EM, Havel J, Hampl A. Intact Cell Mass Spectrometry as a Quality Control Tool for Revealing Minute Phenotypic Changes of Cultured Human Embryonic Stem Cells. Stem Cells Transl Med 2018;7:109-14. [PMID: 29248004 DOI: 10.1002/sctm.17-0107] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
309 Harkness L, Christiansen H, Nehlin J, Barington T, Andersen JS, Kassem M. Identification of a membrane proteomic signature for human embryonic stem cells independent of culture conditions. Stem Cell Research 2008;1:219-27. [DOI: 10.1016/j.scr.2008.06.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
310 Nishihara S. Glycans in stem cell regulation: from Drosophila tissue stem cells to mammalian pluripotent stem cells. FEBS Lett 2018;592:3773-90. [DOI: 10.1002/1873-3468.13167] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
311 Denning C, Anderson D. Cardiomyocytes from human embryonic stem cells as predictors of cardiotoxicity. Drug Discovery Today: Therapeutic Strategies 2008;5:223-32. [DOI: 10.1016/j.ddstr.2008.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
312 Gerwe BA, Angel PM, West FD, Hasneen K, Young A, Orlando R, Stice SL. Membrane proteomic signatures of karyotypically normal and abnormal human embryonic stem cell lines and derivatives. Proteomics 2011;11:2515-27. [DOI: 10.1002/pmic.201000032] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
313 Oh SKW, Chua P, Foon KL, Ng E, Chin A, Choo ABH, Srinivasan R. Quantitative identification of teratoma tissues formed by human embryonic stem cells with TeratomEye. Biotechnol Lett 2009;31:653-8. [DOI: 10.1007/s10529-009-9928-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
314 Quintanilla RH Jr, Asprer JS, Vaz C, Tanavde V, Lakshmipathy U. CD44 is a negative cell surface marker for pluripotent stem cell identification during human fibroblast reprogramming. PLoS One 2014;9:e85419. [PMID: 24416407 DOI: 10.1371/journal.pone.0085419] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 4.9] [Reference Citation Analysis]
315 Kamei K, Ohashi M, Gschweng E, Ho Q, Suh J, Tang J, For Yu ZT, Clark AT, Pyle AD, Teitell MA, Lee KB, Witte ON, Tseng HR. Microfluidic image cytometry for quantitative single-cell profiling of human pluripotent stem cells in chemically defined conditions. Lab Chip 2010;10:1113-9. [PMID: 20390128 DOI: 10.1039/b922884e] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
316 Li QV, Rosen BP, Huangfu D. Decoding pluripotency: Genetic screens to interrogate the acquisition, maintenance, and exit of pluripotency. Wiley Interdiscip Rev Syst Biol Med 2020;12:e1464. [PMID: 31407519 DOI: 10.1002/wsbm.1464] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
317 van Hoof D, Krijgsveld J, Mummery C. Proteomic analysis of stem cell differentiation and early development. Cold Spring Harb Perspect Biol. 2012;4. [PMID: 22317846 DOI: 10.1101/cshperspect.a008177] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
318 O'Rourke PP, Abelman M, Heffernan KG. Centralized banks for human embryonic stem cells: a worthwhile challenge. Cell Stem Cell 2008;2:307-12. [PMID: 18397750 DOI: 10.1016/j.stem.2008.03.018] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
319 Franek M, Kilar A, Fojtík P, Olšinová M, Benda A, Rotrekl V, Dvořáčková M, Fajkus J. Super-resolution microscopy of chromatin fibers and quantitative DNA methylation analysis of DNA fiber preparations. J Cell Sci 2021;134:jcs258374. [PMID: 34350964 DOI: 10.1242/jcs.258374] [Reference Citation Analysis]
320 Frost JM, Udayashankar R, Moore HD, Moore GE. Telomeric NAP1L4 and OSBPL5 of the KCNQ1 cluster, and the DECORIN gene are not imprinted in human trophoblast stem cells. PLoS One 2010;5:e11595. [PMID: 20644730 DOI: 10.1371/journal.pone.0011595] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
321 Som A, Luštrek M, Singh NK, Fuellen G. Derivation of an interaction/regulation network describing pluripotency in human. Gene 2012;502:99-107. [PMID: 22548825 DOI: 10.1016/j.gene.2012.04.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
322 Avior Y, Sagi I, Benvenisty N. Pluripotent stem cells in disease modelling and drug discovery. Nat Rev Mol Cell Biol 2016;17:170-82. [DOI: 10.1038/nrm.2015.27] [Cited by in Crossref: 363] [Cited by in F6Publishing: 281] [Article Influence: 72.6] [Reference Citation Analysis]
323 Hemmrich G, Bosch TC. Compagen, a comparative genomics platform for early branching metazoan animals, reveals early origins of genes regulating stem-cell differentiation. Bioessays 2008;30:1010-8. [DOI: 10.1002/bies.20813] [Cited by in Crossref: 91] [Cited by in F6Publishing: 69] [Article Influence: 7.0] [Reference Citation Analysis]
324 Liu YP, Hematti P. Generation of mesenchymal stromal cells from HOXB4-expressing human embryonic stem cells. Cytotherapy 2009;11:716-25. [PMID: 19878058 DOI: 10.3109/14653240903051566] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
325 Carpenter MK, Frey-Vasconcells J, Rao MS. Developing safe therapies from human pluripotent stem cells. Nat Biotechnol 2009;27:606-13. [PMID: 19587662 DOI: 10.1038/nbt0709-606] [Cited by in Crossref: 103] [Cited by in F6Publishing: 76] [Article Influence: 8.6] [Reference Citation Analysis]
326 Nazor KL, Altun G, Lynch C, Tran H, Harness JV, Slavin I, Garitaonandia I, Müller FJ, Wang YC, Boscolo FS, Fakunle E, Dumevska B, Lee S, Park HS, Olee T, D'Lima DD, Semechkin R, Parast MM, Galat V, Laslett AL, Schmidt U, Keirstead HS, Loring JF, Laurent LC. Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell 2012;10:620-34. [PMID: 22560082 DOI: 10.1016/j.stem.2012.02.013] [Cited by in Crossref: 280] [Cited by in F6Publishing: 232] [Article Influence: 31.1] [Reference Citation Analysis]
327 Yagi H, Tafaleng E, Nagaya M, Hansel MC, Strom SC, Fox IJ, Soto-Gutierrez A. Embryonic and induced pluripotent stem cells as a model for liver disease. Crit Rev Biomed Eng 2009;37:377-98. [PMID: 20528732 DOI: 10.1615/critrevbiomedeng.v37.i4-5.40] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
328 Martins TM, de Paula AC, Gomes DA, Goes AM. Alkaline phosphatase expression/activity and multilineage differentiation potential are the differences between fibroblasts and orbital fat-derived stem cells--a study in animal serum-free culture conditions. Stem Cell Rev Rep 2014;10:697-711. [PMID: 24913281 DOI: 10.1007/s12015-014-9529-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
329 Levina V, Marrangoni AM, DeMarco R, Gorelik E, Lokshin AE. Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One. 2008;3:e3077. [PMID: 18728788 DOI: 10.1371/journal.pone.0003077] [Cited by in Crossref: 304] [Cited by in F6Publishing: 271] [Article Influence: 23.4] [Reference Citation Analysis]
330 Hovatta O, Jaconi M, Töhönen V, Béna F, Gimelli S, Bosman A, Holm F, Wyder S, Zdobnov EM, Irion O, Andrews PW, Antonarakis SE, Zucchelli M, Kere J, Feki A. A teratocarcinoma-like human embryonic stem cell (hESC) line and four hESC lines reveal potentially oncogenic genomic changes. PLoS One 2010;5:e10263. [PMID: 20428235 DOI: 10.1371/journal.pone.0010263] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
331 Kozubenko N, Turnovcova K, Kapcalova M, Butenko O, Anderova M, Rusnakova V, Kubista M, Hampl A, Jendelova P, Sykova E. Analysis of in Vitro and in Vivo Characteristics of Human Embryonic Stem Cell-Derived Neural Precursors. Cell Transplant 2010;19:471-86. [DOI: 10.3727/096368909x484707b] [Cited by in Crossref: 10] [Article Influence: 0.9] [Reference Citation Analysis]
332 Sucha R, Kubickova M, Cervenka J, Hruska-Plochan M, Bohaciakova D, Vodickova Kepkova K, Novakova T, Budkova K, Susor A, Marsala M, Motlik J, Kovarova H, Vodicka P. Targeted mass spectrometry for monitoring of neural differentiation. Biol Open 2021;10:bio058727. [PMID: 34357391 DOI: 10.1242/bio.058727] [Reference Citation Analysis]
333 Takashima Y, Guo G, Loos R, Nichols J, Ficz G, Krueger F, Oxley D, Santos F, Clarke J, Mansfield W, Reik W, Bertone P, Smith A. Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell 2014;158:1254-69. [PMID: 25215486 DOI: 10.1016/j.cell.2014.08.029] [Cited by in Crossref: 549] [Cited by in F6Publishing: 440] [Article Influence: 78.4] [Reference Citation Analysis]
334 Ware CB, Wang L, Mecham BH, Shen L, Nelson AM, Bar M, Lamba DA, Dauphin DS, Buckingham B, Askari B, Lim R, Tewari M, Gartler SM, Issa JP, Pavlidis P, Duan Z, Blau CA. Histone deacetylase inhibition elicits an evolutionarily conserved self-renewal program in embryonic stem cells. Cell Stem Cell 2009;4:359-69. [PMID: 19341625 DOI: 10.1016/j.stem.2009.03.001] [Cited by in Crossref: 125] [Cited by in F6Publishing: 106] [Article Influence: 10.4] [Reference Citation Analysis]
335 Gage BK, Asadi A, Baker RK, Webber TD, Wang R, Itoh M, Hayashi M, Miyata R, Akashi T, Kieffer TJ. The Role of ARX in Human Pancreatic Endocrine Specification. PLoS One 2015;10:e0144100. [PMID: 26633894 DOI: 10.1371/journal.pone.0144100] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
336 Ungefroren H, Groth S, Hyder A, Thomsen N, Hinz H, Reiling N, Grage-griebenow E, Held-feindt J, Schulze M, Nüssler AK, Fändrich F. The Generation of Programmable Cells of Monocytic Origin Involves Partial Repression of Monocyte/Macrophage Markers and Reactivation of Pluripotency Genes. Stem Cells and Development 2010;19:1769-80. [DOI: 10.1089/scd.2009.0351] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
337 Osafune K, Caron L, Borowiak M, Martinez RJ, Fitz-Gerald CS, Sato Y, Cowan CA, Chien KR, Melton DA. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol. 2008;26:313-315. [PMID: 18278034 DOI: 10.1038/nbt1383] [Cited by in Crossref: 622] [Cited by in F6Publishing: 519] [Article Influence: 47.8] [Reference Citation Analysis]
338 Shofuda T, Kanematsu D, Fukusumi H, Yamamoto A, Bamba Y, Yoshitatsu S, Suemizu H, Nakamura M, Sugimoto Y, Furue MK, Kohara A, Akamatsu W, Okada Y, Okano H, Yamasaki M, Kanemura Y. Human Decidua-Derived Mesenchymal Cells Are a Promising Source for the Generation and Cell Banking of Human Induced Pluripotent Stem Cells. Cell Med 2013;4:125-47. [PMID: 26858858 DOI: 10.3727/215517912X658918] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
339 Kelber JA, Panopoulos AD, Shani G, Booker EC, Belmonte JC, Vale WW, Gray PC. Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways. Oncogene. 2009;28:2324-2336. [PMID: 19421146 DOI: 10.1038/onc.2009.97] [Cited by in Crossref: 128] [Cited by in F6Publishing: 112] [Article Influence: 10.7] [Reference Citation Analysis]
340 Blum B, Benvenisty N. The tumorigenicity of human embryonic stem cells. Adv Cancer Res. 2008;100:133-158. [PMID: 18620095 DOI: 10.1016/s0065-230x(08)00005-5] [Cited by in Crossref: 277] [Cited by in F6Publishing: 144] [Article Influence: 21.3] [Reference Citation Analysis]
341 Swartzman E, Shannon M, Lieu P, Chen SM, Mooney C, Wei E, Kuykendall J, Tan R, Settineri T, Egry L, Ruff D. Expanding applications of protein analysis using proximity ligation and qPCR. Methods 2010;50:S23-6. [PMID: 20215017 DOI: 10.1016/j.ymeth.2010.01.024] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
342 Riekstina U, Cakstina I, Parfejevs V, Hoogduijn M, Jankovskis G, Muiznieks I, Muceniece R, Ancans J. Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis. Stem Cell Rev. 2009;5:378-386. [PMID: 20058201 DOI: 10.1007/s12015-009-9094-9] [Cited by in Crossref: 218] [Cited by in F6Publishing: 184] [Article Influence: 19.8] [Reference Citation Analysis]
343 Amps KJ, Jones M, Baker D, Moore HD. In situ cryopreservation of human embryonic stem cells in gas-permeable membrane culture cassettes for high post-thaw yield and good manufacturing practice. Cryobiology 2010;60:344-50. [PMID: 20347760 DOI: 10.1016/j.cryobiol.2010.03.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
344 Ting S, Lecina M, Chan YC, Tse HF, Reuveny S, Oh SK. Nutrient supplemented serum-free medium increases cardiomyogenesis efficiency of human pluripotent stem cells. World J Stem Cells 2013;5:86-97. [PMID: 23904910 DOI: 10.4252/wjsc.v5.i3.86] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
345 Stephenson EL, Mason C, Braude PR. Preimplantation genetic diagnosis as a source of human embryonic stem cells for disease research and drug discovery. BJOG 2009;116:158-65. [PMID: 19076947 DOI: 10.1111/j.1471-0528.2008.02009.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
346 Grybek V, Aubry L, Maupetit-Méhouas S, Le Stunff C, Denis C, Girard M, Linglart A, Silve C. Methylation and transcripts expression at the imprinted GNAS locus in human embryonic and induced pluripotent stem cells and their derivatives. Stem Cell Reports 2014;3:432-43. [PMID: 25241742 DOI: 10.1016/j.stemcr.2014.07.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
347 Toyoda M, Yamazaki-Inoue M, Itakura Y, Kuno A, Ogawa T, Yamada M, Akutsu H, Takahashi Y, Kanzaki S, Narimatsu H, Hirabayashi J, Umezawa A. Lectin microarray analysis of pluripotent and multipotent stem cells. Genes Cells 2011;16:1-11. [PMID: 21155951 DOI: 10.1111/j.1365-2443.2010.01459.x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 51] [Article Influence: 6.2] [Reference Citation Analysis]
348 Xie W, Song C, Young NL, Sperling AS, Xu F, Sridharan R, Conway AE, Garcia BA, Plath K, Clark AT, Grunstein M. Histone h3 lysine 56 acetylation is linked to the core transcriptional network in human embryonic stem cells. Mol Cell 2009;33:417-27. [PMID: 19250903 DOI: 10.1016/j.molcel.2009.02.004] [Cited by in Crossref: 142] [Cited by in F6Publishing: 131] [Article Influence: 11.8] [Reference Citation Analysis]
349 Xu M, Wang X, Tan J, Zhang K, Guan X, Patterson LH, Ding H, Cui H. A novel Lozenge gene in silkworm, Bombyx mori regulates the melanization response of hemolymph. Developmental & Comparative Immunology 2015;53:191-8. [DOI: 10.1016/j.dci.2015.07.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
350 Oh SK, Choo AB. Advances and perspectives in human and mouse embryonic stem cell bioprocessing. Drug Discovery Today: Technologies 2008;5:e125-30. [DOI: 10.1016/j.ddtec.2008.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
351 Sermon KD, Simon C, Braude P, Viville S, Borstlap J, Veiga A. Creation of a registry for human embryonic stem cells carrying an inherited defect: joint collaboration between ESHRE and hESCreg. Hum Reprod 2009;24:1556-60. [PMID: 19346524 DOI: 10.1093/humrep/dep062] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
352 Markouli C, De Deckersberg EC, Dziedzicka D, Regin M, Franck S, Keller A, Gheldof A, Geens M, Sermon K, Spits C. Sustained intrinsic WNT and BMP4 activation impairs hESC differentiation to definitive endoderm and drives the cells towards extra-embryonic mesoderm. Sci Rep 2021;11:8242. [PMID: 33859268 DOI: 10.1038/s41598-021-87547-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
353 Bruck T, Benvenisty N. Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells. Stem Cell Res. 2011;6:187-193. [PMID: 21276761 DOI: 10.1016/j.scr.2010.12.001] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 4.7] [Reference Citation Analysis]
354 Nishikawa S, Goldstein RA, Nierras CR. The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol 2008;9:725-9. [PMID: 18698329 DOI: 10.1038/nrm2466] [Cited by in Crossref: 313] [Cited by in F6Publishing: 258] [Article Influence: 24.1] [Reference Citation Analysis]
355 Brown S, Matta A, Erwin M, Roberts S, Gruber HE, Hanley EN, Little CB, Melrose J. Cell Clusters Are Indicative of Stem Cell Activity in the Degenerate Intervertebral Disc: Can Their Properties Be Manipulated to Improve Intrinsic Repair of the Disc? Stem Cells and Development 2018;27:147-65. [DOI: 10.1089/scd.2017.0213] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
356 Ding H, Keller KC, Martinez IK, Geransar RM, zur Nieden KO, Nishikawa SG, Rancourt DE, zur Nieden NI. NO-β-catenin crosstalk modulates primitive streak formation prior to embryonic stem cell osteogenic differentiation. J Cell Sci 2012;125:5564-77. [PMID: 22946055 DOI: 10.1242/jcs.081703] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
357 Jeon K, Park K, Jetten AM. Efficient Neural Differentiation using Single-Cell Culture of Human Embryonic Stem Cells. J Vis Exp. 2020;. [PMID: 32009654 DOI: 10.3791/60571] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
358 International Stem Cell Initiative Consortium. Akopian V, Andrews PW, Beil S, Benvenisty N, Brehm J, Christie M, Ford A, Fox V, Gokhale PJ, Healy L, Holm F, Hovatta O, Knowles BB, Ludwig TE, McKay RD, Miyazaki T, Nakatsuji N, Oh SK, Pera MF, Rossant J, Stacey GN, Suemori H. Comparison of defined culture systems for feeder cell free propagation of human embryonic stem cells. In Vitro Cell Dev Biol Anim. 2010;46:247-258. [PMID: 20186512 DOI: 10.1007/s11626-010-9297-z] [Cited by in Crossref: 148] [Cited by in F6Publishing: 121] [Article Influence: 13.5] [Reference Citation Analysis]
359 Krivega MV, Geens M, Heindryckx B, Santos-Ribeiro S, Tournaye H, Van de Velde H. Cyclin E1 plays a key role in balancing between totipotency and differentiation in human embryonic cells. Mol Hum Reprod 2015;21:942-56. [PMID: 26416983 DOI: 10.1093/molehr/gav053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
360 Virant-Klun I, Skutella T, Hren M, Gruden K, Cvjeticanin B, Vogler A, Sinkovec J. Isolation of small SSEA-4-positive putative stem cells from the ovarian surface epithelium of adult human ovaries by two different methods. Biomed Res Int 2013;2013:690415. [PMID: 23509763 DOI: 10.1155/2013/690415] [Cited by in Crossref: 24] [Cited by in F6Publishing: 35] [Article Influence: 3.0] [Reference Citation Analysis]
361 Bosio A, Huppert V, Donath S, Hennemann P, Malchow M, Heinlein UAO. Isolation and Enrichment of Stem Cells. In: Martin U, editor. Engineering of Stem Cells. Berlin: Springer Berlin Heidelberg; 2009. pp. 23-72. [DOI: 10.1007/10_2008_38] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
362 Stephenson E, Jacquet L, Miere C, Wood V, Kadeva N, Cornwell G, Codognotto S, Dajani Y, Braude P, Ilic D. Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product-free environment. Nat Protoc 2012;7:1366-81. [PMID: 22722371 DOI: 10.1038/nprot.2012.080] [Cited by in Crossref: 58] [Cited by in F6Publishing: 33] [Article Influence: 6.4] [Reference Citation Analysis]
363 Bianco C, Rangel MC, Castro NP, Nagaoka T, Rollman K, Gonzales M, Salomon DS. Role of Cripto-1 in stem cell maintenance and malignant progression. Am J Pathol 2010;177:532-40. [PMID: 20616345 DOI: 10.2353/ajpath.2010.100102] [Cited by in Crossref: 82] [Cited by in F6Publishing: 71] [Article Influence: 7.5] [Reference Citation Analysis]
364 Preskey D, Allison TF, Jones M, Mamchaoui K, Unger C. Synthetically modified mRNA for efficient and fast human iPS cell generation and direct transdifferentiation to myoblasts. Biochem Biophys Res Commun 2016;473:743-51. [PMID: 26449459 DOI: 10.1016/j.bbrc.2015.09.102] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
365 Danter WR. DeepNEU: cellular reprogramming comes of age - a machine learning platform with application to rare diseases research. Orphanet J Rare Dis. 2019;14:13. [PMID: 30630505 DOI: 10.1186/s13023-018-0983-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
366 Romito A, Cobellis G. Pluripotent Stem Cells: Current Understanding and Future Directions. Stem Cells Int. 2016;2016:9451492. [PMID: 26798367 DOI: 10.1155/2016/9451492] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
367 Ptaszek LM, Cowan CA. Determinants of Pluripotency in Mouse and Human Embryonic Stem Cells. In: Rajasekhar VK, Vemuri MC, editors. Regulatory Networks in Stem Cells. Totowa: Humana Press; 2009. pp. 27-36. [DOI: 10.1007/978-1-60327-227-8_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
368 Liu J, Jones KL, Sumer H, Verma PJ. Stable transgene expression in human embryonic stem cells after simple chemical transfection. Mol Reprod Dev 2009;76:580-6. [PMID: 19034957 DOI: 10.1002/mrd.20983] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
369 Sun C, Zhang J, Zheng D, Wang J, Yang H, Zhang X. Transcriptome variations among human embryonic stem cell lines are associated with their differentiation propensity. PLoS One. 2018;13:e0192625. [PMID: 29444173 DOI: 10.1371/journal.pone.0192625] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
370 Wongtrakoongate P, Li J, Andrews PW. DNMT3B inhibits the re-expression of genes associated with induced pluripotency. Exp Cell Res. 2014;321:231-239. [PMID: 24333507 DOI: 10.1016/j.yexcr.2013.11.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
371 Barta T, Dolezalova D, Holubcova Z, Hampl A. Cell cycle regulation in human embryonic stem cells: links to adaptation to cell culture. Exp Biol Med (Maywood) 2013;238:271-5. [PMID: 23598972 DOI: 10.1177/1535370213480711] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
372 Stefanova VT, Grifo JA, Hansis C. Derivation of novel genetically diverse human embryonic stem cell lines. Stem Cells Dev 2012;21:1559-70. [PMID: 22204497 DOI: 10.1089/scd.2011.0642] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
373 Gokhale PJ, Andrews PW. Human embryonic stem cells: 10 years on. Lab Invest 2009;89:259-62. [PMID: 19153556 DOI: 10.1038/labinvest.2008.162] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
374 Löser P, Schirm J, Guhr A, Wobus AM, Kurtz A. Human embryonic stem cell lines and their use in international research. Stem Cells 2010;28:240-6. [PMID: 20027651 DOI: 10.1002/stem.286] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 0.4] [Reference Citation Analysis]
375 Wesselschmidt RL. The Teratoma Assay: An In Vivo Assessment of Pluripotency. In: Schwartz PH, Wesselschmidt RL, editors. Human Pluripotent Stem Cells. Totowa: Humana Press; 2011. pp. 231-41. [DOI: 10.1007/978-1-61779-201-4_17] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
376 Viter R, Jekabsons K, Kalnina Z, Poletaev N, Hsu SH, Riekstina U. Bioanalytical system for detection of cancer cells with photoluminescent ZnO nanorods. Nanotechnology 2016;27:465101. [DOI: 10.1088/0957-4484/27/46/465101] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
377 Fong CY, Chak LL, Biswas A, Tan JH, Gauthaman K, Chan WK, Bongso A. Human Wharton’s jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev. 2011;7:1-16. [PMID: 20602182 DOI: 10.1007/s12015-010-9166-x] [Cited by in Crossref: 204] [Cited by in F6Publishing: 176] [Article Influence: 20.4] [Reference Citation Analysis]
378 Skelton RJP, Kamp TJ, Elliott DA, Ardehali R. Biomarkers of Human Pluripotent Stem Cell-Derived Cardiac Lineages. Trends Mol Med. 2017;23:651-668. [PMID: 28576602 DOI: 10.1016/j.molmed.2017.05.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
379 Fischer Y, Ganic E, Ameri J, Xian X, Johannesson M, Semb H. NANOG reporter cell lines generated by gene targeting in human embryonic stem cells. PLoS One. 2010;5. [PMID: 20824089 DOI: 10.1371/journal.pone.0012533] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
380 Chen AE, Egli D, Niakan K, Deng J, Akutsu H, Yamaki M, Cowan C, Fitz-Gerald C, Zhang K, Melton DA. Optimal timing of inner cell mass isolation increases the efficiency of human embryonic stem cell derivation and allows generation of sibling cell lines. Cell Stem Cell. 2009;4:103-106. [PMID: 19200798 DOI: 10.1016/j.stem.2008.12.001] [Cited by in Crossref: 140] [Cited by in F6Publishing: 115] [Article Influence: 11.7] [Reference Citation Analysis]
381 Abujarour R, Valamehr B, Robinson M, Rezner B, Vranceanu F, Flynn P. Optimized surface markers for the prospective isolation of high-quality hiPSCs using flow cytometry selection. Sci Rep 2013;3:1179. [PMID: 23378912 DOI: 10.1038/srep01179] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
382 Ovchinnikov DA, Turner JP, Titmarsh DM, Thakar NY, Sin DC, Cooper-White JJ, Wolvetang EJ. Generation of a human embryonic stem cell line stably expressing high levels of the fluorescent protein mCherry. World J Stem Cells 2012;4:71-9. [PMID: 22993664 DOI: 10.4252/wjsc.v4.i7.71] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
383 Bock C, Kiskinis E, Verstappen G, Gu H, Boulting G, Smith ZD, Ziller M, Croft GF, Amoroso MW, Oakley DH, Gnirke A, Eggan K, Meissner A. Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell. 2011;144:439-452. [PMID: 21295703 DOI: 10.1016/j.cell.2010.12.032] [Cited by in Crossref: 723] [Cited by in F6Publishing: 580] [Article Influence: 72.3] [Reference Citation Analysis]
384 Venu P, Chakraborty S, Inamdar MS. Analysis of long-term culture properties and pluripotent character of two sibling human embryonic stem cell lines derived from discarded embryos. In Vitro Cell Dev Biol Anim 2010;46:200-5. [PMID: 20178003 DOI: 10.1007/s11626-010-9277-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
385 Elliott AM, Elliott KA, Kammesheidt A. High resolution array-CGH characterization of human stem cells using a stem cell focused microarray. Mol Biotechnol 2010;46:234-42. [PMID: 20524159 DOI: 10.1007/s12033-010-9294-1] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 4.2] [Reference Citation Analysis]
386 Huntriss JD, Hemmings KE, Hinkins M, Rutherford AJ, Sturmey RG, Elder K, Picton HM. Variable imprinting of the MEST gene in human preimplantation embryos. Eur J Hum Genet 2013;21:40-7. [PMID: 22763377 DOI: 10.1038/ejhg.2012.102] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
387 Liew CG, Andrews PW. Stem cell therapy to treat diabetes mellitus. Rev Diabet Stud 2008;5:203-19. [PMID: 19290381 DOI: 10.1900/RDS.2008.5.203] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
388 Hudson J, Titmarsh D, Hidalgo A, Wolvetang E, Cooper-White J. Primitive cardiac cells from human embryonic stem cells. Stem Cells Dev 2012;21:1513-23. [PMID: 21933026 DOI: 10.1089/scd.2011.0254] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 6.0] [Reference Citation Analysis]
389 Chen H, Aksoy I, Gonnot F, Osteil P, Aubry M, Hamela C, Rognard C, Hochard A, Voisin S, Fontaine E, Mure M, Afanassieff M, Cleroux E, Guibert S, Chen J, Vallot C, Acloque H, Genthon C, Donnadieu C, De Vos J, Sanlaville D, Guérin JF, Weber M, Stanton LW, Rougeulle C, Pain B, Bourillot PY, Savatier P. Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency. Nat Commun 2015;6:7095. [PMID: 25968054 DOI: 10.1038/ncomms8095] [Cited by in Crossref: 101] [Cited by in F6Publishing: 85] [Article Influence: 16.8] [Reference Citation Analysis]
390 Mittal S, Mifflin R, Powell DW. Cancer stem cells: the other face of Janus. Am J Med Sci 2009;338:107-12. [PMID: 19680015 DOI: 10.1097/MAJ.0b013e3181ad5865] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
391 Gu B, Zhang J, Wu Y, Zhang X, Tan Z, Lin Y, Huang X, Chen L, Yao K, Zhang M. Proteomic analyses reveal common promiscuous patterns of cell surface proteins on human embryonic stem cells and sperms. PLoS One 2011;6:e19386. [PMID: 21559292 DOI: 10.1371/journal.pone.0019386] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
392 Abu Dawud R, Schreiber K, Schomburg D, Adjaye J. Human embryonic stem cells and embryonal carcinoma cells have overlapping and distinct metabolic signatures. PLoS One 2012;7:e39896. [PMID: 22768158 DOI: 10.1371/journal.pone.0039896] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
393 Gu X, Li X, Jin Y, Zhang Z, Li M, Liu D, Wei F. CDR1as regulated by hnRNPM maintains stemness of periodontal ligament stem cells via miR-7/KLF4. J Cell Mol Med 2021;25:4501-15. [PMID: 33837664 DOI: 10.1111/jcmm.16541] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
394 Bukovsky A, Caudle MR, Virant-klun I, Gupta SK, Dominguez R, Svetlikova M, Xu F. Immune physiology and oogenesis in fetal and adult humans, ovarian infertility, and totipotency of adult ovarian stem cells. Birth Defect Res C 2009;87:64-89. [DOI: 10.1002/bdrc.20146] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
395 Gillich A, Hayashi K. Switching stem cell state through programmed germ cell reprogramming. Differentiation 2011;81:281-91. [PMID: 21330045 DOI: 10.1016/j.diff.2011.01.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
396 Singh U, Quintanilla RH, Grecian S, Gee KR, Rao MS, Lakshmipathy U. Novel live alkaline phosphatase substrate for identification of pluripotent stem cells. Stem Cell Rev Rep 2012;8:1021-9. [PMID: 22426885 DOI: 10.1007/s12015-012-9359-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 23] [Article Influence: 4.7] [Reference Citation Analysis]
397 Zahorec P, Koller J, Danisovic L, Bohac M. Mesenchymal stem cells for chronic wounds therapy. Cell Tissue Bank 2015;16:19-26. [PMID: 24651970 DOI: 10.1007/s10561-014-9440-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
398 Hu K, Ianov L, Crossman D. Profiling and quantification of pluripotency reprogramming reveal that WNT pathways and cell morphology have to be reprogramed extensively. Heliyon 2020;6:e04035. [PMID: 32490244 DOI: 10.1016/j.heliyon.2020.e04035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
399 Martin C, Olmos É, Collignon M, De Isla N, Blanchard F, Chevalot I, Marc A, Guedon E. Revisiting MSC expansion from critical quality attributes to critical culture process parameters. Process Biochemistry 2017;59:231-43. [DOI: 10.1016/j.procbio.2016.04.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
400 Sokolov MV, Neumann RD. Human embryonic stem cell responses to ionizing radiation exposures: current state of knowledge and future challenges. Stem Cells Int 2012;2012:579104. [PMID: 22966236 DOI: 10.1155/2012/579104] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
401 Han U, Park HH, Kim YJ, Park TH, Park JH, Hong J. Efficient Encapsulation and Sustained Release of Basic Fibroblast Growth Factor in Nanofilm: Extension of the Feeding Cycle of Human Induced Pluripotent Stem Cell Culture. ACS Appl Mater Interfaces 2017;9:25087-97. [DOI: 10.1021/acsami.7b05519] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
402 Arnold A, Naaldijk YM, Fabian C, Wirth H, Binder H, Nikkhah G, Armstrong L, Stolzing A. Reprogramming of Human Huntington Fibroblasts Using mRNA. ISRN Cell Biology 2012;2012:1-12. [DOI: 10.5402/2012/124878] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
403 Salci KR, Lee JH, Laronde S, Dingwall S, Kushwah R, Fiebig-Comyn A, Leber B, Foley R, Dal Cin A, Bhatia M. Cellular Reprogramming Allows Generation of Autologous Hematopoietic Progenitors From AML Patients That Are Devoid of Patient-Specific Genomic Aberrations. Stem Cells 2015;33:1839-49. [PMID: 25764124 DOI: 10.1002/stem.1994] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
404 Shen Y, Matsuno Y, Fouse SD, Rao N, Root S, Xu R, Pellegrini M, Riggs AD, Fan G. X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations. Proc Natl Acad Sci USA. 2008;105:4709-4714. [PMID: 18339804 DOI: 10.1073/pnas.0712018105] [Cited by in Crossref: 151] [Cited by in F6Publishing: 134] [Article Influence: 11.6] [Reference Citation Analysis]
405 Sartipy P. Advancing pluripotent stem cell culture: it is a matter of setting the standard. Stem Cells Dev 2013;22:1159-61. [PMID: 23330735 DOI: 10.1089/scd.2012.0668] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
406 Toyoda H, Nagai Y, Kojima A, Kinoshita-Toyoda A. Podocalyxin as a major pluripotent marker and novel keratan sulfate proteoglycan in human embryonic and induced pluripotent stem cells. Glycoconj J 2017;34:817-23. [PMID: 28980094 DOI: 10.1007/s10719-017-9801-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
407 Colman A, Dreesen O. Induced pluripotent stem cells and the stability of the differentiated state. EMBO Rep 2009;10:714-21. [PMID: 19543232 DOI: 10.1038/embor.2009.142] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
408 Gao L, Thilakavathy K, Nordin N. A plethora of human pluripotent stem cells: Human pluripotent stem cells. Cell Biol Int 2013;37:875-87. [DOI: 10.1002/cbin.10120] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
409 Gopalakrishna-Pillai S, Iverson LE. A DNMT3B alternatively spliced exon and encoded peptide are novel biomarkers of human pluripotent stem cells. PLoS One 2011;6:e20663. [PMID: 21698279 DOI: 10.1371/journal.pone.0020663] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
410 van de Stolpe A, den Toonder J. Workshop meeting report Organs-on-Chips: human disease models. Lab Chip 2013;13:3449. [DOI: 10.1039/c3lc50248a] [Cited by in Crossref: 62] [Cited by in F6Publishing: 44] [Article Influence: 7.8] [Reference Citation Analysis]
411 Healy L, Young L, Stacey GN. Stem cell banks: preserving cell lines, maintaining genetic integrity, and advancing research. Methods Mol Biol 2011;767:15-27. [PMID: 21822864 DOI: 10.1007/978-1-61779-201-4_2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
412 Boulanger CA, Bruno RD, Mack DL, Gonzales M, Castro NP, Salomon DS, Smith GH. Embryonic stem cells are redirected to non-tumorigenic epithelial cell fate by interaction with the mammary microenvironment. PLoS One 2013;8:e62019. [PMID: 23637952 DOI: 10.1371/journal.pone.0062019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
413 Fonseca NA, Cruz AF, Moura V, Simões S, Moreira JN. The cancer stem cell phenotype as a determinant factor of the heterotypic nature of breast tumors. Critical Reviews in Oncology/Hematology 2017;113:111-21. [DOI: 10.1016/j.critrevonc.2017.03.016] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
414 Balbous A, Cortes U, Guilloteau K, Villalva C, Flamant S, Gaillard A, Milin S, Wager M, Sorel N, Guilhot J. A mesenchymal glioma stem cell profile is related to clinical outcome. Oncogenesis. 2014;3:e91. [PMID: 24637491 DOI: 10.1038/oncsis.2014.5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
415 Ben-Yehudah A, Navara CS, Redinger CJ, Mich-Basso JD, Castro CA, Oliver S, Chensny LJ, Richards TJ, Kaminski N, Schatten G. Pluripotency genes overexpressed in primate embryonic stem cells are localized on homologues of human chromosomes 16, 17, 19, and X. Stem Cell Res 2010;4:25-37. [PMID: 19854689 DOI: 10.1016/j.scr.2009.09.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
416 Wang X. Computational analysis of expression of human embryonic stem cell-associated signatures in tumors. BMC Res Notes 2011;4:471. [PMID: 22041030 DOI: 10.1186/1756-0500-4-471] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
417 Hope K, Bhatia M. Clonal interrogation of stem cells. Nat Methods 2011;8:S36-40. [PMID: 21451511 DOI: 10.1038/nmeth.1590] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
418 Petrus-Reurer S, Kumar P, Padrell Sánchez S, Aronsson M, André H, Bartuma H, Plaza Reyes A, Nandrot EF, Kvanta A, Lanner F. Preclinical safety studies of human embryonic stem cell-derived retinal pigment epithelial cells for the treatment of age-related macular degeneration. Stem Cells Transl Med 2020;9:936-53. [PMID: 32319201 DOI: 10.1002/sctm.19-0396] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
419 Strasák L, Bártová E, Harnicarová A, Galiová G, Krejcí J, Kozubek S. H3K9 acetylation and radial chromatin positioning. J Cell Physiol 2009;220:91-101. [PMID: 19248079 DOI: 10.1002/jcp.21734] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
420 Tang C, Weissman IL, Drukker M. Immunogenicity of in vitro maintained and matured populations: potential barriers to engraftment of human pluripotent stem cell derivatives. Methods Mol Biol 2013;1029:17-31. [PMID: 23756939 DOI: 10.1007/978-1-62703-478-4_2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
421 Kuroda T, Yasuda S, Tachi S, Matsuyama S, Kusakawa S, Tano K, Miura T, Matsuyama A, Sato Y. SALL3 expression balance underlies lineage biases in human induced pluripotent stem cell differentiation. Nat Commun. 2019;10:2175. [PMID: 31092818 DOI: 10.1038/s41467-019-09511-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
422 Yen ML, Hou CH, Peng KY, Tseng PC, Jiang SS, Shun CT, Chen YC, Kuo ML. Efficient derivation and concise gene expression profiling of human embryonic stem cell-derived mesenchymal progenitors (EMPs). Cell Transplant 2011;20:1529-45. [PMID: 21396155 DOI: 10.3727/096368910X564067] [Cited by in Crossref: 44] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
423 Förstera B, a Dzaye OD, Winkelmann A, Semtner M, Benedetti B, Markovic DS, Synowitz M, Wend P, Fähling M, Junier M, Glass R, Kettenmann H, Meier JC. Intracellular glycine receptor function facilitates glioma formation in vivo. Journal of Cell Science. [DOI: 10.1242/jcs.146662] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
424 Farin A, Liu CY, Elder JB, Langmoen IA, Apuzzo ML. The biological restoration of central nervous system architecture and function: part 1-foundations and historical landmarks in contemporary stem cell biology. Neurosurgery 2009;64:15-39; discussion 34. [PMID: 19145154 DOI: 10.1227/01.NEU.0000337580.02706.DC] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
425 Caballero M, Pappa AK, Roden KS, Krochmal DJ, van Aalst JA. Osteoinduction of umbilical cord and palate periosteum-derived mesenchymal stem cells on poly(lactic-co-glycolic) acid nanomicrofibers. Ann Plast Surg 2014;72:S176-83. [PMID: 24691324 DOI: 10.1097/SAP.0000000000000107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
426 Tomita S, Sakao M, Kurita R, Niwa O, Yoshimoto K. A polyion complex sensor array for markerless and noninvasive identification of differentiated mesenchymal stem cells from human adipose tissue. Chem Sci 2015;6:5831-6. [PMID: 28970874 DOI: 10.1039/c5sc01259g] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
427 Cunningham JJ, Ulbright TM, Pera MF, Looijenga LH. Lessons from human teratomas to guide development of safe stem cell therapies. Nat Biotechnol. 2012;30:849-857. [PMID: 22965062 DOI: 10.1038/nbt.2329] [Cited by in Crossref: 124] [Cited by in F6Publishing: 106] [Article Influence: 15.5] [Reference Citation Analysis]
428 El-Badawy A, Ghoneim MA, Gabr MM, Salah RA, Mohamed IK, Amer M, El-Badri N. Cancer cell-soluble factors reprogram mesenchymal stromal cells to slow cycling, chemoresistant cells with a more stem-like state. Stem Cell Res Ther 2017;8:254. [PMID: 29115987 DOI: 10.1186/s13287-017-0709-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
429 Sikorski DJ, Caron NJ, VanInsberghe M, Zahn H, Eaves CJ, Piret JM, Hansen CL. Clonal analysis of individual human embryonic stem cell differentiation patterns in microfluidic cultures. Biotechnol J. 2015;10:1546-1554. [PMID: 26059045 DOI: 10.1002/biot.201500035] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
430 Boyd NL, Robbins KR, Dhara SK, West FD, Stice SL. Human embryonic stem cell-derived mesoderm-like epithelium transitions to mesenchymal progenitor cells. Tissue Eng Part A. 2009;15:1897-1907. [PMID: 19196144 DOI: 10.1089/ten.tea.2008.0351] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 7.1] [Reference Citation Analysis]
431 Medvedev SP, Grigor'eva EV, Shevchenko AI, Malakhova AA, Dementyeva EV, Shilov AA, Pokushalov EA, Zaidman AM, Aleksandrova MA, Plotnikov EY, Sukhikh GT, Zakian SM. Human induced pluripotent stem cells derived from fetal neural stem cells successfully undergo directed differentiation into cartilage. Stem Cells Dev 2011;20:1099-112. [PMID: 20846027 DOI: 10.1089/scd.2010.0249] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
432 Philonenko ES, Shutova MV, Chestkov IV, Lagarkova MA, Kiselev SL. Current progress and potential practical application for human pluripotent stem cells. Int Rev Cell Mol Biol. 2011;292:153-196. [PMID: 22078961 DOI: 10.1016/b978-0-12-386033-0.00004-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
433 Wilkinson AC, Ryan DJ, Kucinski I, Wang W, Yang J, Nestorowa S, Diamanti E, Tsang JC, Wang J, Campos LS, Yang F, Fu B, Wilson N, Liu P, Gottgens B. Expanded potential stem cell media as a tool to study human developmental hematopoiesis in vitro. Exp Hematol 2019;76:1-12.e5. [PMID: 31326613 DOI: 10.1016/j.exphem.2019.07.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
434 Noto Z, Yoshida T, Okabe M, Koike C, Fathy M, Tsuno H, Tomihara K, Arai N, Noguchi M, Nikaido T. CD44 and SSEA-4 positive cells in an oral cancer cell line HSC-4 possess cancer stem-like cell characteristics. Oral Oncology 2013;49:787-95. [DOI: 10.1016/j.oraloncology.2013.04.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
435 McIntyre BA, Alev C, Mechael R, Salci KR, Lee JB, Fiebig-Comyn A, Guezguez B, Wu Y, Sheng G, Bhatia M. Expansive generation of functional airway epithelium from human embryonic stem cells. Stem Cells Transl Med 2014;3:7-17. [PMID: 24300555 DOI: 10.5966/sctm.2013-0119] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
436 Docherty K, Bernardo AS, Vallier L. Embryonic stem cell therapy for diabetes mellitus. Seminars in Cell & Developmental Biology 2007;18:827-38. [DOI: 10.1016/j.semcdb.2007.09.009] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]
437 de Peppo GM, Svensson S, Lennerås M, Synnergren J, Stenberg J, Strehl R, Hyllner J, Thomsen P, Karlsson C. Human embryonic mesodermal progenitors highly resemble human mesenchymal stem cells and display high potential for tissue engineering applications. Tissue Eng Part A 2010;16:2161-82. [PMID: 20136402 DOI: 10.1089/ten.TEA.2009.0629] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
438 Qin H, Diaz A, Blouin L, Lebbink RJ, Patena W, Tanbun P, LeProust EM, McManus MT, Song JS, Ramalho-Santos M. Systematic identification of barriers to human iPSC generation. Cell 2014;158:449-61. [PMID: 25036638 DOI: 10.1016/j.cell.2014.05.040] [Cited by in Crossref: 66] [Cited by in F6Publishing: 50] [Article Influence: 9.4] [Reference Citation Analysis]
439 Smith KP, Luong MX, Stein GS. Pluripotency: toward a gold standard for human ES and iPS cells. J Cell Physiol. 2009;220:21-29. [PMID: 19326392 DOI: 10.1002/jcp.21681] [Cited by in Crossref: 83] [Cited by in F6Publishing: 67] [Article Influence: 6.9] [Reference Citation Analysis]
440 Kyttälä A, Moraghebi R, Valensisi C, Kettunen J, Andrus C, Pasumarthy KK, Nakanishi M, Nishimura K, Ohtaka M, Weltner J, Van Handel B, Parkkonen O, Sinisalo J, Jalanko A, Hawkins RD, Woods NB, Otonkoski T, Trokovic R. Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential. Stem Cell Reports. 2016;6:200-212. [PMID: 26777058 DOI: 10.1016/j.stemcr.2015.12.009] [Cited by in Crossref: 130] [Cited by in F6Publishing: 100] [Article Influence: 26.0] [Reference Citation Analysis]
441 Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat Rev Cancer. 2011;11:268-277. [PMID: 21390058 DOI: 10.1038/nrc3034] [Cited by in Crossref: 587] [Cited by in F6Publishing: 469] [Article Influence: 58.7] [Reference Citation Analysis]
442 Goldring CE, Duffy PA, Benvenisty N, Andrews PW, Ben-David U, Eakins R, French N, Hanley NA, Kelly L, Kitteringham NR, Kurth J, Ladenheim D, Laverty H, McBlane J, Narayanan G, Patel S, Reinhardt J, Rossi A, Sharpe M, Park BK. Assessing the safety of stem cell therapeutics. Cell Stem Cell. 2011;8:618-628. [PMID: 21624806 DOI: 10.1016/j.stem.2011.05.012] [Cited by in Crossref: 161] [Cited by in F6Publishing: 135] [Article Influence: 17.9] [Reference Citation Analysis]
443 Kadereit S, Trounson A. In vitro immunogenicity of undifferentiated pluripotent stem cells (PSC) and derived lineages. Semin Immunopathol 2011;33:551-62. [DOI: 10.1007/s00281-011-0265-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
444 Bongso A, Fong C. Human Embryonic Stem Cells: Their Nature, Properties, and Uses. In: Baharvand H, editor. Trends in Stem Cell Biology and Technology. Totowa: Humana Press; 2009. pp. 1-17. [DOI: 10.1007/978-1-60327-905-5_1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
445 Johannesson B, Sagi I, Gore A, Paull D, Yamada M, Golan-Lev T, Li Z, LeDuc C, Shen Y, Stern S, Xu N, Ma H, Kang E, Mitalipov S, Sauer MV, Zhang K, Benvenisty N, Egli D. Comparable frequencies of coding mutations and loss of imprinting in human pluripotent cells derived by nuclear transfer and defined factors. Cell Stem Cell. 2014;15:634-642. [PMID: 25517467 DOI: 10.1016/j.stem.2014.10.002] [Cited by in Crossref: 87] [Cited by in F6Publishing: 74] [Article Influence: 12.4] [Reference Citation Analysis]
446 Sundberg M, Skottman H, Suuronen R, Narkilahti S. Production and isolation of NG2+ oligodendrocyte precursors from human embryonic stem cells in defined serum-free medium. Stem Cell Research 2010;5:91-103. [DOI: 10.1016/j.scr.2010.04.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
447 Aflatoonian B, Ruban L, Shamsuddin S, Baker D, Andrews P, Moore H. Generation of Sheffield (Shef) human embryonic stem cell lines using a microdrop culture system. In Vitro Cell Dev Biol Anim 2010;46:236-41. [PMID: 20224972 DOI: 10.1007/s11626-010-9294-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
448 Tannenbaum SE, Turetsky TT, Singer O, Aizenman E, Kirshberg S, Ilouz N, Gil Y, Berman-Zaken Y, Perlman TS, Geva N, Levy O, Arbell D, Simon A, Ben-Meir A, Shufaro Y, Laufer N, Reubinoff BE. Derivation of xeno-free and GMP-grade human embryonic stem cells--platforms for future clinical applications. PLoS One 2012;7:e35325. [PMID: 22745653 DOI: 10.1371/journal.pone.0035325] [Cited by in Crossref: 67] [Cited by in F6Publishing: 54] [Article Influence: 7.4] [Reference Citation Analysis]
449 Na J, Plews J, Li J, Wongtrakoongate P, Tuuri T, Feki A, Andrews PW, Unger C. Molecular mechanisms of pluripotency and reprogramming. Stem Cell Res Ther 2010;1:33. [PMID: 20974014 DOI: 10.1186/scrt33] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
450 O'Connor MD, Kardel MD, Iosfina I, Youssef D, Lu M, Li MM, Vercauteren S, Nagy A, Eaves CJ. Alkaline phosphatase-positive colony formation is a sensitive, specific, and quantitative indicator of undifferentiated human embryonic stem cells. Stem Cells 2008;26:1109-16. [PMID: 18276800 DOI: 10.1634/stemcells.2007-0801] [Cited by in Crossref: 111] [Cited by in F6Publishing: 95] [Article Influence: 8.5] [Reference Citation Analysis]
451 Brindley DA, French A, Suh J, Roberts M, Davies B, Pinedo-Villanueva R, Wartolowska K, Rooke K, Kramm A, Judge A, Morrey M, Chandra A, Hurley H, Grover L, Bingham I, Siegel B, Rattley MS, Buckler RL, McKeon D, Krumholz K, Hook L, May M, Rikabi S, Pigott R, Morys M, Sabokbar A, Titus E, Laabi Y, Lemaitre G, Zahkia R, Sipp D, Horne R, Bravery C, Williams D, Wall I, Snyder EY, Karp JM, Barker RW, Bure K, Carr AJ, Reeve B. The implementation of novel collaborative structures for the identification and resolution of barriers to pluripotent stem cell translation. Stem Cells Dev 2013;22 Suppl 1:63-72. [PMID: 24304079 DOI: 10.1089/scd.2013.0403] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
452 Sidney LE, Branch MJ, Dua HS, Hopkinson A. Effect of culture medium on propagation and phenotype of corneal stroma-derived stem cells. Cytotherapy. 2015;17:1706-1722. [PMID: 26454751 DOI: 10.1016/j.jcyt.2015.08.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
453 Pascal LE, Vêncio RZ, Goo YA, Page LS, Shadle CP, Liu AY. Temporal expression profiling of the effects of secreted factors from prostate stromal cells on embryonal carcinoma stem cells. Prostate 2009;69:1353-65. [PMID: 19455603 DOI: 10.1002/pros.20982] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
454 Golunova A, Velychkivska N, Mikšovská Z, Chochola V, Jaroš J, Hampl A, Pop-Georgievski O, Proks V. Direct and Indirect Biomimetic Peptide Modification of Alginate: Efficiency, Side Reactions, and Cell Response. Int J Mol Sci 2021;22:5731. [PMID: 34072085 DOI: 10.3390/ijms22115731] [Reference Citation Analysis]
455 Zanella F, Lyon RC, Sheikh F. Modeling heart disease in a dish: from somatic cells to disease-relevant cardiomyocytes. Trends Cardiovasc Med 2014;24:32-44. [PMID: 24054750 DOI: 10.1016/j.tcm.2013.06.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
456 Faradonbeh MZ, Gharechahi J, Mollamohammadi S, Pakzad M, Taei A, Rassouli H, Baharvand H, Salekdeh GH. An orthogonal comparison of the proteome of human embryonic stem cells with that of human induced pluripotent stem cells of different genetic background. Mol BioSyst 2012;8:1833. [DOI: 10.1039/c2mb25018g] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
457 Moore JC, Sadowy S, Alikani M, Toro-Ramos AJ, Swerdel MR, Hart RP, Cohen RI. A high-resolution molecular-based panel of assays for identification and characterization of human embryonic stem cell lines. Stem Cell Res 2010;4:92-106. [PMID: 20060795 DOI: 10.1016/j.scr.2009.11.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
458 Nakao H, Nagai Y, Kojima A, Toyoda H, Kawasaki N, Kawasaki T. Binding specificity of R-10G and TRA-1-60/81, and substrate specificity of keratanase II studied with chemically synthesized oligosaccharides. Glycoconj J 2017;34:789-95. [PMID: 28293867 DOI: 10.1007/s10719-017-9765-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
459 Sousa BR, Parreira RC, Fonseca EA, Amaya MJ, Tonelli FMP, Lacerda SMSN, Lalwani P, Santos AK, Gomes KN, Ulrich H, Kihara AH, Resende RR. Human adult stem cells from diverse origins: An overview from multiparametric immunophenotyping to clinical applications: Human Adult Stem Cells from Diverse Origins. Cytometry 2014;85:43-77. [DOI: 10.1002/cyto.a.22402] [Cited by in Crossref: 107] [Cited by in F6Publishing: 87] [Article Influence: 13.4] [Reference Citation Analysis]
460 Nekanti U, Rao VB, Bahirvani AG, Jan M, Totey S, Ta M. Long-term expansion and pluripotent marker array analysis of Wharton's jelly-derived mesenchymal stem cells. Stem Cells Dev. 2010;19:117-130. [PMID: 19619003 DOI: 10.1089/scd.2009.0177] [Cited by in Crossref: 109] [Cited by in F6Publishing: 99] [Article Influence: 9.9] [Reference Citation Analysis]
461 Riaz A, Zhao X, Dai X, Li W, Liu L, Wan H, Yu Y, Wang L, Zhou Q. Mouse cloning and somatic cell reprogramming using electrofused blastomeres. Cell Res 2011;21:770-8. [PMID: 21187860 DOI: 10.1038/cr.2010.180] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
462 Xu H, Schaniel C, Lemischka IR, Ma'ayan A. Toward a complete in silico, multi-layered embryonic stem cell regulatory network. Wiley Interdiscip Rev Syst Biol Med 2010;2:708-33. [PMID: 20890967 DOI: 10.1002/wsbm.93] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
463 Furth ME, Atala A. Stem cell sources to treat diabetes. J Cell Biochem 2009;106:507-11. [PMID: 19130494 DOI: 10.1002/jcb.22000] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
464 Melo-Braga MN, Schulz M, Liu Q, Swistowski A, Palmisano G, Engholm-Keller K, Jakobsen L, Zeng X, Larsen MR. Comprehensive quantitative comparison of the membrane proteome, phosphoproteome, and sialiome of human embryonic and neural stem cells. Mol Cell Proteomics 2014;13:311-28. [PMID: 24173317 DOI: 10.1074/mcp.M112.026898] [Cited by in Crossref: 51] [Cited by in F6Publishing: 21] [Article Influence: 6.4] [Reference Citation Analysis]
465 Martinez C, Rath S, Van Gulden S, Pelaez D, Alfonso A, Fernandez N, Kos L, Cheung H, Ramaswamy S. Periodontal ligament cells cultured under steady-flow environments demonstrate potential for use in heart valve tissue engineering. Tissue Eng Part A 2013;19:458-66. [PMID: 22958144 DOI: 10.1089/ten.TEA.2012.0149] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
466 Parte S, Bhartiya D, Telang J, Daithankar V, Salvi V, Zaveri K, Hinduja I. Detection, characterization, and spontaneous differentiation in vitro of very small embryonic-like putative stem cells in adult mammalian ovary. Stem Cells Dev. 2011;20:1451-1464. [PMID: 21291304 DOI: 10.1089/scd.2010.0461] [Cited by in Crossref: 151] [Cited by in F6Publishing: 139] [Article Influence: 15.1] [Reference Citation Analysis]
467 Ko TY. Prognostic significance of octamer-4 expression in primary lung adenocarcinoma. Asian J Surg 2021;44:425-6. [PMID: 33280979 DOI: 10.1016/j.asjsur.2020.10.028] [Reference Citation Analysis]
468 Caron NJ, Gage BK, O'connor MD, Eaves CJ, Kieffer TJ, Piret JM. A human embryonic stem cell line adapted for high throughput screening: A hESC Line Adapted for HTS. Biotechnol Bioeng 2013;110:2706-16. [DOI: 10.1002/bit.24936] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
469 Wu H, Kim KJ, Mehta K, Paxia S, Sundstrom A, Anantharaman T, Kuraishy AI, Doan T, Ghosh J, Pyle AD, Clark A, Lowry W, Fan G, Baxter T, Mishra B, Sun Y, Teitell MA. Copy number variant analysis of human embryonic stem cells. Stem Cells 2008;26:1484-9. [PMID: 18369100 DOI: 10.1634/stemcells.2007-0993] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
470 Park MH, Park JE, Kim MS, Lee KY, Park HJ, Yun JI, Choi JH, Lee Es, Lee ST. Development of a high-yield technique to isolate spermatogonial stem cells from porcine testes. J Assist Reprod Genet 2014;31:983-91. [PMID: 24938360 DOI: 10.1007/s10815-014-0271-7] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
471 Aflatoonian B, Ruban L, Jones M, Aflatoonian R, Fazeli A, Moore H. In vitro post-meiotic germ cell development from human embryonic stem cells. Human Reproduction 2009;24:3150-9. [DOI: 10.1093/humrep/dep334] [Cited by in Crossref: 92] [Cited by in F6Publishing: 80] [Article Influence: 7.7] [Reference Citation Analysis]
472 Galán A, Simón C. Monitoring stemness in long-term hESC cultures by real-time PCR. Methods Mol Biol 2010;584:135-50. [PMID: 19907976 DOI: 10.1007/978-1-60761-369-5_8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
473 Kardel MD, Eaves CJ. Modeling human hematopoietic cell development from pluripotent stem cells. Exp Hematol 2012;40:601-11. [PMID: 22510344 DOI: 10.1016/j.exphem.2012.04.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
474 Giuffrida D, Rogers IM, Nagy A, Calogero AE, Brown TJ, Casper RF. Human embryonic stem cells secrete soluble factors that inhibit cancer cell growth. Cell Prolif. 2009;42:788-798. [PMID: 19732065 DOI: 10.1111/j.1365-2184.2009.00640.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
475 Silva SS, Rowntree RK, Mekhoubad S, Lee JT. X-chromosome inactivation and epigenetic fluidity in human embryonic stem cells. Proc Natl Acad Sci USA. 2008;105:4820-4825. [PMID: 18339803 DOI: 10.1073/pnas.0712136105] [Cited by in Crossref: 215] [Cited by in F6Publishing: 183] [Article Influence: 16.5] [Reference Citation Analysis]
476 Ghosh Z, Huang M, Hu S, Wilson KD, Dey D, Wu JC. Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells. Cancer Res 2011;71:5030-9. [PMID: 21646469 DOI: 10.1158/0008-5472.CAN-10-4402] [Cited by in Crossref: 68] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
477 Miguita L, Deboni MCZ, Sharpe P, Mantesso A. Characterization of progenitor/stem cell population from human dental socket and their multidifferentiation potential. Cell Tissue Bank 2020;21:31-46. [PMID: 31807957 DOI: 10.1007/s10561-019-09794-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
478 Harvey AJ, O'Brien C, Lambshead J, Sheedy JR, Rathjen J, Laslett AL, Gardner DK. Physiological oxygen culture reveals retention of metabolic memory in human induced pluripotent stem cells. PLoS One 2018;13:e0193949. [PMID: 29543848 DOI: 10.1371/journal.pone.0193949] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
479 Aykul S, Parenti A, Chu KY, Reske J, Floer M, Ralston A, Martinez-Hackert E. Biochemical and Cellular Analysis Reveals Ligand Binding Specificities, a Molecular Basis for Ligand Recognition, and Membrane Association-dependent Activities of Cripto-1 and Cryptic. J Biol Chem 2017;292:4138-51. [PMID: 28126904 DOI: 10.1074/jbc.M116.747501] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
480 Gallegos-cárdenas A, Webb R, Jordan E, West R, West FD, Yang J, Wang K, Stice SL. Pig Induced Pluripotent Stem Cell-Derived Neural Rosettes Developmentally Mimic Human Pluripotent Stem Cell Neural Differentiation. Stem Cells and Development 2015;24:1901-11. [DOI: 10.1089/scd.2015.0025] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
481 . Compare and conquer. Nat Methods 2008;5:275. [PMID: 18396475 DOI: 10.1038/nmeth0408-275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
482 Hanley J, Rastegarlari G, Nathwani AC. An introduction to induced pluripotent stem cells. Br J Haematol. 2010;151:16-24. [PMID: 20666774 DOI: 10.1111/j.1365-2141.2010.08296.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
483 Schott JW, Hoffmann D, Maetzig T, Müller FJ, Steinemann D, Zychlinski D, Cantz T, Baum C, Schambach A. Improved retroviral episome transfer of transcription factors enables sustained cell fate modification. Gene Ther 2014;21:938-49. [PMID: 25102011 DOI: 10.1038/gt.2014.69] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
484 Nagano K, Yoshida Y, Isobe T. Cell surface biomarkers of embryonic stem cells. Proteomics. 2008;8:4025-4035. [PMID: 18763704 DOI: 10.1002/pmic.200800073] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 4.4] [Reference Citation Analysis]
485 Frudinger A, Marksteiner R, Pfeifer J, Margreiter E, Paede J, Thurner M. Skeletal muscle-derived cell implantation for the treatment of sphincter-related faecal incontinence. Stem Cell Res Ther 2018;9:233. [PMID: 30213273 DOI: 10.1186/s13287-018-0978-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
486 Ahrlund-Richter L, De Luca M, Marshak DR, Munsie M, Veiga A, Rao M. Isolation and production of cells suitable for human therapy: challenges ahead. Cell Stem Cell 2009;4:20-6. [PMID: 19058776 DOI: 10.1016/j.stem.2008.11.012] [Cited by in Crossref: 94] [Cited by in F6Publishing: 75] [Article Influence: 7.2] [Reference Citation Analysis]
487 Tan J, Li Y, Qu W, Liu L, Jiang L, Sun K. Derivation of embryonic stem cell line from frozen human embryos and neural differentiation. NeuroReport 2008;19:1451-5. [DOI: 10.1097/wnr.0b013e32830e4c35] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
488 Kibschull M, Mileikovsky M, Michael IP, Lye SJ, Nagy A. Human embryonic fibroblasts support single cell enzymatic expansion of human embryonic stem cells in xeno-free cultures. Stem Cell Res 2011;6:70-82. [PMID: 20934930 DOI: 10.1016/j.scr.2010.08.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
489 Gordeeva OF, Mitalipov SM. Pluripotent stem cells: Maintenance of genetic and epigenetic stability and prospects of cell technologies. Russ J Dev Biol 2008;39:325-36. [DOI: 10.1134/s1062360408060015] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
490 Viero C, Forostyak O, Sykova E, Dayanithi G. Getting it right before transplantation: example of a stem cell model with regenerative potential for the CNS. Front Cell Dev Biol 2014;2:36. [PMID: 25364743 DOI: 10.3389/fcell.2014.00036] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
491 Alagaratnam S, Lind GE, Kraggerud SM, Lothe RA, Skotheim RI. The testicular germ cell tumour transcriptome: The TGCT transcriptome. International Journal of Andrology 2011;34:e133-51. [DOI: 10.1111/j.1365-2605.2011.01169.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 3.2] [Reference Citation Analysis]
492 Beltrão-Braga PC, Pignatari GC, Russo FB, Fernandes IR, Muotri AR. In-a-dish: induced pluripotent stem cells as a novel model for human diseases. Cytometry A 2013;83:11-7. [PMID: 23281003 DOI: 10.1002/cyto.a.22231] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
493 Hirvonen T, Suila H, Tiitinen S, Natunen S, Laukkanen ML, Kotovuori A, Reinman M, Satomaa T, Alfthan K, Laitinen S, Takkinen K, Räbinä J, Valmu L. Production of a recombinant antibody specific for i blood group antigen, a mesenchymal stem cell marker. Biores Open Access 2013;2:336-45. [PMID: 24083089 DOI: 10.1089/biores.2013.0026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
494 Wu R, Xu C, Jin F, Tan Z, Gu B, Chen L, Yao X, Zhang M. Derivation, characterization and differentiation of a new human embryonic stem cell line from a Chinese hatched blastocyst assisted by a non-contact laser system: Derivation of human embryonic stem cells. Human Cell 2010;23:89-102. [DOI: 10.1111/j.1749-0774.2010.00090.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
495 Bagherpoor AJ, Kučírek M, Fedr R, Sani SA, Štros M. Nonhistone Proteins HMGB1 and HMGB2 Differentially Modulate the Response of Human Embryonic Stem Cells and the Progenitor Cells to the Anticancer Drug Etoposide. Biomolecules 2020;10:E1450. [PMID: 33076532 DOI: 10.3390/biom10101450] [Reference Citation Analysis]
496 Wu J, Sun Y, Block TJ, Marinkovic M, Zhang ZL, Chen R, Yin Y, Song J, Dean DD, Lu Z, Chen XD. Umbilical cord blood-derived non-hematopoietic stem cells retrieved and expanded on bone marrow-derived extracellular matrix display pluripotent characteristics. Stem Cell Res Ther 2016;7:176. [PMID: 27906056 DOI: 10.1186/s13287-016-0437-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
497 Duncombe TA, Tentori AM, Herr AE. Microfluidics: reframing biological enquiry. Nat Rev Mol Cell Biol 2015;16:554-67. [PMID: 26296163 DOI: 10.1038/nrm4041] [Cited by in Crossref: 176] [Cited by in F6Publishing: 108] [Article Influence: 29.3] [Reference Citation Analysis]
498 International Stem Cell Initiative. Amps K, Andrews PW, Anyfantis G, Armstrong L, Avery S, Baharvand H, Baker J, Baker D, Munoz MB, Beil S, Benvenisty N, Ben-Yosef D, Biancotti JC, Bosman A, Brena RM, Brison D, Caisander G, Camarasa MV, Chen J, Chiao E, Choi YM, Choo AB, Collins D, Colman A, Crook JM, Daley GQ, Dalton A, De Sousa PA, Denning C, Downie J, Dvorak P, Montgomery KD, Feki A, Ford A, Fox V, Fraga AM, Frumkin T, Ge L, Gokhale PJ, Golan-Lev T, Gourabi H, Gropp M, Lu G, Hampl A, Harron K, Healy L, Herath W, Holm F, Hovatta O, Hyllner J, Inamdar MS, Irwanto AK, Ishii T, Jaconi M, Jin Y, Kimber S, Kiselev S, Knowles BB, Kopper O, Kukharenko V, Kuliev A, Lagarkova MA, Laird PW, Lako M, Laslett AL, Lavon N, Lee DR, Lee JE, Li C, Lim LS, Ludwig TE, Ma Y, Maltby E, Mateizel I, Mayshar Y, Mileikovsky M, Minger SL, Miyazaki T, Moon SY, Moore H, Mummery C, Nagy A, Nakatsuji N, Narwani K, Oh SK, Oh SK, Olson C, Otonkoski T, Pan F, Park IH, Pells S, Pera MF, Pereira LV, Qi O, Raj GS, Reubinoff B, Robins A, Robson P, Rossant J, Salekdeh GH, Schulz TC, Sermon K, Sheik Mohamed J, Shen H, Sherrer E, Sidhu K, Sivarajah S, Skottman H, Spits C, Stacey GN, Strehl R, Strelchenko N, Suemori H, Sun B, Suuronen R, Takahashi K, Tuuri T, Venu P, Verlinsky Y, Ward-van Oostwaard D, Weisenberger DJ, Wu Y, Yamanaka S, Young L, Zhou Q. Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage. Nat Biotechnol. 2011;29:1132-1144. [PMID: 22119741 DOI: 10.1038/nbt.2051] [Cited by in Crossref: 378] [Cited by in F6Publishing: 293] [Article Influence: 37.8] [Reference Citation Analysis]
499 Allison TF, Smith AJH, Anastassiadis K, Sloane-Stanley J, Biga V, Stavish D, Hackland J, Sabri S, Langerman J, Jones M, Plath K, Coca D, Barbaric I, Gokhale P, Andrews PW. Identification and Single-Cell Functional Characterization of an Endodermally Biased Pluripotent Substate in Human Embryonic Stem Cells. Stem Cell Reports 2018;10:1895-907. [PMID: 29779895 DOI: 10.1016/j.stemcr.2018.04.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
500 Archibald PR, Chandra A, Thomas D, Chose O, Massouridès E, Laâbi Y, Williams DJ. Comparability of automated human induced pluripotent stem cell culture: a pilot study. Bioprocess Biosyst Eng 2016;39:1847-58. [PMID: 27503483 DOI: 10.1007/s00449-016-1659-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
501 Sakurada K, Mcdonald F, Shimada F. Regenerative Medicine and Stem Cell Based Drug Discovery. Angew Chem Int Ed 2008;47:5718-38. [DOI: 10.1002/anie.200700724] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
502 Bar S, Benvenisty N. Epigenetic aberrations in human pluripotent stem cells. EMBO J 2019;38:e101033. [PMID: 31088843 DOI: 10.15252/embj.2018101033] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 13.5] [Reference Citation Analysis]
503 Budel L, Djabali K. Rapid isolation and expansion of skin-derived precursor cells from human primary fibroblast cultures. Biol Open 2017;6:1745-55. [PMID: 29141956 DOI: 10.1242/bio.025130] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
504 Aleckovic M, Simón C. Is teratoma formation in stem cell research a characterization tool or a window to developmental biology? Reproductive BioMedicine Online 2008;17:270-80. [DOI: 10.1016/s1472-6483(10)60206-4] [Cited by in Crossref: 30] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
505 Vuoristo S, Toivonen S, Weltner J, Mikkola M, Ustinov J, Trokovic R, Palgi J, Lund R, Tuuri T, Otonkoski T. A novel feeder-free culture system for human pluripotent stem cell culture and induced pluripotent stem cell derivation. PLoS One 2013;8:e76205. [PMID: 24098444 DOI: 10.1371/journal.pone.0076205] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
506 Slamecka J, Laurini J, Shirley T, Hoerstrup SP, Weber B, Owen L, McClellan S. Reprogramming Primary Amniotic Fluid and Membrane Cells to Pluripotency in Xeno-free Conditions. J Vis Exp 2017. [PMID: 29286443 DOI: 10.3791/56003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
507 Hemberger M, Pedersen R. Epigenome Disruptors. Science 2010;330:598-9. [DOI: 10.1126/science.1199006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
508 Jia Q, Zhang X, Deng T, Gao J. Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells. Cell Reprogram. 2013;15:143-150. [PMID: 23438193 DOI: 10.1089/cell.2012.0048] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
509 Munoz J, Low TY, Kok YJ, Chin A, Frese CK, Ding V, Choo A, Heck AJ. The quantitative proteomes of human-induced pluripotent stem cells and embryonic stem cells. Mol Syst Biol 2011;7:550. [PMID: 22108792 DOI: 10.1038/msb.2011.84] [Cited by in Crossref: 97] [Cited by in F6Publishing: 83] [Article Influence: 9.7] [Reference Citation Analysis]
510 Faucon PC, Pardee K, Kumar RM, Li H, Loh YH, Wang X. Gene networks of fully connected triads with complete auto-activation enable multistability and stepwise stochastic transitions. PLoS One 2014;9:e102873. [PMID: 25057990 DOI: 10.1371/journal.pone.0102873] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.9] [Reference Citation Analysis]
511 Layh-Schmitt G, Lu S, Navid F, Brooks SR, Lazowick E, Davis KM, Montagna C, Gadina M, Colbert RA. Generation and differentiation of induced pluripotent stem cells reveal ankylosing spondylitis risk gene expression in bone progenitors. Clin Rheumatol 2017;36:143-54. [PMID: 27864696 DOI: 10.1007/s10067-016-3469-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
512 Efthymiou AG, Steiner J, Pavan WJ, Wincovitch S, Larson DM, Porter FD, Rao MS, Malik N. Rescue of an in vitro neuron phenotype identified in Niemann-Pick disease, type C1 induced pluripotent stem cell-derived neurons by modulating the WNT pathway and calcium signaling. Stem Cells Transl Med. 2015;4:230-238. [PMID: 25637190 DOI: 10.5966/sctm.2014-0127] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
513 Imaizumi M, Sato Y, Yang DT, Thibeault SL. In vitro epithelial differentiation of human induced pluripotent stem cells for vocal fold tissue engineering. Ann Otol Rhinol Laryngol 2013;122:737-47. [PMID: 24592576 DOI: 10.1177/000348941312201203] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
514 Ilic D, Caceres E, Lu S, Julian P, Foulk R, Krtolica A. Effect of karyotype on successful human embryonic stem cell derivation. Stem Cells Dev 2010;19:39-46. [PMID: 19485710 DOI: 10.1089/scd.2009.0136] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
515 Dabelsteen S, Hercule P, Barron P, Rice M, Dorsainville G, Rheinwald JG. Epithelial cells derived from human embryonic stem cells display p16INK4A senescence, hypermotility, and differentiation properties shared by many P63+ somatic cell types. Stem Cells 2009;27:1388-99. [PMID: 19489101 DOI: 10.1002/stem.64] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
516 Priddle H, Allegrucci C, Burridge P, Munoz M, Smith NM, Devlin L, Sjoblom C, Chamberlain S, Watson S, Young LE, Denning C. Derivation and characterisation of the human embryonic stem cell lines, NOTT1 and NOTT2. In Vitro Cell Dev Biol Anim 2010;46:367-75. [PMID: 20177995 DOI: 10.1007/s11626-010-9290-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
517 Kobold S, Guhr A, Kurtz A, Löser P. Human embryonic and induced pluripotent stem cell research trends: complementation and diversification of the field. Stem Cell Reports 2015;4:914-25. [PMID: 25866160 DOI: 10.1016/j.stemcr.2015.03.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
518 Bibikova M, Laurent LC, Ren B, Loring JF, Fan JB. Unraveling epigenetic regulation in embryonic stem cells. Cell Stem Cell 2008;2:123-34. [PMID: 18371433 DOI: 10.1016/j.stem.2008.01.005] [Cited by in Crossref: 121] [Cited by in F6Publishing: 100] [Article Influence: 9.3] [Reference Citation Analysis]
519 Frost J, Monk D, Moschidou D, Guillot PV, Stanier P, Minger SL, Fisk NM, Moore HD, Moore GE. The effects of culture on genomic imprinting profiles in human embryonic and fetal mesenchymal stem cells. Epigenetics 2011;6:52-62. [PMID: 20864803 DOI: 10.4161/epi.6.1.13361] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
520 Strizzi L, Postovit LM, Margaryan NV, Seftor EA, Abbott DE, Seftor RE, Salomon DS, Hendrix MJ. Emerging roles of nodal and Cripto-1: from embryogenesis to breast cancer progression. Breast Dis 2008;29:91-103. [PMID: 19029628 DOI: 10.3233/bd-2008-29110] [Cited by in Crossref: 48] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
521 Xu XQ, Sun W. Perspective from the heart: the potential of human pluripotent stem cell-derived cardiomyocytes. J Cell Biochem 2013;114:39-46. [PMID: 22903726 DOI: 10.1002/jcb.24359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
522 Rathjen J, Yeo C, Yap C, Tan BSN, Rathjen PD, Gardner DK. Culture environment regulates amino acid turnover and glucose utilisation in human ES cells. Reprod Fertil Dev 2014;26:703. [DOI: 10.1071/rd12276] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
523 Umekage M, Sato Y, Takasu N. Overview: an iPS cell stock at CiRA. Inflamm Regen 2019;39:17. [PMID: 31497180 DOI: 10.1186/s41232-019-0106-0] [Cited by in Crossref: 37] [Cited by in F6Publishing: 26] [Article Influence: 18.5] [Reference Citation Analysis]
524 Yagi H, Soto-Gutierrez A, Kitagawa Y. Whole-organ re-engineering: a regenerative medicine approach to digestive organ replacement. Surg Today 2013;43:587-94. [PMID: 23184357 DOI: 10.1007/s00595-012-0396-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
525 Gertow K, Cedervall J, Jamil S, Ali R, Imreh MP, Gulyas M, Sandstedt B, Ahrlund-Richter L. Early events in xenograft development from the human embryonic stem cell line HS181--resemblance with an initial multiple epiblast formation. PLoS One 2011;6:e27741. [PMID: 22140465 DOI: 10.1371/journal.pone.0027741] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
526 Nishihara S. Glycans define the stemness of naïve and primed pluripotent stem cells. Glycoconj J 2017;34:737-47. [PMID: 27796614 DOI: 10.1007/s10719-016-9740-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
527 Narayan S, Bryant G, Shah S, Berrozpe G, Ptashne M. OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts. Cell Rep 2017;20:1585-96. [PMID: 28813671 DOI: 10.1016/j.celrep.2017.07.071] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 7.7] [Reference Citation Analysis]
528 Doi D, Morizane A, Kikuchi T, Onoe H, Hayashi T, Kawasaki T, Motono M, Sasai Y, Saiki H, Gomi M, Yoshikawa T, Hayashi H, Shinoyama M, Refaat MM, Suemori H, Miyamoto S, Takahashi J. Prolonged maturation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ESC-derived neural cells in a primate model of Parkinson's disease. Stem Cells. 2012;30:935-945. [PMID: 22328536 DOI: 10.1002/stem.1060] [Cited by in Crossref: 116] [Cited by in F6Publishing: 88] [Article Influence: 12.9] [Reference Citation Analysis]
529 Aguilar-Gallardo C, Poo M, Gomez E, Galan A, Sanchez E, Marques-Mari A, Ruiz V, Medrano J, Riboldi M, Valbuena D, Simon C. Derivation, characterization, differentiation, and registration of seven human embryonic stem cell lines (VAL-3, -4, -5, -6M, -7, -8, and -9) on human feeder. In Vitro Cell Dev Biol Anim 2010;46:317-26. [PMID: 20186513 DOI: 10.1007/s11626-010-9285-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
530 Zhang LF, Ogawa Y, Ahn JY, Namekawa SH, Silva SS, Lee JT. Telomeric RNAs mark sex chromosomes in stem cells. Genetics 2009;182:685-98. [PMID: 19380904 DOI: 10.1534/genetics.109.103093] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
531 Acero L. Internationalization, science and health: global regenerative medicine and the parallel markets. Cien Saude Colet. 2015;20:433-440. [PMID: 25715137 DOI: 10.1590/1413-81232015202.22272013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
532 International Stem Cell Initiative. Assessment of established techniques to determine developmental and malignant potential of human pluripotent stem cells. Nat Commun. 2018;9:1925. [PMID: 29765017 DOI: 10.1038/s41467-018-04011-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 12.7] [Reference Citation Analysis]
533 Pijuan-Galitó S, Tamm C, Schuster J, Sobol M, Forsberg L, Merry CL, Annerén C. Human serum-derived protein removes the need for coating in defined human pluripotent stem cell culture. Nat Commun 2016;7:12170. [PMID: 27405751 DOI: 10.1038/ncomms12170] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
534 Miyoshi N, Ishii H, Nagai K, Hoshino H, Mimori K, Tanaka F, Nagano H, Sekimoto M, Doki Y, Mori M. Defined factors induce reprogramming of gastrointestinal cancer cells. Proc Natl Acad Sci U S A 2010;107:40-5. [PMID: 20018687 DOI: 10.1073/pnas.0912407107] [Cited by in Crossref: 187] [Cited by in F6Publishing: 164] [Article Influence: 15.6] [Reference Citation Analysis]
535 Lensch MW, Daley GQ. Human embryonic stem cells flock together. Nat Biotechnol 2007;25:748-50. [DOI: 10.1038/nbt0707-748] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
536 Frydman N, Féraud O, Bas C, Amit M, Frydman R, Bennaceur-griscelli A, Tachdjian G. Characterization of human PGD blastocysts with unbalanced chromosomal translocations and human embryonic stem cell line derivation. Reproductive BioMedicine Online 2009;19:57-70. [DOI: 10.1016/s1472-6483(10)61070-x] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
537 Bacon K, Lavoie A, Rao BM, Daniele M, Menegatti S. Past, Present, and Future of Affinity-based Cell Separation Technologies. Acta Biomater 2020;112:29-51. [PMID: 32442784 DOI: 10.1016/j.actbio.2020.05.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
538 Nakatsu MN, Deng SX. Enrichment of human corneal epithelial stem/progenitor cells by magnetic bead sorting using SSEA4 as a negative marker. Methods Mol Biol 2013;1014:71-7. [PMID: 23690006 DOI: 10.1007/978-1-62703-432-6_5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
539 Kropp C, Kempf H, Halloin C, Robles-Diaz D, Franke A, Scheper T, Kinast K, Knorpp T, Joos TO, Haverich A, Martin U, Zweigerdt R, Olmer R. Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors. Stem Cells Transl Med. 2016;5:1289-1301. [PMID: 27369897 DOI: 10.5966/sctm.2015-0253] [Cited by in Crossref: 84] [Cited by in F6Publishing: 65] [Article Influence: 16.8] [Reference Citation Analysis]
540 Gage BK, Riedel MJ, Karanu F, Rezania A, Fujita Y, Webber TD, Baker RK, Wideman RD, Kieffer TJ. Cellular reprogramming of human amniotic fluid cells to express insulin. Differentiation 2010;80:130-9. [DOI: 10.1016/j.diff.2010.05.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
541 Zhang X, Han B, Huang J, Zheng B, Geng Q, Aziz F, Dong Q. Prognostic Significance of OCT4 Expression in Adenocarcinoma of the Lung. Japanese Journal of Clinical Oncology 2010;40:961-6. [DOI: 10.1093/jjco/hyq066] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
542 Sagi I, De Pinho JC, Zuccaro MV, Atzmon C, Golan-lev T, Yanuka O, Prosser R, Sadowy A, Perez G, Cabral T, Glaser B, Tsang SH, Goland R, Sauer MV, Lobo R, Benvenisty N, Egli D. Distinct Imprinting Signatures and Biased Differentiation of Human Androgenetic and Parthenogenetic Embryonic Stem Cells. Cell Stem Cell 2019;25:419-432.e9. [DOI: 10.1016/j.stem.2019.06.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
543 Sengoku S, Sumikura K, Oki T, Nakatsuji N. Redefining the Concept of Standardization for Pluripotent Stem Cells. Stem Cell Rev and Rep 2011;7:221-6. [DOI: 10.1007/s12015-010-9204-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
544 Whetton AD, Williamson AJ, Krijgsveld J, Lee BH, Lemischka I, Oh S, Pera M, Mummery C, Heck AJ. The Time Is Right: Proteome Biology of Stem Cells. Cell Stem Cell 2008;2:215-7. [DOI: 10.1016/j.stem.2008.02.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
545 Erdélyi-Belle B, Török G, Apáti Á, Sarkadi B, Schaff Z, Kiss A, Homolya L. Expression of Tight Junction Components in Hepatocyte-Like Cells Differentiated from Human Embryonic Stem Cells. Pathol Oncol Res 2015;21:1059-70. [PMID: 25845432 DOI: 10.1007/s12253-015-9936-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
546 Barnett P, van den Hoff MJ. Cardiac regeneration: different cells same goal. Med Biol Eng Comput 2011;49:723-32. [PMID: 21499802 DOI: 10.1007/s11517-011-0776-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
547 Kusena JWT, Shariatzadeh M, Thomas RJ, Wilson SL. Understanding cell culture dynamics: a tool for defining protocol parameters for improved processes and efficient manufacturing using human embryonic stem cells. Bioengineered 2021;12:979-96. [PMID: 33757391 DOI: 10.1080/21655979.2021.1902696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
548 Emre N, Vidal JG, Elia J, O'Connor ED, Paramban RI, Hefferan MP, Navarro R, Goldberg DS, Varki NM, Marsala M, Carson CT. The ROCK inhibitor Y-27632 improves recovery of human embryonic stem cells after fluorescence-activated cell sorting with multiple cell surface markers. PLoS One 2010;5:e12148. [PMID: 20730054 DOI: 10.1371/journal.pone.0012148] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.8] [Reference Citation Analysis]
549 Bagherpoor AJ, Dolezalova D, Barta T, Kučírek M, Sani SA, Ešner M, Kunova Bosakova M, Vinarský V, Peskova L, Hampl A, Štros M. Properties of Human Embryonic Stem Cells and Their Differentiated Derivatives Depend on Nonhistone DNA-Binding HMGB1 and HMGB2 Proteins. Stem Cells Dev 2017;26:328-40. [PMID: 27863459 DOI: 10.1089/scd.2016.0274] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
550 Kjartansdóttir KR, Gabrielsen A, Reda A, Söder O, Bergström-Tengzelius R, Andersen CY, Hovatta O, Stukenborg JB, Fedder J. Differentiation of stem cells upon deprivation of exogenous FGF2: a general approach to study spontaneous differentiation of hESCs in vitro. Syst Biol Reprod Med 2012;58:330-8. [PMID: 22708801 DOI: 10.3109/19396368.2012.694009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
551 Parr CJ, Katayama S, Miki K, Kuang Y, Yoshida Y, Morizane A, Takahashi J, Yamanaka S, Saito H. MicroRNA-302 switch to identify and eliminate undifferentiated human pluripotent stem cells. Sci Rep 2016;6:32532. [PMID: 27608814 DOI: 10.1038/srep32532] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 9.2] [Reference Citation Analysis]
552 Turner J, Quek LE, Titmarsh D, Krömer JO, Kao LP, Nielsen L, Wolvetang E, Cooper-White J. Metabolic profiling and flux analysis of MEL-2 human embryonic stem cells during exponential growth at physiological and atmospheric oxygen concentrations. PLoS One 2014;9:e112757. [PMID: 25412279 DOI: 10.1371/journal.pone.0112757] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
553 Borowiak M, Melton DA. How to make beta cells? Curr Opin Cell Biol. 2009;21:727-732. [PMID: 19781928 DOI: 10.1016/j.ceb.2009.08.006] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
554 de Rham C, Villard J. How to cross immunogenetic hurdles to human embryonic stem cell transplantation. Semin Immunopathol 2011;33:525-34. [PMID: 21461719 DOI: 10.1007/s00281-011-0262-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
555 Apáti A, Orbán TI, Varga N, Németh A, Schamberger A, Krizsik V, Erdélyi-Belle B, Homolya L, Várady G, Padányi R, Karászi E, Kemna EW, Német K, Sarkadi B. High level functional expression of the ABCG2 multidrug transporter in undifferentiated human embryonic stem cells. Biochim Biophys Acta 2008;1778:2700-9. [PMID: 18793608 DOI: 10.1016/j.bbamem.2008.08.010] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 4.6] [Reference Citation Analysis]
556 Mitchell PD, Ratcliffe E, Hourd P, Williams DJ, Thomas RJ. A Quality-by-Design Approach to Risk Reduction and Optimization for Human Embryonic Stem Cell Cryopreservation Processes. Tissue Engineering Part C: Methods 2014;20:941-50. [DOI: 10.1089/ten.tec.2013.0595] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
557 Dolgin E. NIH accused of being overly literal on stem cell approvals. Nat Med 2012;18:325. [PMID: 22395676 DOI: 10.1038/nm0312-325] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
558 Dormeyer W, van Hoof D, Mummery CL, Krijgsveld J, Heck AJR. A practical guide for the identification of membrane and plasma membrane proteins in human embryonic stem cells and human embryonal carcinoma cells. Proteomics 2008;8:4036-53. [DOI: 10.1002/pmic.200800143] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
559 Krutá M, Bálek L, Hejnová R, Dobšáková Z, Eiselleová L, Matulka K, Bárta T, Fojtík P, Fajkus J, Hampl A, Dvořák P, Rotrekl V. Decrease in Abundance of Apurinic/Apyrimidinic Endonuclease Causes Failure of Base Excision Repair in Culture-Adapted Human Embryonic Stem Cells. STEM CELLS 2013;31:693-702. [DOI: 10.1002/stem.1312] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
560 Wartenberg H, Miething A, Møllgård K. The Origin of a New Progenitor Stem Cell Group in Human Development. Adv Anat Embryol Cell Biol 2019;230:1-70. [PMID: 30543033 DOI: 10.1007/978-3-030-02050-7_1] [Reference Citation Analysis]
561 Shum C, Macedo SC, Warre-Cornish K, Cocks G, Price J, Srivastava DP. Utilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neurons. Horm Behav 2015;74:228-42. [PMID: 26143621 DOI: 10.1016/j.yhbeh.2015.06.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
562 O'leary T, Heindryckx B, Lierman S, Van der Jeught M, Duggal G, De Sutter P, Chuva de Sousa Lopes SM. Derivation of human embryonic stem cells using a post–inner cell mass intermediate. Nat Protoc 2013;8:254-64. [DOI: 10.1038/nprot.2012.157] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
563 Varum S, Momcilović O, Castro C, Ben-Yehudah A, Ramalho-Santos J, Navara CS. Enhancement of human embryonic stem cell pluripotency through inhibition of the mitochondrial respiratory chain. Stem Cell Res 2009;3:142-56. [PMID: 19716358 DOI: 10.1016/j.scr.2009.07.002] [Cited by in Crossref: 119] [Cited by in F6Publishing: 100] [Article Influence: 9.9] [Reference Citation Analysis]
564 Chen KG, Mallon BS, McKay RD, Robey PG. Human pluripotent stem cell culture: considerations for maintenance, expansion, and therapeutics. Cell Stem Cell. 2014;14:13-26. [PMID: 24388173 DOI: 10.1016/j.stem.2013.12.005] [Cited by in Crossref: 213] [Cited by in F6Publishing: 166] [Article Influence: 30.4] [Reference Citation Analysis]
565 Gossett DR, Weaver WM, Ahmed NS, Di Carlo D. Sequential array cytometry: multi-parameter imaging with a single fluorescent channel. Ann Biomed Eng 2011;39:1328-34. [PMID: 21136165 DOI: 10.1007/s10439-010-0199-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
566 Fong CY, Peh GS, Gauthaman K, Bongso A. Separation of SSEA-4 and TRA-1-60 labelled undifferentiated human embryonic stem cells from a heterogeneous cell population using magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS). Stem Cell Rev Rep 2009;5:72-80. [PMID: 19184635 DOI: 10.1007/s12015-009-9054-4] [Cited by in Crossref: 94] [Cited by in F6Publishing: 73] [Article Influence: 7.8] [Reference Citation Analysis]
567 Mori E, Fujikura J, Noguchi M, Nakao K, Matsubara M, Sone M, Taura D, Kusakabe T, Ebihara K, Tanaka T, Hosoda K, Takahashi K, Asaka I, Inagaki N. Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations. Metabolism. 2016;65:543-556. [PMID: 26975546 DOI: 10.1016/j.metabol.2015.12.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
568 Lu L, Li Y, Du MJ, Zhang C, Zhang XY, Tong HZ, Liu L, Han TL, Li WD, Yan L, Yin NB, Li HD, Zhao ZM. Characterization of a Self-renewing and Multi-potent Cell Population Isolated from Human Minor Salivary Glands. Sci Rep 2015;5:10106. [PMID: 26054627 DOI: 10.1038/srep10106] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.7] [Reference Citation Analysis]
569 de Peppo GM, Marolt D. State of the art in stem cell research: human embryonic stem cells, induced pluripotent stem cells, and transdifferentiation. J Blood Transfus 2012;2012:317632. [PMID: 24089646 DOI: 10.1155/2012/317632] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
570 Yabut O, Bernstein HS. The promise of human embryonic stem cells in aging-associated diseases. Aging (Albany NY) 2011;3:494-508. [PMID: 21566262 DOI: 10.18632/aging.100328] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
571 Yanagihara K, Liu Y, Kanie K, Takayama K, Kokunugi M, Hirata M, Fukuda T, Suga M, Nikawa H, Mizuguchi H, Kato R, Furue MK. Prediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells. Stem Cells Dev. 2016;25:1884-1897. [PMID: 27733097 DOI: 10.1089/scd.2016.0099] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
572 Borstlap J, Luong MX, Rooke HM, Aran B, Damaschun A, Elstner A, Smith KP, Stein GS, Veiga A. International stem cell registries. In Vitro Cell Dev Biol Anim. 2010;46:242-246. [PMID: 20177992 DOI: 10.1007/s11626-010-9295-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
573 Stacey G. Banking stem cells for research and clinical applications. Prog Brain Res 2012;200:41-58. [PMID: 23195414 DOI: 10.1016/B978-0-444-59575-1.00003-X] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
574 Hovatta O, Stojkovic M, Nogueira M, Varela-Nieto I. European scientific, ethical, and legal issues on human stem cell research and regenerative medicine. Stem Cells 2010;28:1005-7. [PMID: 20533567 DOI: 10.1002/stem.436] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
575 Major AG, Pitty LP, Farah CS. Cancer stem cell markers in head and neck squamous cell carcinoma. Stem Cells Int 2013;2013:319489. [PMID: 23533441 DOI: 10.1155/2013/319489] [Cited by in Crossref: 58] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
576 Shaw ML, Williams EJ, Hawes S, Saffery R. Characterisation of histone variant distribution in human embryonic stem cells by transfection of in vitro transcribed mRNA. Mol Reprod Dev 2009;76:1128-42. [PMID: 19606468 DOI: 10.1002/mrd.21077] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
577 Fujikura J, Nakao K, Sone M, Noguchi M, Mori E, Naito M, Taura D, Harada-shiba M, Kishimoto I, Watanabe A, Asaka I, Hosoda K, Nakao K. Induced pluripotent stem cells generated from diabetic patients with mitochondrial DNA A3243G mutation. Diabetologia 2012;55:1689-98. [DOI: 10.1007/s00125-012-2508-2] [Cited by in Crossref: 66] [Cited by in F6Publishing: 58] [Article Influence: 7.3] [Reference Citation Analysis]
578 Salomonis N, Dexheimer PJ, Omberg L, Schroll R, Bush S, Huo J, Schriml L, Ho Sui S, Keddache M, Mayhew C, Shanmukhappa SK, Wells J, Daily K, Hubler S, Wang Y, Zambidis E, Margolin A, Hide W, Hatzopoulos AK, Malik P, Cancelas JA, Aronow BJ, Lutzko C. Integrated Genomic Analysis of Diverse Induced Pluripotent Stem Cells from the Progenitor Cell Biology Consortium. Stem Cell Reports 2016;7:110-25. [PMID: 27293150 DOI: 10.1016/j.stemcr.2016.05.006] [Cited by in Crossref: 64] [Cited by in F6Publishing: 51] [Article Influence: 12.8] [Reference Citation Analysis]
579 Bar S, Schachter M, Eldar-geva T, Benvenisty N. Large-Scale Analysis of Loss of Imprinting in Human Pluripotent Stem Cells. Cell Reports 2017;19:957-68. [DOI: 10.1016/j.celrep.2017.04.020] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
580 Zhao W, Ji X, Zhang F, Li L, Ma L. Embryonic stem cell markers. Molecules 2012;17:6196-236. [PMID: 22634835 DOI: 10.3390/molecules17066196] [Cited by in Crossref: 111] [Cited by in F6Publishing: 86] [Article Influence: 12.3] [Reference Citation Analysis]
581 Weng MK, Zimmer B, Pöltl D, Broeg MP, Ivanova V, Gaspar JA, Sachinidis A, Wüllner U, Waldmann T, Leist M. Extensive transcriptional regulation of chromatin modifiers during human neurodevelopment. PLoS One 2012;7:e36708. [PMID: 22590590 DOI: 10.1371/journal.pone.0036708] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
582 Galan A, Diaz-Gimeno P, Poo ME, Valbuena D, Sanchez E, Ruiz V, Dopazo J, Montaner D, Conesa A, Simon C. Defining the genomic signature of totipotency and pluripotency during early human development. PLoS One 2013;8:e62135. [PMID: 23614026 DOI: 10.1371/journal.pone.0062135] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
583 Natunen S, Satomaa T, Pitkänen V, Salo H, Mikkola M, Natunen J, Otonkoski T, Valmu L. The binding specificity of the marker antibodies Tra-1-60 and Tra-1-81 reveals a novel pluripotency-associated type 1 lactosamine epitope. Glycobiology 2011;21:1125-30. [PMID: 21159783 DOI: 10.1093/glycob/cwq209] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 5.6] [Reference Citation Analysis]
584 Kibschull M, Lye SJ, Okino ST, Sarras H. Quantitative large scale gene expression profiling from human stem cell culture micro samples using multiplex pre-amplification. Syst Biol Reprod Med 2016;62:84-91. [PMID: 26237078 DOI: 10.3109/19396368.2015.1062578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
585 Zare S, Kurd S, Rostamzadeh A, Nilforoushzadeh MA. Types of Stem Cells in Regenerative Medicine: A Review. J Skin Stem Cell 2014;1. [DOI: 10.17795/jssc28471] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
586 Suga M, Kii H, Niikura K, Kiyota Y, Furue MK. Development of a Monitoring Method for Nonlabeled Human Pluripotent Stem Cell Growth by Time-Lapse Image Analysis. Stem Cells Transl Med 2015;4:720-30. [PMID: 25972146 DOI: 10.5966/sctm.2014-0242] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
587 Esmail S, Danter WR. DeepNEU: Artificially Induced Stem Cell (aiPSC) and Differentiated Skeletal Muscle Cell (aiSkMC) Simulations of Infantile Onset POMPE Disease (IOPD) for Potential Biomarker Identification and Drug Discovery. Front Cell Dev Biol. 2019;7:325. [PMID: 31867331 DOI: 10.3389/fcell.2019.00325] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
588 Kinehara M, Kawamura S, Tateyama D, Suga M, Matsumura H, Mimura S, Hirayama N, Hirata M, Uchio-Yamada K, Kohara A. Protein kinase C regulates human pluripotent stem cell self-renewal. PLoS One. 2013;8:e54122. [PMID: 23349801 DOI: 10.1371/journal.pone.0054122] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 5.9] [Reference Citation Analysis]
589 Mandal A, Bhowmik S, Patki A, Viswanathan C, Majumdar AS. Derivation, characterization, and gene expression profile of two new human ES cell lines from India. Stem Cell Res 2010;5:173-87. [PMID: 20826120 DOI: 10.1016/j.scr.2010.07.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
590 Gerlach JC, Lübberstedt M, Edsbagge J, Ring A, Hout M, Baun M, Rossberg I, Knöspel F, Peters G, Eckert K, Wulf-Goldenberg A, Björquist P, Stachelscheid H, Urbaniak T, Schatten G, Miki T, Schmelzer E, Zeilinger K. Interwoven four-compartment capillary membrane technology for three-dimensional perfusion with decentralized mass exchange to scale up embryonic stem cell culture. Cells Tissues Organs 2010;192:39-49. [PMID: 20197653 DOI: 10.1159/000291014] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
591 Isasi R, Knoppers BM, Andrews PW, Bredenoord A, Colman A, Hin LE, Hull S, Kim OJ, Lomax G, Morris C, Sipp D, Stacey G, Wahlstrom J, Zeng F; International Stem Cell Forum Ethics Working Party. Disclosure and management of research findings in stem cell research and banking: policy statement. Regen Med 2012;7:439-48. [PMID: 22594334 DOI: 10.2217/rme.12.23] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
592 Tanaka A, Woltjen K, Miyake K, Hotta A, Ikeya M, Yamamoto T, Nishino T, Shoji E, Sehara-Fujisawa A, Manabe Y, Fujii N, Hanaoka K, Era T, Yamashita S, Isobe K, Kimura E, Sakurai H. Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro. PLoS One. 2013;8:e61540. [PMID: 23626698 DOI: 10.1371/journal.pone.0061540] [Cited by in Crossref: 118] [Cited by in F6Publishing: 115] [Article Influence: 14.8] [Reference Citation Analysis]
593 Kume K, Ikeda M, Miura S, Ito K, Sato KA, Ohmori Y, Endo F, Katagiri H, Ishida K, Ito C, Iwaya T, Nishizuka SS. α-Amanitin Restrains Cancer Relapse from Drug-Tolerant Cell Subpopulations via TAF15. Sci Rep 2016;6:25895. [PMID: 27181033 DOI: 10.1038/srep25895] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 4.6] [Reference Citation Analysis]
594 Burridge PW, Thompson S, Millrod MA, Weinberg S, Yuan X, Peters A, Mahairaki V, Koliatsos VE, Tung L, Zambidis ET. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PLoS One. 2011;6:e18293. [PMID: 21494607 DOI: 10.1371/journal.pone.0018293] [Cited by in Crossref: 286] [Cited by in F6Publishing: 252] [Article Influence: 28.6] [Reference Citation Analysis]
595 Kirwan P, Jura M, Merkle FT. Generation and Characterization of Functional Human Hypothalamic Neurons. Curr Protoc Neurosci 2017;81:3.33.1-3.33.24. [PMID: 29064566 DOI: 10.1002/cpns.40] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
596 Zhang XY, Dong QG, Huang JS, Huang AM, Shi CL, Jin B, Sha HF, Feng JX, Geng Q, Zhou J. The expression of stem cell-related indicators as a prognostic factor in human lung adenocarcinoma. J Surg Oncol. 2010;102:856-862. [PMID: 20818602 DOI: 10.1002/jso.21718] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
597 Buduru SD, Gulei D, Zimta AA, Tigu AB, Cenariu D, Berindan-Neagoe I. The Potential of Different Origin Stem Cells in Modulating Oral Bone Regeneration Processes. Cells 2019;8:E29. [PMID: 30625993 DOI: 10.3390/cells8010029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
598 Jeong H, Choo S, Kim K, Hong K, Moon S, Cha H, Kim T. Conductive hybrid matrigel layer to enhance electrochemical signals of human embryonic stem cells. Sensors and Actuators B: Chemical 2017;242:224-30. [DOI: 10.1016/j.snb.2016.11.045] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
599 Ishikawa T, Kobayashi M, Yanagi S, Kato C, Takashima R, Kobayashi E, Hagiwara K, Ochiya T. Human induced hepatic lineage-oriented stem cells: autonomous specification of human iPS cells toward hepatocyte-like cells without any exogenous differentiation factors. PLoS One. 2015;10:e0123193. [PMID: 25875613 DOI: 10.1371/journal.pone.0123193] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
600 Krutá M, Šeneklová M, Raška J, Salykin A, Zerzánková L, Pešl M, Bártová E, Franek M, Baumeisterová A, Košková S, Neelsen KJ, Hampl A, Dvořák P, Rotrekl V. Mutation frequency dynamics in HPRT locus in culture-adapted human embryonic stem cells and induced pluripotent stem cells correspond to their differentiated counterparts. Stem Cells Dev 2014;23:2443-54. [PMID: 24836366 DOI: 10.1089/scd.2013.0611] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
601 Dvash T, Lavon N, Fan G. Variations of X chromosome inactivation occur in early passages of female human embryonic stem cells. PLoS One. 2010;5:e11330. [PMID: 20593031 DOI: 10.1371/journal.pone.0011330] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
602 Brosnan K, Want A, Coopman K, Hewitt CJ. Multiparameter flow cytometry for the characterization of human embryonic stem cells. Biotechnol Lett 2013;35:55-65. [DOI: 10.1007/s10529-012-1052-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
603 Wnorowski A, Yang H, Wu JC. Progress, obstacles, and limitations in the use of stem cells in organ-on-a-chip models. Adv Drug Deliv Rev 2019;140:3-11. [PMID: 29885330 DOI: 10.1016/j.addr.2018.06.001] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
604 Melo-braga MN, Meyer M, Zeng X, Larsen MR. Characterization of human neural differentiation from pluripotent stem cells using proteomics/PTMomics-Current state-of-the-art and challenges. Proteomics 2015;15:656-74. [DOI: 10.1002/pmic.201400388] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
605 Doulames VM, Plant GW. Induced Pluripotent Stem Cell Therapies for Cervical Spinal Cord Injury. Int J Mol Sci 2016;17:530. [PMID: 27070598 DOI: 10.3390/ijms17040530] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
606 Nestor MW, Noggle SA. Standardization of human stem cell pluripotency using bioinformatics. Stem Cell Res Ther 2013;4:37. [PMID: 23680084 DOI: 10.1186/scrt185] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
607 O'Brien CM, Chy HS, Zhou Q, Blumenfeld S, Lambshead JW, Liu X, Kie J, Capaldo BD, Chung TL, Adams TE, Phan T, Bentley JD, McKinstry WJ, Oliva K, McMurrick PJ, Wang YC, Rossello FJ, Lindeman GJ, Chen D, Jarde T, Clark AT, Abud HE, Visvader JE, Nefzger CM, Polo JM, Loring JF, Laslett AL. New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem Cells. Stem Cells 2017;35:626-40. [PMID: 28009074 DOI: 10.1002/stem.2558] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
608 Hunt MM, Meng G, Rancourt DE, Gates ID, Kallos MS. Factorial Experimental Design for the Culture of Human Embryonic Stem Cells as Aggregates in Stirred Suspension Bioreactors Reveals the Potential for Interaction Effects Between Bioprocess Parameters. Tissue Engineering Part C: Methods 2014;20:76-89. [DOI: 10.1089/ten.tec.2013.0040] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 6.1] [Reference Citation Analysis]
609 Gupta MK, Illich DJ, Gaarz A, Matzkies M, Nguemo F, Pfannkuche K, Liang H, Classen S, Reppel M, Schultze JL, Hescheler J, Sarić T. Global transcriptional profiles of beating clusters derived from human induced pluripotent stem cells and embryonic stem cells are highly similar. BMC Dev Biol 2010;10:98. [PMID: 20843318 DOI: 10.1186/1471-213X-10-98] [Cited by in Crossref: 57] [Cited by in F6Publishing: 40] [Article Influence: 5.2] [Reference Citation Analysis]
610 Wright AJ, Andrews PW. Surface marker antigens in the characterization of human embryonic stem cells. Stem Cell Res 2009;3:3-11. [PMID: 19398226 DOI: 10.1016/j.scr.2009.04.001] [Cited by in Crossref: 66] [Cited by in F6Publishing: 51] [Article Influence: 5.5] [Reference Citation Analysis]
611 Calloni R, Cordero EA, Henriques JA, Bonatto D. Reviewing and updating the major molecular markers for stem cells. Stem Cells Dev. 2013;22:1455-1476. [PMID: 23336433 DOI: 10.1089/scd.2012.0637] [Cited by in Crossref: 99] [Cited by in F6Publishing: 79] [Article Influence: 12.4] [Reference Citation Analysis]
612 Kumar R, Sharma A, Pattnaik AK, Varadwaj PK. Stem cells: An overview with respect to cardiovascular and renal disease. J Nat Sci Biol Med. 2010;1:43-52. [PMID: 22096336 DOI: 10.4103/0976-9668.71674] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
613 Tchieu J, Kuoy E, Chin MH, Trinh H, Patterson M, Sherman SP, Aimiuwu O, Lindgren A, Hakimian S, Zack JA, Clark AT, Pyle AD, Lowry WE, Plath K. Female human iPSCs retain an inactive X chromosome. Cell Stem Cell 2010;7:329-42. [PMID: 20727844 DOI: 10.1016/j.stem.2010.06.024] [Cited by in Crossref: 202] [Cited by in F6Publishing: 167] [Article Influence: 18.4] [Reference Citation Analysis]
614 Damjanov I, Andrews PW. Teratomas produced from human pluripotent stem cells xenografted into immunodeficient mice - a histopathology atlas. Int J Dev Biol 2016;60:337-419. [PMID: 28000905 DOI: 10.1387/ijdb.160274id] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
615 Klimanskaya I, Rosenthal N, Lanza R. Derive and conquer: sourcing and differentiating stem cells for therapeutic applications. Nat Rev Drug Discov 2008;7:131-42. [PMID: 18079756 DOI: 10.1038/nrd2403] [Cited by in Crossref: 126] [Cited by in F6Publishing: 88] [Article Influence: 9.7] [Reference Citation Analysis]
616 Kumar KK, Aboud AA, Bowman AB. The potential of induced pluripotent stem cells as a translational model for neurotoxicological risk. Neurotoxicology 2012;33:518-29. [PMID: 22330734 DOI: 10.1016/j.neuro.2012.02.005] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
617 Wang YC, Stein JW, Lynch CL, Tran HT, Lee CY, Coleman R, Hatch A, Antontsev VG, Chy HS, O'Brien CM, Murthy SK, Laslett AL, Peterson SE, Loring JF. Glycosyltransferase ST6GAL1 contributes to the regulation of pluripotency in human pluripotent stem cells. Sci Rep 2015;5:13317. [PMID: 26304831 DOI: 10.1038/srep13317] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.8] [Reference Citation Analysis]
618 Udayashankar R, Baker D, Tuckerman E, Laird S, Li TC, Moore HD. Characterization of invasive trophoblasts generated from human embryonic stem cells. Hum Reprod 2011;26:398-406. [PMID: 21163855 DOI: 10.1093/humrep/deq350] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
619 Naujok O, Burns C, Jones PM, Lenzen S. Insulin-producing surrogate β-cells from embryonic stem cells: are we there yet? Mol Ther. 2011;19:1759-1768. [PMID: 21829172 DOI: 10.1038/mt.2011.165] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
620 Murphy P, Kabir MH, Srivastava T, Mason ME, Dewi CU, Lim S, Yang A, Djordjevic D, Killingsworth MC, Ho JWK, Harman DG, O'Connor MD. Light-focusing human micro-lenses generated from pluripotent stem cells model lens development and drug-induced cataract in vitro. Development. 2018;145. [PMID: 29217756 DOI: 10.1242/dev.155838] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
621 van Diepen L, Buettner FFR, Hoffmann D, Thiesler CT, von Bohlen Und Halbach O, von Bohlen Und Halbach V, Jensen LR, Steinemann D, Edvardson S, Elpeleg O, Schambach A, Gerardy-Schahn R, Kuss AW. A patient-specific induced pluripotent stem cell model for West syndrome caused by ST3GAL3 deficiency. Eur J Hum Genet 2018;26:1773-83. [PMID: 30089820 DOI: 10.1038/s41431-018-0220-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
622 Pino-Barrio MJ, García-García E, Menéndez P, Martínez-Serrano A. V-myc immortalizes human neural stem cells in the absence of pluripotency-associated traits. PLoS One 2015;10:e0118499. [PMID: 25764185 DOI: 10.1371/journal.pone.0118499] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
623 Kim KP, Thurston A, Mummery C, Ward-van Oostwaard D, Priddle H, Allegrucci C, Denning C, Young L. Gene-specific vulnerability to imprinting variability in human embryonic stem cell lines. Genome Res 2007;17:1731-42. [PMID: 17989250 DOI: 10.1101/gr.6609207] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 5.0] [Reference Citation Analysis]
624 Guo G, von Meyenn F, Santos F, Chen Y, Reik W, Bertone P, Smith A, Nichols J. Naive Pluripotent Stem Cells Derived Directly from Isolated Cells of the Human Inner Cell Mass. Stem Cell Reports. 2016;6:437-446. [PMID: 26947977 DOI: 10.1016/j.stemcr.2016.02.005] [Cited by in Crossref: 204] [Cited by in F6Publishing: 153] [Article Influence: 40.8] [Reference Citation Analysis]
625 Huang CC, Pelaez D, Bendala JD, Garcia-godoy F, Cheung HS. Plasticity of stem cells derived from adult periodontal ligament. Regenerative Medicine 2009;4:809-21. [DOI: 10.2217/rme.09.55] [Cited by in Crossref: 96] [Cited by in F6Publishing: 73] [Article Influence: 8.0] [Reference Citation Analysis]
626 Rehakova D, Souralova T, Koutna I. Clinical-Grade Human Pluripotent Stem Cells for Cell Therapy: Characterization Strategy. IJMS 2020;21:2435. [DOI: 10.3390/ijms21072435] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
627 Tian R, Wang S, Elisma F, Li L, Zhou H, Wang L, Figeys D. Rare cell proteomic reactor applied to stable isotope labeling by amino acids in cell culture (SILAC)-based quantitative proteomics study of human embryonic stem cell differentiation. Mol Cell Proteomics 2011;10:M110.000679. [PMID: 20530636 DOI: 10.1074/mcp.M110.000679] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
628 Stavish D, Böiers C, Price C, Frith TJR, Halliwell J, Saldaña-Guerrero I, Wray J, Brown J, Carr J, James C, Barbaric I, Andrews PW, Enver T. Generation and trapping of a mesoderm biased state of human pluripotency. Nat Commun 2020;11:4989. [PMID: 33020476 DOI: 10.1038/s41467-020-18727-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
629 Takeda-Kawaguchi T, Sugiyama K, Chikusa S, Iida K, Aoki H, Tamaoki N, Hatakeyama D, Kunisada T, Shibata T, Fusaki N, Tezuka K. Derivation of iPSCs after culture of human dental pulp cells under defined conditions. PLoS One 2014;9:e115392. [PMID: 25521610 DOI: 10.1371/journal.pone.0115392] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
630 Kopyov A, Uhlendorf TL, Cohen RW. Why use pre-differentiated cells to address complex multi-factorial neurodegenerative diseases? Neural Regen Res 2021;16:1413-4. [PMID: 33318432 DOI: 10.4103/1673-5374.300990] [Reference Citation Analysis]
631 Lees JG, Rathjen J, Sheedy JR, Gardner DK, Harvey AJ. Distinct profiles of human embryonic stem cell metabolism and mitochondria identified by oxygen. Reproduction 2015;150:367-82. [PMID: 26159831 DOI: 10.1530/REP-14-0633] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
632 White JM, Kuda-Wedagedara AN, Wicker MN, Spratt DE, Schopperle WM, Heath E, Viola NT. Detecting TRA-1-60 in Cancer via a Novel Zr-89 Labeled ImmunoPET Imaging Agent. Mol Pharm 2020;17:1139-47. [PMID: 32069422 DOI: 10.1021/acs.molpharmaceut.9b01181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
633 Bouma MJ, van Iterson M, Janssen B, Mummery CL, Salvatori DCF, Freund C. Differentiation-Defective Human Induced Pluripotent Stem Cells Reveal Strengths and Limitations of the Teratoma Assay and In Vitro Pluripotency Assays. Stem Cell Reports. 2017;8:1340-1353. [PMID: 28494940 DOI: 10.1016/j.stemcr.2017.03.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 6.7] [Reference Citation Analysis]
634 Konze SA, van Diepen L, Schröder A, Olmer R, Möller H, Pich A, Weißmann R, Kuss AW, Zweigerdt R, Buettner FF. Cleavage of E-cadherin and β-catenin by calpain affects Wnt signaling and spheroid formation in suspension cultures of human pluripotent stem cells. Mol Cell Proteomics 2014;13:990-1007. [PMID: 24482122 DOI: 10.1074/mcp.M113.033423] [Cited by in Crossref: 40] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
635 Glotzbach JP, Wong VW, Gurtner GC, Longaker MT. Regenerative medicine. Curr Probl Surg 2011;48:148-212. [PMID: 21295632 DOI: 10.1067/j.cpsurg.2010.11.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
636 Hannan NR, Wolvetang EJ. Adipocyte differentiation in human embryonic stem cells transduced with Oct4 shRNA lentivirus. Stem Cells Dev 2009;18:653-60. [PMID: 18764734 DOI: 10.1089/scd.2008.0160] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
637 Edwards RG. From embryonic stem cells to blastema and MRL mice. Reprod Biomed Online 2008;16:425-61. [PMID: 18339268 DOI: 10.1016/s1472-6483(10)60605-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
638 King FW, Liszewski W, Ritner C, Bernstein HS. High-throughput tracking of pluripotent human embryonic stem cells with dual fluorescence resonance energy transfer molecular beacons. Stem Cells Dev 2011;20:475-84. [PMID: 20624034 DOI: 10.1089/scd.2010.0219] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
639 Luk ST, Ng KY, Zhou L, Tong M, Wong TL, Yu H, Lo CM, Man K, Guan XY, Lee TK, Ma S. Deficiency in Embryonic Stem Cell Marker Reduced Expression 1 Activates Mitogen-Activated Protein Kinase Kinase 6-Dependent p38 Mitogen-Activated Protein Kinase Signaling to Drive Hepatocarcinogenesis. Hepatology 2020;72:183-97. [PMID: 31680287 DOI: 10.1002/hep.31020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
640 Hielscher D, Kaebisch C, Braun BJV, Gray K, Tobiasch E. Stem Cell Sources and Graft Material for Vascular Tissue Engineering. Stem Cell Rev and Rep 2018;14:642-67. [DOI: 10.1007/s12015-018-9825-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
641 Hentze H, Soong PL, Wang ST, Phillips BW, Putti TC, Dunn NR. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies. Stem Cell Res. 2009;2:198-210. [PMID: 19393593 DOI: 10.1016/j.scr.2009.02.002] [Cited by in Crossref: 287] [Cited by in F6Publishing: 230] [Article Influence: 23.9] [Reference Citation Analysis]
642 Patel SN, Wu Y, Bao Y, Mancebo R, Au-young J, Grigorenko E. TaqMan® OpenArray® High-Throughput Transcriptional Analysis of Human Embryonic and Induced Pluripotent Stem Cells. In: Lakshmipathy U, Vemuri MC, editors. Pluripotent Stem Cells. Totowa: Humana Press; 2013. pp. 191-201. [DOI: 10.1007/978-1-62703-348-0_15] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
643 Mandenius C, Steel D, Noor F, Meyer T, Heinzle E, Asp J, Arain S, Kraushaar U, Bremer S, Class R, Sartipy P. Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review: Cardiotoxicity testing using derived stem cells. J Appl Toxicol 2011;31:191-205. [DOI: 10.1002/jat.1663] [Cited by in Crossref: 62] [Cited by in F6Publishing: 41] [Article Influence: 6.2] [Reference Citation Analysis]
644 Lowry WE, Richter L, Yachechko R, Pyle AD, Tchieu J, Sridharan R, Clark AT, Plath K. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci USA. 2008;105:2883-2888. [PMID: 18287077 DOI: 10.1073/pnas.0711983105] [Cited by in Crossref: 735] [Cited by in F6Publishing: 640] [Article Influence: 56.5] [Reference Citation Analysis]
645 Hernandez D, Ruban L, Mason C. Feeder-Free Culture of Human Embryonic Stem Cells for Scalable Expansion in a Reproducible Manner. Stem Cells and Development 2011;20:1089-98. [DOI: 10.1089/scd.2009.0507] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]